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ABSTRACT OF THE DISSERTATION

Dynamic Characterization of the IKK:INBD:NF-NB Negative Feedback Loop
Using Real-Time Bioluminescence Imaging
by
Britney Lane Moss
Doctor of Philosophy in Molecular Cell Biology
Washington University in St Louis, 2011
Dr. David Piwnica-Worms, Chairperson

The transcription factor NF-NB is a pivotal regulator of mammalian cell
function, modulating genes implicated in cellular stress responses, proliferation,
differentiation, cell survival and apoptosis, as well as immune and inflammatory
responses. Improper regulation of NF-NB signaling has been implicated in a myriad of
human pathological disorders, including cardiovascular and neurodegenerative diseases,
chronic inflammation, and various cancers. A key regulatory node within canonical NFN%signaling is the IKK:NF-N%:,N%D negative feedback loop that plays a major role in
regulating the strength and duration of NF-N%transcriptional activity.

We have

developed and characterized an unique bioluminescent reporter (N%o,N%D-FLuc) that
recapitulates this transcriptionally coupled negative feedback loop, and have extensively
utilized this reporter to interrogate how diverse stimuli (i.e., ligand type, duration,
concentration, sequential stimulation, etc.) impact the IKK:NF-N%:,N%D negative
feedback loop in cellulo and in vivo. We found that the negative feedback loop
ii

exhibits differential and reproducible dynamic patterns in response to modulation of
TNFĮ concentration or pulse duration, and that responses to TNFĮ exhibited a
remarkable degree of synchronicity at the level of single cells, cell populations, and in
vivo. Furthermore, we discovered a TNFĮ–induced transient refractory period (lasting
up to 120 min) during which cells were unable to fully degrade ,N%Dfollowing a
second TNFĮ challenge, and identified nuclear export of NF-N%:,N%D complexes as a
rate-limiting step that may impact this refractory period. A high-throughput RNAi
screen to identify new phosphatase and kinase regulators of TNFĮ-induced IKK:NFN%:,N%D negative feedback loop dynamics revealed a vast array of different IțBĮ-FLuc
dynamic profiles, highlighting the large number and diverse activities of kinases and
phosphatases regulating the NF-țB pathway. Two of these hits, PTPRJ and DAPK3,
have been validated and are the subjects of current investigations to understand the
physiological and/or pathophysiological relevance in NF-țB, especially in the context
of TNFĮ signaling during cancer and inflammation in the liver. In conclusion, our
studies using dynamic, real-time bioluminescence imaging have demonstrated the utility
of employing bioluminescent reporters alongside traditional biochemical assays, in
silico modeling, and cell/molecular biology techniques to rigorously interrogate how
diverse stimuli impact the IKK:NF-N%:,N%D negative feedback loop in single cells, cell
populations, and at the organ- and tissue-level in vivo.
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CHAPTER ONE
Introduction

The transcription factor NF-NB is a pivotal regulator of mammalian cell function,
modulating genes implicated in cellular stress responses, proliferation, differentiation, cell
survival and apoptosis, as well as immune and inflammatory responses [1]. Improper regulation
of NF-NB signaling has been implicated in a myriad of human pathological disorders, including
chronic inflammation, various cancers, as well as cardiovascular and neurodegenerative diseases
[2, 3]. In recent years, bioluminescence imaging has proven an invaluable tool to probe the
complex dynamics of NF-NB signaling both in vitro and in vivo.

1.1

NF-NB SIGNALING : A HISTORICAL PERSPECTIVE
The NF-NB transcription factor was originally identified by Sen and Baltimore as a

protein bound only to the k light-chain enhancer DNA at the sequence GGGACTTTCC and was
called NF-NB because it was a nuclear factor that bound selectively to the k enhancer and was
originally found in extracts of B-cell tumors but not other cell lines [4, 5]. Soon after they also
showed that NF-NB is a factor that pre-exists in an apparently inhibited state, is released from that
inhibition by LPS treatment, and that inhibited NF-NB is not specific to B-lineage cells as it was
evident in T cells and even HeLa cells [6]. Furthermore, work in the Baltimore lab established
that the inactive form of NF-NB is in the cytoplasm and can be liberated from its inhibited form
by treatment of cytoplasmic extracts with a detergent [7]. This discovery led to purification of the
1

inhibitor, which was named INB [8]. Years of intense research that followed demonstrated that
NF-NB is expressed in almost all cell types and tissues, and specific NF-NB binding sites are
present in the promoters/enhancers of a large number of genes, especially those involved in
inflammation, innate immune responses, adaptive immune responses, secondary lymphoid organ
development and osteoclastogenesis [9, 10]. Concurrent to the discovery and elucidation of NFNB transcription factors and NF-NB signaling pathways, other researchers were investigating two
proteins, v-Rel and Dorsal, that also exhibited variable nucleo-cytoplasmic subcellular
localization. Along with NF-NB, these proteins were eventually recognized as members of the
same family, and the biological processes investigated in these original studies – immunity (NFNB), oncogenesis (v-Rel), and development (Dorsal) –continue to be areas that provoke much of
the interest in NF-NB [11].

1.2

CANONICAL NF-NB SIGNALING & THE IKK:INBD:NF-NB NEGATIVE

FEEDBACK LOOP
The vertebrate NF-NB transcription factor family consists of five members: p50/p105,
p52/p100, c-Rel, RelA (aka p65), and RelB; different NF-NB complexes are formed from homoand heterodimers of these family members [12].

These proteins are related via a highly

conserved N-terminal DNA binding/dimerization domain called the Rel homology domain
(RHD) and bind to 9-10 base pair DNA sites (NB sites) which have a remarkably loose consensus
sequence (5'-GGGRNWYYCC-3'; R, A or G; N, any nucleotide; W, A or T; Y, C or T) [13]. The
vertebrate NF-NB family proteins can form both homo- and heterodimers in vivo, except for RelB
which only forms homodimers in vivo. Interestingly, use of cell lines null for various NF-NB
family members has shown that there is little correlation between the sequence of the NB DNA2

binding site and the function/subunit specificity of NF-NB dimers, indicating that NF-NB family
member specificity for endogenous promoters is not solely encoded by the NB site sequence itself
[14].
NF-NB transcription factors are rapidly activated in response to numerous stimuli
allowing quick regulation of a few hundred genes [15-17] that can be divided into four major
families [2, 17]: (1) pro-inflammatory genes (e.g., COX 2, IL-1, TNFD iNOS, ICAM-1, Eselectin, etc.), (2) pro-proliferative genes (e.g., Cyclin D, c-Myc), (3) anti-apoptotic genes (Bcl2,
BclXL, xIAPs, cIAPs), and (4) auto-inhibitory genes (e.g., A20, CYLD, SOCS-1 and INBD). This
rapid response system requires the sequestration of NF-NB dimers in the cytoplasm through
interaction with inhibitory INB proteins. As with the NF-NB transcription factors, there are
several INB proteins (INBĮ, INBȕ, BCL-3, INBİ, INBȜ, and the NF-NB precursor proteins p100
and p105) that are characterized by five to seven ankyrin repeats that assemble into long cylinders
capable of interacting with the nuclear localization signal (NLS) of the given NF-NB dimer and of
interfering with sequences involved in DNA binding [13, 18]. For INBĮ, this NLS masking is
only partially effective and thus NF-NB–INBĮ complexes shuttle into the nucleus even in the
absence of cellular stimulation; however, INBĮ also contains a nuclear export sequence (NES),
which causes the rapid export of NF-NB–INBĮ complexes back to the cytoplasm, resulting in
steady state population within the cytosol [19-21].
In resting cells, NF-NB dimers are sequestered in the cytoplasm through binding to
isoforms of the INB family. Canonical activation of NF-NB (Fig 1.1) relies on ligand-dependent
stimulation of IKK, a large heterotrimeric kinase complex containing two catalytic subunits
(IKKD and IKKE) and a regulatory subunit (IKKJ, NEMO) [20, 22]. Many different surface
receptors signal to IKK through multiprotein complexes containing TRAFs (TNF receptor
3

associated factors which seem to serve as adaptors and may mediate K63-linked regulatory
ubiquitination events) and a multitude of other adaptor proteins (with specific receptors
interacting with specific subsets of TRAFs and other adaptors; Fig 1.1) that recruit and activate
the IKK complex [22, 23].

Activation of IKK requires phosphorylation of T loop serines,

however, the precise mechanism by which this occurs (trans-autophosphorylation or through
phosphorylation by an upstream kinase) remains a major unanswered question, and adaptor
protein mediated multimerization also seems to significantly contribute to IKK activation [23].
Upon activation, IKK phosphorylates IN%D (on Ser 32/36), thus rendering INBD a substrate for
poly-ubiquitination and proteasomal degradation. This series of events releases NF-NB to freely
translocate to the nucleus where it can modulate expression of its target genes, including INBD,
thus forming a transcriptionally-coupled negative feedback loop [24]. This newly synthesized
INBD enters the nucleus and binds to NF-NB which dissociates from the DNA and the complex
translocates back to the cytoplasm [24-26], and, along with the activity of INBİ, drive NF-NB
nuclear:cytoplasmic oscillations [24, 27, 28]. Thus, this negative feedback loop plays a major role
in regulating the strength and duration of NF-NB transcriptional activity [29-32]. With respect to
the negative feedback, other transcriptionally-independent processes, aimed at auto-inhibition of
NF-NB activity, do exist. Such mechanisms down-regulate NF-NB signaling on a much shorter
timeframe (sec-min). These include homologous receptor desensitization [33, 34], asymmetric
heterologous

receptor

desensitization

[34,

35],

autocatalytic

C-terminal

IKK

hyperphosphorylation [36] and protein phosphatase 2E (PP2E)-dependent dephosphorylation of
IKK [37].

4

1.3

CLINICAL RELEVANCE OF NF-NB SIGNALING IN THE LIVER
NF-NB is well established as a regulator of a large number of genes involved in the

different aspects of oncogenesis defined by Hanahan and Weinberg [38], and in the last few
years, constitutive activation of NF-NB has been causally linked to liver neoplastic progression
via the transcriptional activation of genes involved in oncogenesis (reviewed in [39]).

In

hepatocytes, inappropriate and persistent NF-NB activation can occur as a result of viral infection,
carcinogen exposure, growth factor stimulation, and chronic inflammation (which can result from
viral hepatitis and eventually lead to cirrhosis and hepatocellular carcinoma (HCC) development).
Furthermore, it has been posited that chronic inflammation may actually account for
approximately 20% of all human cancers [40].

Because NF-NB is a central regulator of

inflammatory processes, it has been proposed that NF-NB activation during inflammation may
represent a mechanism of protection against pro-apoptotic signals from the immune system [4143].

To this end, Pikarsky and colleagues employed an Mdr2-knockout mouse model of

hepatitis-induced HCC formation to show that the inflammatory process triggered hepatocyte NFNB activation through upregulation of TNFD in adjacent endothelial and inflammatory cells [43].
They further found that suppressing NF-NB through anti-TNFD therapy or induction of an INBsuperrepressor during the late stages of tumor development induced apoptosis and blocked
progression of HCC. However, recent mouse models utilizing an inducible, hepatocyte-specific
NEMO knockout have indicated that loss of NF-NB activity can actually promote HCC tumor
development [41, 44], showing increased rates of both apoptosis and proliferation. Thus, a more
in-depth understanding of the complexities and intricacies of NF-NB signaling in the liver is
required to appropriately translate the use of NF-NB-targeted therapeutics to liver pathologies.

5

1.4

THE NF-NB SIGNALING PATHWAY AS AN EXEMPLARY PROVING

GROUND FOR SYSTEMS BIOLOGY APPROACHES IN MAMMALIAN CELLS
Cells have evolved complex molecular networks to sense cues from the environment and
transmit them throughout the cell to elicit appropriate biological responses. These signaling
pathways require certain elemental properties (such as sensitivity, reversibility, a capacity to be
regulated, and robustness) that are crucial to reliably maintaining the organization and function of
cells within organisms. In addition, these networks equip cells with the ability to distinguish
often weak signals from background noise with high precision and selectivity [45, 46]. These
molecular networks are made up of sets of recurring regulation patterns, network motifs, that link
together in a variety of combinations to create a web of connectivity within a given signaling
cascade or between multiple cascades [47].

Feedback loops, processes that connect output

signals back to their input, represent one of the most frequently observed biological network
motifs and are now appreciated as a useful framework for understanding how signaling networks
elicit specific cellular responses. In particular, negative feedback loops, defined as sequential
regulatory steps that feed the output signal (inverted) back to the input, represent a single motif
that is capable of generating many distinct signaling functions, including stabilizing basal
signaling levels, limiting maximal signaling output, enabling adaptive response, and creating
transient signal responses [46].
In the past, much of the work elucidating these complex molecular networks focused on
identifying the key molecules within the network and biochemically defining their individual
interactions [45, 48]. Additionally, the techniques typically employed to define these networks
were static, destructive, semi-quantitative, in vitro biochemical methodologies that lack
spatiotemporal resolution and average information from a large number of cells. Recently, the
focus of attention is shifting towards experimental and computational modeling approaches that
6

address the question of how biological networks operate as a system to perform biological
functions, specifically within the context of a single cell. Recent developments in optical imaging
and biophysical methods have enabled significant advances in the ability to capture
spatiotemporal signaling information in a single cell, leading to the development and refinement
of mathematical and dynamical models of molecular networks [49].
One cellular signaling pathway that has emerged as an exemplary illustration of how
molecular network topology can be probed through the coupled use of live-cell imaging and
computational simulation is the NF-țB pathway. Because of its biological importance, the NFțB pathway has been extensively studied and has emerged as an exemplary proving ground for
systems biology approaches that couple computational modeling and cellular imaging with
conventional cell biology methods to study dynamic NFN% responses to cytokines.
Recent studies have shown that continuous stimulation or sequential pulsing of TNFĮ can
induce oscillations in NFN% nuclear translocation that are dependent upon cycles of degradation
and re-synthesis of INB proteins (i.e., negative feedback loops), and that the frequency of these
NFN% oscillations encode distinct gene expression profiles [27, 28, 31, 50, 51]. Additional
work has suggested that the amplitude of NFN% activity, but not the temporal profile, is
particularly sensitive to changes in TNFĮ concentration and is crucially dependent on the
transient nature of IKK activity [52]. Recently, single cell imaging has emerged as a paradigmof-choice to study the dynamics of NFN% nuclear localization as monitored by
nuclear:cytoplasmic shuttling of NFN% proteins fused to fluorescent protein reporters. Coupled
with computational modeling, these single cell studies have revealed stochastic, heterogeneous,
and paracrine NFN% responses at the single cell level, especially in response to low
concentrations of TNFĮ [53-56]. A key unresolved issue in the field relates to how biological
robustness is achieved within cell populations displaying heterogeneous and dynamic single-cell
7

behavior [49, 55, 56], and the physiologic relevancy of these single-cell phenomena to tissue- and
organ-level biological responses in vivo. And if these asynchronous and oscillatory NF-țB
signaling behaviors are relevant in vivo, what impact do they have on responses to chronic and/or
acute waves of TNFĮ (or a variety of other cytokines), and what are the implications for
therapeutic targeting of NF-țB? As has been posited by others [57], “…it may be necessary to
develop a new generation of biomarkers that predict ‘‘healthy” asynchronised oscillatory NF-țB
activity versus ‘‘unhealthy” synchronised oscillatory NF-țB. Distinguishing between these
variables may enable us to effectively target NF-țB to promote resolution of inammation and
wound-healing in the context of ongoing injury.”

1.5

BIOLUMINESCENCE IMAGING AND THE NF-NB PATHWAY
One goal of molecular imaging is to advance the understanding of biology and medicine

through noninvasive in vivo investigation of the cellular and molecular events mediating normal
physiology and pathologic processes [58, 59]. While some aspects of molecular imaging relate to
clinical applications, a great deal of basic research is performed with cellular and animal models
of development, normal physiology, and disease. In practice, molecular imaging can complement
and, in some cases, replace conventional laboratory techniques. Routinely used methodologies in
the laboratory and in vitro settings are based on destructive sampling of cells or tissues which
yield only a static snapshot at a given experimental endpoint.

New molecular imaging

technologies now allow for noninvasive, repetitive, real-time in vivo imaging of dynamic
biological processes.
One of these molecular imaging strategies, genetically-encoded imaging reporters, can be
introduced into cells and transgenic animals to enable noninvasive, longitudinal studies of
8

dynamic biological processes in intact cells and living animals [58, 59]. These reporters can
produce signal intrinsically (e.g., fluorescent proteins), through enzymatic activation of an
inactive substrate (luciferases), by enzymatic modification of an imagable (e.g., optical) substrate
with selective retention in reporter cells, or by direct binding or import of an active (e.g.,
radiolabeled) reporter substrate or probe. Except in the context of gene therapy, geneticallyencoded reporters are less likely to be used in humans, but possess a fundamental advantage in
basic and pre-clinical research in that once validated, a single genetically-encoded reporter can
theoretically be cloned into a variety of vectors to interrogate a broad array of regulatory
pathways. Compared to injectable radiopharmaceuticals, for example, this eliminates constraints
inherent to traditional routes of synthesizing, labeling and validating a new and different
radioligand for every new receptor or protein of interest.
The most common reporters include firefly luciferase (bioluminescence imaging), green
fluorescence protein (fluorescence imaging), transferrin receptor (magnetic resonance imaging),
Herpes Simplex Virus-1 thymidine kinase (positron emission tomography) and variants with
enhanced spectral and kinetic properties optimized for use in vivo [58, 60]. When cloned into
promoter/enhancer sequences or engineered into fusion proteins, imaging reporters enable
fundamental processes such as transcriptional regulation, signal transduction cascades, proteinprotein interactions, protein degradation, oncogenic transformation, cell trafficking and targeted
drug action to be temporally and spatially recorded in vivo. Ideally, the magnitude and time
course of reporter gene activity should parallel the strength and duration of endogenous target
gene expression. Genetically-encoded imaging reporters also provide the potential for a stable
source of signal enabling longitudinal studies in living organisms with high temporal and, in
some cases, high spatial resolution.

9

Bioluminescence imaging (BLI) assays rely on the use of luciferase enzymes that
catalyze the oxidation of a specific substrate, luciferin, into an oxyluciferin (in the presence of
molecular oxygen and ATP), with the concurrent emission of one photon of light [61]. There are
many naturally-occurring luciferases with matching substrates available, though most are
blue/green and therefore less suitable for deep tissue imaging. The luciferases that have been
found to be most useful for molecular imaging are firefly luciferase (550-570 nm peak emission),
Renilla luciferase (480 nm), green or red click beetle luciferases (537 nm, 613 nm) and Gaussia
luciferase (460 nm) [62-65]. Nonetheless, the favorable attributes of luciferin-based imaging
provide a versatile platform for studying biology in vivo.
BLI of luciferase reporters provides a relatively simple, robust, and cost-effective means
to image fundamental biological processes in live cells and in vivo.

Luciferases exhibit

exceptionally high signal-to-noise levels (almost no background noise sources exist, save for
food-derived phosphorescence), provide an extremely quantitative read-out, are active
immediately after translation (a favorable property as compared to many fluorescent proteins),
and have a relatively short half-life (t1/2

3–6 h, and even shorter when artificially modified with

degradation sequences) allowing for dynamic measurements with high temporal sensitivity [66].
Nevertheless, bioluminescence remains dependent on substrate pharmacokinetics, except in the
case of bacterial lux operons, and relies upon ultrasensitive CCD cameras for detection due to the
extremely dim light out of luciferases. BLI has also traditionally been subject to restricted spatial
resolution, but recent advances in low-light microscopy are enabling microscopic analysis of
bioluminescent reporters in single cells and sub-cellular compartments [49, 59, 67-69], making it
possible to use a single bioluminescent reporter for microscopic and macroscopic studies.
In particular, BLI has proven useful to study NF-N% transcriptional activity in vivo.
Recently, a transgenic mouse expressing a luciferase driven by an NF-N% responsive promoter
10

has been used to examine prostate NF-N% activity in response to acute and chronic cytokine
exposure [70], an approach that may be amenable to the in vivo study of pharmacological NF-N%
modulators. In another study, Ma et al used NF-N%-Luc mice as donors or recipients in mouse
models of cardiac transplantation and tissue ischemia-reperfusion injury (IRI) [71]. They showed
elevated NF-N% activity in both the cardiac allografts and the IRI cardiac grafts, and used mAbs
and ligands to examine inhibition of NF-N% signaling in vivo.
Imaging post-transcriptional events in the NF-N% signaling pathways, such as
translational regulation, protein-protein interactions (PPI), protein processing or protein
degradation, can be accomplished by fusing the reporter gene to the protein of interest, thereby
generating a molecular sensor that activates (or deactivates) the reporter in response to a given
protein interaction or modification. For example, we have previously shown that an INBD-firefly
luciferase (INBD-FLuc) fusion reporter driven by a constitutive CMV promoter enables
quantitative monitoring of INBD degradation (which can be directly correlated to IKK activity)
and can be used in cultured cells to provide a continuous, noninvasive readout of the kinetics and
dynamics of ligand-induced IKK activation [72]. This reporter was additionally used in vivo to
monitor the real-time activity of IKK in response to LPS-mediated activation. Applying this
approach to a tumor xenograft model expressing the ,N%D-FLuc fusion reporter, robust time- and
dose-dependent pharmacodynamic characterization of a novel IKK inhibitor (PS-1145) was
characterized using a minimal number of animals. Thus, bioluminescence imaging provides a
unique toolkit that is well-suited to rigorously interrogate the real-time dynamics of NF-N%
signaling in live cells and live animals.

11

1.6

FIGURES

Figure 1.1: Activation of Canonical NF-țB Signaling by TNF-Į. Binding of homotrimeric
TNFĮ ligands drives trimerization of TNF-R1 and results in TRADD-dependent TRAF2 and
RIP1 recruitment. TRAF2 mediates K63-linked ubiquitination of RIP1 and recruits the IKK
complex via the catalytic subunit NEMO. Autoubiquitination of TRAF2 causes TAK1 activation
by interaction via TAB2/3. In consequence, TAK1 phosphorylates and activates IKKȕ (IKK2),
which in turn phosphorylates IțBĮ, leading to proteasomal degradation and release of NF-țB
which can then translocate into the nucleus and modulate transcription. Modified from Vucur, et
al [73].
12
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CHAPTER TWO
Identification of a Ligand-Induced Transient Refractory
Period in Nuclear Factor-țB Signaling

2.1

INTRODUCTION
Adequate resolution of an inflammatory reaction is as equally important as

initiation. Persistent or fulminant responses can cause detrimental consequences both
locally and systemically [1], and resolution of inflammation is important for both
termination of an acute response as well as for prevention of destructive chronic
responses. It is therefore not surprising that mechanisms aimed at rapid and specific
initiation of pro-inflammatory reactions have co-evolved with mechanisms that provide
timely termination of such processes. From a systems biology perspective, such
“switchability” can be achieved by intracellular feedback loops that permit ligandinduced desensitization and re-sensitization of pro-inflammatory signaling cascades [2].
In this regard, recent studies have shown that nuclear factor-NB (NF-NB)
signaling plays a critical role in both initiation and resolution of inflammation [2, 3]. The
transcription factor NF-NB is a key regulator of innate and adaptive immune responses, as
well as a mediator of cell survival and proliferation [4]. Improper regulation of NF-NB
contributes to induction and progression of a wide range of human disorders, including a
variety of pathological inflammatory conditions, neurodegenerative diseases as well as
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many types of cancer [5, 6]. In resting cells, inactive NF-NB is sequestered in the
cytoplasm by binding to members of the inhibitor of NF-NB (INB) family. Canonical
activation of NF-NB depends on INB kinase (IKK)-regulated proteasomal degradation of
INBD, an event that frees NF-NB for nuclear translocation within minutes [4, 7]. Upon
nuclear transport, NF-NB regulates the transcription of a few hundred genes [8-10] that
can be divided into four major families [10, 11]: (1) pro-inflammatory genes (e.g., COX 2,
IL-1, TNFD iNOS, ICAM-1, E-selectin, etc.), (2) pro-proliferative genes (e.g., Cyclin D,
c-Myc), (3) anti-apoptotic genes (Bcl2, BclXL, xIAPs, cIAPs), and (4) auto-inhibitory
genes (e.g., A20, CYLD, SOCS-1 and INBD).
With respect to the latter, other transcriptionally-independent processes, aimed at
auto-inhibition of NF-NB activity, do exist. Such mechanisms down-regulate NF-NB
signaling on a much shorter timeframe (sec-min). These include homologous receptor
desensitization [12, 13], asymmetric heterologous receptor desensitization [13, 14],
autocatalytic C-terminal IKK hyperphosphorylation [15] and protein phosphatase 2E
(PP2E)-dependent dephosphorylation of IKK [16].
Considering the complex nature of the inflammatory milieu, one would expect
that stationary tissue-residing cells are exposed to a myriad of temporally-distinct NFNB-stimulating cues. For instance, cells can be directly stimulated by pathogen-derived
products (e.g., LPS through TLR4 receptors [17]), exposed to numerous soluble proinflammatory stimuli produced by circulating effector cells (e.g., cytokines, chemokines,
etc.), and/or experience inflammation-induced oxidative stress [18]. These signals can
occur simultaneously or sequentially to one another. For example, systemic
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administration of bacterial LPS to mice was shown to induce transient production of
TNFD (serum levels peaking at ~1.5 h and quickly returning to baseline), but IL-1E
production was delayed and prolonged (first detected at 2 h, but lasting >5-6 h) [19].
Thus, cells co-expressing TLR4, IL-1 and TNFD receptors would sequentially interrogate
signals arising from LPS, TNFD and IL-1Eeach of which could independently activate
NF-NB.
Central to any signaling desensitization mechanism is a refractory period during
which cells cannot fully respond to a second insult (autologous or heterologous
desensitization). Therefore, consideration of the dynamic pattern of stimulus exposure
described above begs the immediate question of whether cells can instantly initiate an
NF-NB response to a second activating stimulus, and if not, when will such cells be able
to remount a full response again? Specifically, are ligand-preconditioned cells capable of
eliciting NF-NB activation to the same extent as naïve cells?
Little is known about the capacity of cells to activate NF-NB in response to a
second activating challenge since the highly dynamic nature of this process presents
many technical difficulties. These include low temporal resolution of conventional
transcriptionally-dependent NF-NB reporter gene assays, low throughput, inability to
acquire longitudinal data and the semi-quantitative nature of traditional biochemical
assays (e.g., EMSA, immunoblotting, etc.). Such limitations render these assays
incapable of accurate analysis of the early, ligand-induced dynamic changes in the
capacity of cells to elicit a response to a second challenge.
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To efficiently address this question, we generated an improved, transcriptionallycoupled version of a previously published genetically-encoded INBD-firefly luciferase
(INBD-FLuc) fusion reporter [20] in conjunction with dynamic, live-cell bioluminescence
imaging of cultured cells. We chose to focus on HepG2 human hepatoma cells as a model
system because, (1) NF-NB signaling has been extensively studied in these cells, (2)
HepG2 cells have been shown to activate NF-NB in response to a variety of proinflammatory ligands [21], (3) these cells can be easily transfected with readily-available
reagents, and most importantly, (4) the pivotal role that NF-NB signaling plays in
hepatocytes to regulate inflammation, apoptosis and carcinogenesis [22].
Using bioluminescence imaging of live cells in conjunction with a variety of
biochemical assays, we demonstrate herein that a 30 sec preconditioning exposure to
TNFD is sufficient to robustly activate IKK, culminating in INBD degradation, NF-NB
nuclear translocation, and strong transcriptional up-regulation of INBD. Furthermore, the
capacity of preconditioned cells to degrade INBD in response to a second TNFD challenge
is transiently refractory, regaining full responsiveness approximately 120 min later.
Finally, both IKK regulation and possibly NF-NB nuclear export, but not receptor
dynamics, govern this transient refractory period. This study highlights the interlocking
layers of NF-NB regulation, ensuring efficient and timely propagation as well as
termination of pro-inflammatory signals.

20

2.2

RESULTS

Real-time

bioluminescence

imaging

of

pNB5ĺINBD-FLuc-expressing

cells

recapitulated IKK-induced dynamics of endogenous INBD. To monitor ligand-induced
INBD rapid dynamics as well as physiologic transcriptionally-coupled behavior, we
modified our previous INBD-FLuc fusion reporter [20] to be driven by a synthetic
promoter comprised of 5 tandem NB response elements (TGGGGACTTTCCGC)
followed by a minimal TATA-box. We hypothesized that this reporter would allow
quantitative measurements of IKK-induced degradation as well as NF-NB-induced resynthesis and post-translational stabilization of INBD from intact living cells (Fig. 2.1A).
To validate use of this reporter, HepG2 cells were transiently transfected with a plasmid
encoding the reporter and allowed to recover for two days before stimulation with a
continuous or 30 sec pulse of TNFD (20 ng/mL) to induce IKK activation. Upon addition
of TNFD, a rapid and dramatic decrease in bioluminescence was observed when readouts
were normalized to untreated controls [20] under both continuous (C) and 30 sec pulse
(P) regimens (Fig. 2. 1B, C). This decrease in normalized bioluminescence, reflecting
IKK-induced reporter degradation was followed by a sharp increase in bioluminescence,
reflecting NF-NB-dependent reporter re-synthesis, reaching maximum values at ~120 min
and then gradually declining toward baseline. Note that the rate at which INBD levels
return to baseline is steeper under continuous TNFD treatment compared to the 30 sec
pulse, providing evidence for reactivation of ligand-induced INBD degradation during
continuous stimulation [23]. The magnitude of the initial decrease in bioluminescence
was greater in continuously-treated cells than in 30 sec-pulsed cells (70% vs. 40% of
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initial, respectively), indicating that a 30 sec pulse of TNFD leads to approximately 50%
depletion of the INBD-NF-NB pool compared to continuous TNFD exposure (Fig. 2.1C,
120 min). These data suggested that, (a) this reporter construct could report on both IKKinduced INBD degradation and successive re-synthesis of INBD, (b) a 30 sec pulse of
TNFD at a saturating concentration (20 mg/mL) elicited robust IKK activity, culminating
in INBD degradation and a full INBD transcriptional up-regulation, and (c) with the
current NB5 synthetic promoter system, there was a non-linear relationship between INBD
degradation and NF-NB-dependent re-synthesis of INBD (i.e., saturation of INBD resynthesis even at sub-maximal INBD degradation levels).
Strikingly, Western blot analysis revealed that endogenous INBD behaved exactly
as the reporter under both C and P conditions, recapitulating the degree of degradation,
recovery, and return to baseline (Fig. 2.1D). Pretreating pNB5ĺINBD-FLuc-expressing
HepG2 cells with cycloheximide did not affect degradation of INBD-FLuc, but abolished
signal recovery, indicating that this phase was totally dependent upon transcription and
translation of new INBD-FLuc (Fig. 2.1E).

TNFD preconditioning induces a transient refractory period of INBD processing.
Upon a pro-inflammatory insult in vivo, effector cells (e.g., circulating macrophages)
release TNFD and other activating cytokines in a temporally- and spatially-discrete
manner. As a consequence, stationary target cells (e.g., epithelial cells, endothelial cells,
hepatocytes, etc.) will sense a stochastic rise in the levels of such pro-inflammatory
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ligands. In such a dynamic environment, as ligand-secreting cells continuously migrate to
sites of inflammation, it is anticipated that over time, target cells will experience multiple
pulses of activating ligands.
We therefore aimed to elucidate the effects of such ligand pulses on the capacity of
hepatocytes to respond to a subsequent challenge of the same ligand. Having shown that,
(a) pNB5ĺINBD-FLuc provided an accurate readout of INBD processing in intact cells
and that, (b) a 30 sec pulse was sufficient to induce robust IKK activity, we next sought
to investigate whether a short 30 sec preconditioning pulse with TNFD had a substantial
effect on the capacity of cells to process INBD upon a subsequent continuous TNFD
challenge.
HepG2 cells transiently expressing pNB5ĺINBD-FLuc were given a 30 sec pulse of
TNFD 20 ng/mL) or vehicle at t0, washed, replaced in media containing D-luciferin and
repeatedly imaged (every 5 min) prior to a TNFD challenge. At t30, t60, t120, or t240 (min)
after pulsing, cells were then challenged with a second continuous concentration of
TNFD (20 ng/mL)and live-cell imaging was continued up to 360 min. To compare the
processing dynamics of INBD-FLuc in naïve (un-preconditioned) cells with that of
preconditioned cells, the resulting bioluminescence profiles of preconditioned cells (black
lines, Figure 2.2A) were plotted along with the bioluminescence profile of unpreconditioned cells (i.e., only treated with continuous TNFD at t0, red line, Figure 2.2A).
The different graph panels represent the differential dynamics of INBD-FLuc processing
as the preconditioning pulse-challenge (P-C) intervals temporally increased (0-240 min).
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We observed that challenging preconditioned cells with a continuous exposure to
TNFD near the time that they had achieved maximal degradation from the
preconditioning pulse (i.e., 30 min post preconditioning) resulted in a small amount of
additional INBD degradation. As the interval between preconditioning and challenge
increased, the magnitude of challenge-induced INBD degradation also increased. These
data suggested that the TNFD-NF-NB system possessed a built-in refractory period
following TNFD treatment that prevented cells from fully responding to a second
exposure to ligand. To quantify this phenomenon independent of confounding factors that
may affect dynamic bioluminescence readouts (e.g., D-luciferin, ATP, O2 or pH
dynamics), and to verify its existence for endogenous INBD, we performed a similar
experiment, but instead of live-cell imaging, we harvested whole-cell lysates at tX+25 min
(time of maximal INBD degradation after a ligand challenge given at tX (Fig. 2.1C); for a
schematic timeline see Fig. 2.2B). INBD-FLuc reporter levels in these lysates were
analyzed by bioluminescence imaging (upon addition of saturating D-luciferin and ATP),
and endogenous INBD levels were determined by Western blot analysis and semiquantitative densitometric analysis (Fig. 2.2C). From these data, we were then able to
calculate responsiveness levels for both INBD and INBD-FLuc as a function of time after
TNFD preconditioning. Responsiveness at each challenge time was calculated by
determining the magnitude of INBD degradation induced by TNFD challenge divided by
the magnitude of INBD degradation in un-preconditioned cells from the same plate.
Specifically, the ratio at tX+25

min

of INBD in preconditioned cells challenged with

TNFDover preconditioned cells challenged with vehicle was divided by the ratio at tX+25
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min

of INBDin un-preconditioned cells challenged with TNFD over un-preconditioned

cells challenged with vehicle, the latter ratio representing the maximal possible response.
We observed a strong correlation (r=0.95) between levels of responsiveness for
endogenous INBD and INBD-FLuc (Table 2.1). Consistent with our earlier observations
derived from live-cell dynamic bioluminescence imaging experiments (Fig. 2.2A), we
observed that at 30 min post-preconditioning, cells were approximately half as responsive
as naïve (i.e., un-preconditioned) cells to a TNFD challenge, and had gained full
responsiveness by 120 min. Thus, a transient refractory period seemed to exist from 30120 min post TNFD preconditioning that rendered the cells unable to fully respond (as
measured via INBD degradation) to a second challenge of TNFD, and beyond this period,
the cells were able to mount a full response to a second TNFD challenge. Notably, similar
experiments performed with HeLa cells stably expressing pCMVĺINBD-FLuc
(HeLaINBD-FLuc [20]), yielded almost identical results (data not shown), suggesting that, (1)
the TNFD-induced transient refractory period was not limited to hepatocytes, and (2) this
effect was independent of both NF-NB-induced INBD transcription and the initial levels
of INBD-FLuc (substantially higher in HeLaINBD-FLuc [20]).

The ligand-induced transient refractory period for INBD processing correlated in
part with temporal down-regulation of IKK, but not receptor dynamics.
Hypothetically, this loss and regain of the capacity of cells to process INBD can be
explained by, (1) internalization or shedding of TNFD receptors (TNFR), followed by
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their recycling to the cell membrane [24, 25], (2) transient down-regulation of IKK
activity as previously reported [15, 26], or alternatively, (3) by a yet unknown mechanism
of regulation, downstream of IKK. We therefore sought to establish the relative
contributions of receptor dynamics and IKK regulation to this refractory period.
To determine the extent of receptor dynamics in governing the observed loss and
regain of INBD processing, we took advantage of a discovery, made 20 years ago [14],
that IL-1E induces transient down-regulation of TNFD receptors, but not vice versa (i.e.,
TNFD has no effect on either the affinity or the number of IL-1E surface receptors), as
tested in a variety of cell lines and primary cells. Hence, we aimed to determine INBD
responsiveness to an IL-1E challenge as a function of time after TNFD preconditioning in
HepG2 cells. Cells expressing pNB5ĺINBD-FLuc were treated with a 30 sec pulse of
TNFD (20 ng/mL) followed by a continuous challenge with IL-1E, initiated at increasing
P-C intervals (0-240 min). INBD processing was analyzed by live-cell dynamic
bioluminescence imaging (Fig. 2.3A). Using this experimental setup, we again observed a
transient refractory period (from 30-120 min post-TNFD preconditioning) during which
HepG2 cells exhibited decreased INBD responsiveness. The magnitude of the ligandinduced degradation increased as the interval to the IL-1E challenge increased, becoming
fully responsive again by 120 min (Fig. 2.3A). These data suggested that even in the
absence of ligand-induced receptor desensitization or cross-regulation, the capacity of
cells to process INBD was compromised within the first two hours after a short TNFD
stimulation.
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We next aimed at deciphering whether transient down-regulation of IKK activity
could explain the observed loss and regain in INBD responsiveness. We therefore
performed a series of IKK kinase assays in order to directly measure the temporal activity
profile of IKK, a central junction of the TNFD and IL-1E pathways that integrates signals
from a myriad of upstream regulators (e.g., TRAFs, MEKK, TAB, TAK, NIK, RIP, A20,
PKC], etc. [2, 7, 27]). HepG2 cells were treated with TNFD (20 ng/mL) either as a 30 sec
pulse or continuously. At the indicated time points, cells were harvested, IKK complexes
were immunoprecipitated and assayed for their capacity to phosphorylate exogenous
GST-INBD(1-54) [23]. We found that for both 30 sec pulses and continuous TNFD
exposure, temporal profiles of IKK activity were almost identical, with both peaking at
10 min. However, consistent with our earlier findings that continuous TNFD treatment
elicits greater INBD degradation than a 30 sec pulse (Fig. 2.1C), continuous TNFD
treatment exhibited slightly elevated and more sustained levels of IKK activity compared
to pulsed TNFD treatment (Fig. 2.3B). Importantly, Western blot analysis showed that
IKK complex levels (as determined by IKKD protein) did not change over the
experimental time course (Fig. 2.3C), confirming that the increase in net kinase activity
was due specifically to IKK activation.
IKK-KA data were also collected from preconditioned cells, 10 minutes postchallenge (at the time of maximal IKK activity, see Fig. 2.3B) at increasing P-C intervals
(0-240 min). Using these data together with the IKK activity profiles generated for 30 sec
pulse and continuous TNFD treatment regimens (Fig. 2.3B), we were able to calculate the
net capacity of IKK to phosphorylate INBD as a function of time after TNFD
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preconditioning (i.e., IKK responsiveness, Table 2.1, see methods section for details on
this calculation). Based on this calculation, we noted that the capacity of IKK to respond
to a second challenge of TNFD was significantly compromised at 30 min post TNFD
preconditioning and then gradually increased, reaching ~75% responsiveness by 120 min.
Up to 240 min, IKK activity did not fully recover to initial levels, consistent with other
reports indicating that upon TNFD stimulation, IKK activity rapidly and transiently
declines due to autocatalytic C-terminal hyperphosphorylation [15] and PP2CE-dependent
dephosphorylation [16], followed by late NF-NB-dependent down regulation, a process
attributed, in part, to A20, an IKK-inhibitory protein [27]. Hence, these data suggested
that, (1) the observed ligand-induced transient refractory period of INBD processing
(Figs. 2.2 and 2.3, Table 2.1) correlated only in part with ligand-induced transient downregulation of IKK activity, and that, (2) the level to which cells are able to degrade INBD
was not linear with the capacity of IKK to phosphorylate INBD i.e., full INBD
responsiveness was observed as soon as 120 min post TNFD preconditioning (Figs. 2.2
and 2.3A), a time point where IKK responsiveness was still compromised (Table 2.1).
These data indicated that either submaximal IKK activity could now fully support ligandinduced INBDdegradation following the refractory period, or that additional ligandresponsive elements existed that converged on INBDҏ to induce a full responseҠ.

Computational modeling of NF-NB signaling suggested an additional layer of
regulation, downstream of IKK, governing the observed refractory period for INBD
processing. The NF-NB pathway provides an excellent example of a complex signaling
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system employing numerous temporally distinct auto-regulatory mechanisms and
negative feedback loops. IKK enzymatic activity, which is both endogenously and
exogenously regulated, controls the degradation of its own substrate (INBD), which is
later strongly up-regulated in an NF-NB-dependent manner (Fig. 2.1A). Rapid changes in
substrate availability, conformation and sub-cellular localization imply that alternative
mechanisms of regulation might exist, other than changes in enzymatic activity. Although
a ligand-induced transient refractory period of INBD processing could be explained in
part by down-regulation of IKK activity, we were intrigued to examine whether an
alternative regulatory mechanism, based on substrate (INBD) dynamics, might exist to
complement or "back up" IKK regulation. Obviously, inhibition of IKK was not a viable
option for analyzing downstream regulation, since such inhibition will result in complete
loss of responsiveness in the absence or presence of preconditioning. We therefore
decided to undertake a computational approach and explore INBD dynamics in silico,
assuming no down-regulation of IKK activity. We used a well-accepted computational
model that used experimentally- or hypothetically-driven IKK activity profiles as inputs
and in return, calculated ligand-induced dynamics of 24 different sub-populations of
mediators on the IKK-NF-NB axis.
As a first step, to test the robustness of the model, we sought to compare our INBDFLuc bioluminescence imaging data for 30 sec pulsing and continuous TNFD treatments
(Fig. 2.1C) with the dynamics of INBD, as predicted by the computational model. To
accomplish this, we used as inputs the IKK activity profiles generated for 30 sec pulse
and continuous TNFD treatment regimens (Fig. 2.4A, left panel; see methods section for
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details on numerical processing of the raw data to fit the model). The dynamics of six
different free and complexed INBDsub-populations could be predicted by the model (i.e.,
free INBDcyt, INBD:IKKcyt, INBD:NF-NBcyt, INBD:IKK:NF-NBcyt, free INBDnuc and
INBD:NF-NBnuc). Since live-cell bioluminescence imaging of INBD-FLuc could not
distinguish between these populations, we summed up the predicted concentrations of all
INBD sub-populations and plotted the predicted total INBD levels as a function of time
(Fig. 2.4A, right panel). For both treatment regimens, we noted an excellent correlation
between the predicted profiles of INBD and the experimentally-generated profiles of
INBD-FLuc (Fig. 2.1C). The timing and extent of INBD degradation as well as the overall
dynamic behavior were highly similar. However, differences in the amplitude and timing
of re-synthesis (experimental: ~8 fold-initial at ~120 min; computational: 1.2-1.5 foldinitial at ~90 min) were observed and could be explained by dynamic differences between
the endogenous INBD promoter and the synthetic NB5-TATA promoter driving INBDFLuc (i.e., differences in binding affinity and cooperativity towards NF-NB).
We next generated hypothetical IKK profiles representing IKK activities from
preconditioned/challenged cells, assuming no upstream receptor or IKK regulation (i.e.,
experimentally-derived challenge-specific IKK activity were overlaid on top of
experimentally-derived precondition-specific residual IKK activity). These hypothetical
IKK activity profiles (Fig. 2.4B-E, left panels, each generated with a different P-C
interval) were used as inputs for computing total INBD dynamics (Fig. 2.4B-E, right
panels). Surprisingly, the computational model predicted that even in the absence of
receptor dynamics or IKK regulation, INBD processing would be transiently
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compromised (compare for example the second, challenge-induced degradation phase at
120 or 240 min with the ones at 30 or 60 min). These data suggested that although IKK
down-regulation partially correlated with the ligand-induced transient refractory period
for INBD processing, an additional regulatory mechanism was present downstream of
IKK. Importantly, INBD availability per se was not sufficient to explain changes in INBD
responsiveness because, as confirmed experimentally and computationally, at 60 min
post-preconditioning, the INBD concentration had already recovered, while degradation
potential was still low (compare Figs. 2.2A, 2.2C, Table 2.1 and 2.4C).

Nuclear export of INBD:NF-NB complexes may also control the capacity of cells to
process INBD. Having demonstrated experimentally the phenomenon of a ligand-induced
transient refractory period for INBD processing and after dissecting biochemically and
computationally the origins of this observation, we next sought to more closely examine
the components of the computational model in order to identify candidates, downstream
of IKK, capable of regulating INBD responsiveness. While examining the rate constants
of a variety of reactions used by the model, we noticed that free vs. NF-NB-bound INBD
differed tremendously in their capacity to associate with IKK (1.35 vs. 11.1 PM-1 min-1,
respectively) and to be degraded in an IKK-dependant manner (0.12 vs. 0.00006 min-1,
respectively). These differences in IKK association and ligand-induced degradation were
experimentally established by Zandi et al. [28].
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This led us to put forward the following model (Fig. 2.5A): (1) free INBDand NFNB-bound INBDrepresent “protected” and “unprotected” populations with respect to
ligand-induced, IKK-dependent proteasomal degradation. (2) Under steady-state
conditions, there is a stoichiometric excess of INBD over NF-NB in the cytoplasm (~0.7
NF-NB per INBD according to the model). This may explain our observations that even at
saturating concentrations of TNFD or IL-1E, INBD degradation never exceeded 70-80%
of initial (e.g., Fig. 2.1C). (3) Upon ligand stimulation, NF-NB-bound INBD is degraded,
NF-NB translocates to the nucleus and INBD is resynthesized. (4) At this point, although
INBD is highly abundant, its capacity to be degraded in response to a second stimulus is
still severely compromised because NF-NB is in the nucleus. (5) INBD can freely shuttle
between the cytoplasm and the nucleus, pulling NF-NB molecules (that lack nuclear
export signals [29]) back to the cytoplasm. This step may be the rate limiting step for
acquisition of full responsiveness. (6) Newly-synthesized INBD molecules uncomplexed
with NF-NB are rapidly degraded [30], and only after all NF-NB molecules are recovered
back to the cytosol and the NF-NB-bound-INBD over free-INBD ratio returns to prestimulation levels (~0.7), are cells able to mount a full response again.
To experimentally examine the nuclear export hypothesis, we sought to analyze
ligand-induced changes in cytoplasmic INBD:NF-NB complexes. However, the
computational model predicted that ligand-induced changes of cytoplasmic INBD:NF-NB
and total cytoplasmic NF-NB were essentially the same (i.e., at any given time, virtually
all cytoplasmic NF-NB was bound to INBD, Fig. 2.5B , suggesting that monitoring
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cytoplasmic total NF-NB was an excellent approximation for following cytoplasmic
INBD:NF-NB complexes. We therefore pulsed HepG2 cells for 30 sec with TNFD (20
ng/mL) and at various times after stimulation, we fixed, permeabilized and
immunostained the cells for p65 NF-NB (Fig. 2.5C). We found that upon a 30 sec TNFD
pulse, p65 rapidly translocated to the nucleus (maximal by 30 min), but by 60-120 min
was back in the cytoplasm. The excellent temporal correlation between the levels of
cytoplasmic NF-NB (as derived computationally or experimentally, Fig. 2.5B and 5C,
respectively) and the competence of cells to degrade INBD in response to a proinflammatory ligand (i.e., Table 2.1) strongly suggested that nuclear transport of NF-NB
provided a potential alternative mechanism to transiently desensitize INBD processing
(refractory period), in addition to the mechanism of IKK down-regulation (Fig. 2.3B, C;
Table 2.1).

2.3

DISCUSSION
Ligand-induced desensitization is a common theme in many biological systems

[13], thereby allowing cells to mount an appropriate response independently of ligand

exposure time. Thus, prolonged exposures will not result in excessive responses, but
instead, cells are enabled to build up a downstream response, while being unable to
perceive a second activating cue. Desensitization and re-sensitization are traditionally
perceived to be linked to receptor dynamics (internalization, shedding and recycling),
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however, any mediator or regulator along a signaling pathway can be hypothetically
desensitized, therefore transiently blocking signal transduction [13].
In this work, we demonstrated that while cells can efficiently activate NF-NB in
response to a TNFD exposure as short as 30 sec, such stimulation was followed by a
refractory period during which the capacity of cells to respond to a second homologous or
heterologous stimulus was severely compromised. We further found that this transient
refractory period correlated in part with a temporal down-regulation of IKK activity, but
not with receptor desensitization. Computational modeling enabled us to identify an
additional layer of regulation, downstream of IKK, controlling the capacity of cells to
respond to a second challenge. Ligand-induced dynamic changes in substrate (INBD)
availability, conformation and sub-cellular localization form the basis for this
mechanism. Further analysis led us to conclude that nuclear export of NF-NB may be a
rate limiting step in controlling INBD homeostatic metabolism, a term recently coined by
O’Dea et al. [31].
Our study highlights the multifaceted regulation of NF-NB signaling (Fig. 2.6) and
sheds light on the refractory nature of INBD processing as a route to transiently
desensitize NF-NB activity upon subsequent rounds of stimulation. Rapid and transient
deactivation of IKK activity as well as temporal reduction in its capacity to respond to a
subsequent challenge (IKK responsiveness) seems to play a crucial role in this process.
Previous studies indicated that both the amplitude and the timing of IKK activation affect
not only the intensity of NF-NB-dependent transcription, but also the specificity of the
transcriptional response [23, 32]. This indicated that besides resolution of the
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inflammatory response and induction of a refractory period (temporally preventing
subsequent rounds of INBD degradation upon re-stimulation), rapid down-regulation of
IKK activity [26] plays a pivotal role in determining the type of elicited transcriptional
program.
In addition to IKK regulation, our work demonstrated that nuclear export of
INBD:NF-NB complexes may have also regulated INBD responsiveness (Figs. 2.4 and
2.5). This suggested that NF-NB positively controls INBD both transcriptionally and post-

translationally.

Such

double-layered

feedback

regulation

ensures

that

NF-NB

transcriptional activity will fully resume only after reconstitution of the cytosolic pool of
NF-NB. Two other INB isoforms, INBE and INBH , are degraded more slowly under both
TNFD-induced and unstimulated conditions [23, 33] and have been implicated in
dampening INBD-mediated oscillations of NF-NB activity [33-35]. INBH has been shown
to be highly NF-NB inducible in MEFs, and contribute to nuclear export of NF-NB, but
only at times greater than 3 hrs post-stimulation [36]. Thus, it is seems unlikely that INBH
contributes substantially to the export of NF-NB over the 2 hrs of the refractory period
observed in the present study. It may be interesting to determine whether similar transient
refractory periods exist for processing of other INB isoforms.
While TNFD-induced re-synthesis of endogenous INBD peaks at ~60-90 min post
onset of stimulation (as validated both experimentally and computationally, Figs. 2.1D
and 2.4A, respectively), maximum levels of newly-synthesized INBD-FLuc reporter were
observed ~120 min after TNFD stimulation (Figs. 2.1C, 2.1E, and 2.2A). This
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discrepancy may be explained by differences likely to be present in affinity and
cooperativity of binding of NF-NB to endogenous vs. synthetic promoters (the
endogenous promoter contains 3 distant NB sites, while the synthetic promoter contains 5
tandem high affinity NB sites). Nevertheless, since both endogenous INBD and INBDFLuc exhibit similar half-life times [20], differences in the timing of re-synthesis cannot
be explained by differences in turnover rate. Following the peak of INBD re-synthesis,
both endogenous INBD and our INBD-Fluc reporter begin returning to baseline levels
faster under continuous TNFD treatment, suggesting that ligand-induced reactivation of
INBD degradation is occurring under continuous TNFD exposure, as expected [23].
In the present and previous studies [20], we demonstrated that dynamic
bioluminescence imaging of INBD-FLuc reporters in live cells provides robust and
accurate readouts of ligand-induced INBD dynamics. In effect, real time bioluminescence
imaging was equivalent to performing continuous on-line Western blots of INBD at five
minute intervals. An analogous transcriptionally-coupled reporter (kB5ĺINBD-EGFP)
was generated by Nelson et al. [34] for monitoring INBD dynamics in single cells by livecell fluorescence microscopy. While such a system provides the means to monitor ligandinduced translocations and oscillations in INBD levels, temporal resolution of this
reporter is limited by the long maturation time of EGFP (>1 h, [37, 38]). This notion, and
the fact that Nelson et al. co-overexpressed p65-DsRed [34, 35] may explain the vast
difference between the observed period of INBD-EGFP oscillations (~300 min) and the
period of endogenous INBD oscillations, as predicted computationally (~90-120 min,
[33]). While longer term INBD oscillatory behavior was not the focus of the present study,
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we did observe single oscillations within ~150-180 min. Because FLuc is active
immediately upon translation, our reporter should afford greater temporal resolution,
enabling accurate readouts of INBD dynamics and oscillations in live cells for such
studies as well as the multi-stimulation protocols as described herein.
Of note, a previous study aimed at analysis of INBD stabilization indicated a role for
p38 in INBD stabilization, and in some cell lines, in prevention of sequential degradation
of INBD upon concurrent exposure to TNFD following continuous pretreatment with IL1E [39]. However, since IL-1E has been shown to induce rapid and dramatic downregulation of TNFD receptors (but not vice versa) [14], inhibition of TNFD-inducedINBD
processing, as observed by Place et al., could be attributed directly to receptor dynamics
rather than INBD stabilization. This confounding factor highlights the importance of
asymmetric receptor cross-desensitization, a phenomenon that remains poorly
understood, but has far-reaching physiological consequences.
In conclusion, TNFD preconditioning protocols and dynamic imaging revealed a
transient suppression of the capacity of cells to process INBD. This refractory period for
INBD processing was controlled both by IKK activity and NF-NB distribution. In
particular, the data suggested that nuclear export of NF-NB may provide additional ratelimiting regulation governing the refractory period machinery. These regulatory
mechanisms provide a "molecular timer" controlling the amplitude, timing and specificity
of the NF-NB-mediated transcriptional program.
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2.4

METHODS

Materials- D-luciferin (potassium salt) was from Biosynth (Naperville, IL). Human tumor
necrosis factor D (TNFD) and interleukin-1E (IL-1E) were from R&D systems (Minneapolis,
MN). Complete protease inhibitors cocktail was from Roche (Basel, Switzerland).
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adenosine triphosphate (32P-ATP) was from Perkin-Elmer (Waltham, MA). Carbenicillin,
isopropyl ȕ-D-1-thiogalactopyranoside (IPTG), ampicillin, kanamycin, glutathione S-transferase
(GST), E-glycerolphosphate, NaCl, NaF, Na3VO4, KOH, MgCl2, ethylenediaminetetraacetic acid
(EDTA), phenylmethylsulfonyl fluoride (PMSF), NP-40, Tween-20, Triton X-100, ATP,
dithiothreitol (DTT), paraformaldehyde, cycloheximide (CHX) and HEPES were from SigmaAldrich (St. Louis, MO).

Plasmids- pNB5ĺFLuc (Stratagene, La Jolla, CA) contains five repeats of a NB motif upstream
of a minimal TATA box controlling expression of firefly luciferase. pNB5ĺINBD-FLuc was
produced by cloning an EcoRI – HpaI (blunt) fragment from pCMVĺINBD-FLuc [20] into the
EcoRI and EcoRV (blunt) sites of pNB5ĺFLuc. pNB5ĺFLuc, pCMVĺINBD-FLuc and
pNB5ĺINBD-FLuc were propagated in TOP10 electrocompetent E. Coli (Invitrogen, Carlsbad,
CA) and purified using Qiagen HiSpeed Maxi Kits (Qiagen, Valencia, CA). pGST-INBDN
(encoding for GST fused to the N-terminal fragment of human INBD (1-54)) was a kind gift from
Prof. Alexander Hoffmann (UCSD, San Diego, CA). pGST-INBDN was propagated in BL21
codon+ E. Coli cells (Stratagene).
Cells and Transfections- HepG2 human hepatoma cells were from the American Type Culture
Collection (ATCC, Manassas, VA). Cells were cultured in DMEM supplemented with heatinactivated FBS (10%) and L-glutamine (2 mM). Cell cultures were grown at 37oC in a
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humidified atmosphere of 5% CO2. HepG2 cells (105) were transiently transfected (Fugene 6,
Roche) with pNB5ĺINBD-FLuc (200 ng/well) and plated in black-coated 24-well plates (In Vitro
Systems GmbH, Gottingen, Germany). Cells were then allowed to recover for 48 h prior to
imaging.

Dynamic Bioluminescence live-cell imaging- Prior to imaging, cells were washed with prewarmed phosphate-buffered saline (PBS, pH 7.4) and placed into 900 PL of colorless HEPESbuffered DMEM, supplemented as above and with D-luciferin (150 Pg/mL). Cells were allowed
to equilibrate for 1 hour (37°C) before proceeding with ligand stimulation and imaging. Four
different stimulation regimens were included in this study:
(1) Continuous TNFD (C): TNFD (final concentration 20 ng/mL) or vehicle (colorless DMEM)
was added (100 PL) to D-luciferin-containing DMEM and imaging was performed before, and at
the indicated time points after addition of TNFD.
(2) TNFD Pulse (30 sec, P): cells were pulsed for 30 sec with TNFD (20 ng/mL) or vehicle,
washed with PBS, returned to D-luciferin-containing DMEM and imaged before, and at the
indicated time points after the pulse of TNFD.
(3) TNFD Preconditioning (30 sec pulse) followed by Continuous TNFD challenge (P+C): At
t0 cells were pulsed for 30 sec with TNFD (20 ng/mL) or vehicle, washed with PBS, returned to
D-luciferin-containing DMEM (900 PL) and imaged before, and at the indicated time points after
the pulse of TNFD. At tx, TNFD (final concentration 20 ng/mL) or vehicle (colorless DMEM)
were again added (100 PL) and imaging was performed before, and at the indicated time points
after addition of TNFD.
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(4) TNFD Preconditioning (30 sec pulse) followed by Continuous IL-1E challenge (P+C): As
in (3), but continuous challenge was performed with IL-1E (10 ng/mL).
TNFD or IL-1E challenge was performed at the following time points: tx = 0 (no
preconditioning), 30, 60, 120 and 240 min post preconditioning. Assay plates were imaged using
an IVIS-100 imaging system (Xenogen Caliper, Alameda, CA). Acquisition parameters were as
follows: acquisition time, 60 sec; binning, 4; FOV, 10 cm; f/stop, 1; filter, open; image-image
interval, 5 min; number of acquisitions, 73 (360 min).
To analyze ligand-induced regulation of de novo reporter re-synthesis, cells were
pretreated with cycloheximide (100 Pg/mL) for 1 hour before continuous stimulation with TNFD
and bioluminescence imaging (as above).

INBDResponsiveness Assays- HepG2 cells, transfected with pNB5ĺINBD-FLuc (as above) or
HeLa cells, stably expressing pCMVĺINBD-FLuc [20], were plated in 4 wells of a six-well plate
(one plate per time point) and grown for 48 hours. At t0, all wells were washed with pre-warmed
PBS, pulsed for 30 sec with TNFD (20 ng/mL, 1 mL) or vehicle (PBS), washed again with PBS,
returned to regular medium (1 mL) and placed in a 37ºC incubator. This procedure was defined as
TNFD preconditioning (P). At tx, two wells were treated (continuously) with TNFD (20 ng/mL)
and two wells were treated with vehicle only (PBS). This procedure was defined as TNFD
challenge (C). Following this TNFD challenge, cells were returned to the incubator. At tx + 25

min

(time of maximal INBD degradation [20]; see Fig. 2.2A for schematic timeline), cells were
harvested (by scraping) in reporter lysis buffer (Promega, Madison, WI). Cell lysates were
normalized for protein content by bicinchoninic acid (BCA) protein assay (Promega), aliquoted
and frozen (-80 ºC) for in vitro bioluminescence and Western blot analyses (see below). For in
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vitro bioluminescence assays, lysates (10 PL, in triplicate) were mixed with luciferase assay
buffer (190 PL; HEPES, 25 mM; NaCl, 154 mM; MgSO4, 5.4mM; DTT, 10 mM; ATP, 5 mM;
D-luciferin, 150 Pg/mL; pH 8.0) in a 96-well plate immediately prior to imaging. Assay plates
were imaged using the IVIS-100 (acquisition time, 10 sec; binning, 4; FOV, 10 cm; f/stop, 1;
filter, open).

Western Blot Analyses- Whole-cell lysates were resolved by 10% or 7.5% SDS-PAGE,
transferred to a PVDF membrane and probed for the indicated proteins using standard
immunoblotting techniques. Primary antibodies against total human INBD, E-actin and IKKD
were from Santa Cruz Biosciences (Santa Cruz, CA). Anti-phospho-INBD (Ser 32/36) was from
Cell Signaling Technologies (Danvers, MA). Secondary horseradish peroxidase-labeled antimouse and anti-rabbit IgG antibodies were from GE Healthcare Biosciences (Piscataway, NJ).
IKK Kinase Assay (IKK-KA)- IKK-KA reactions were carried out as per Werner et al [23] and
quantified in a medium-throughput manner as per Hastie et al [40]. Briefly, HepG2 cells were
grown in 10 cm tissue culture dishes to confluency. Cells were then washed in PBS (once) and
treated with 20 ng/mL TNFDusing three different treatment regimens: P, C or P+C (see above).
To capture the full IKK activity profiles of cells treated with continuous (C) or pulse (P)
regimens, cytosolic extracts were prepared at t = 0 (before), 5, 10, 15, 30, 60, 120, or 240 min
post TNFD treatment. To capture maximal IKK activity of P+C-treated cells, cytosolic extracts
were prepared 10 min post TNFD challenge (given at 10, 30, 60, 120 and 240 min post
preconditioning). Cells were harvested by removing media, washing in ice-cold PBS + EDTA (1
mM), scraping, and pelleting at 2000 g. To prepare cytosolic extracts, cell pellets were
resuspended in 200 PL of CE Buffer (10 mM HEPES-KOH, pH 7.9, 250 mM NaCl, 1 mM
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EDTA, 0.5% NP-40, 0.2% Tween 20, 2 mM DTT, 20 mM E-glycerophosphate, 10 mM NaF, and
0.1 mM Na3VO4 supplemented with complete protease inhibitor cocktail), incubated on ice (2
min), vortexed (1 min), and pelleted at 2000 g. Supernatants were collected, normalized for
protein content by Bradford Assay (Pierce, Rockford, IL) and stored at -80°C. To
immunoprecipitate IKK complexes, cytoplasmic extracts (100 PL) were incubated with antiIKKJ antibody (15 PL, overnight, 4ºC with rotation) and then with Protein G 4FF bead slurry (20
PL, 50% (v/v)). Beads were pelleted at 4600 RPM, washed twice with CE Buffer (500 PL) and
once with Kinase Buffer (500 PL, 20 mM HEPES, pH 7.7, 20 mM E-glycerophosphate, 100 mM
NaCl, 0.1 mM Na3VO4, 10 mM MgCl2, 2 mM DTT supplemented with complete protease
inhibitor cocktail). For the IKK kinase reaction, beads were incubated for 30 min at 30ºC in
Kinase Buffer (20 PL) containing 20 PM ATP, 10 PCi 32P-ATP, and 0.5 Pg GST-INBD  .
Beads were removed by centrifugation (4600 RPM) and 15 PL of each reaction supernatant was
spotted onto a 1 cm2 square of P81 phosphocellulose paper (Millipore, Billerica, MA) and
immediately immersed into phosphoric acid (75 mM) for 5 min. Phosphoric acid washes were
performed two more times, papers were rinsed in acetone, and then allowed to dry. Each paper
was transferred to a scintillation vial and radioactivity was determined on a beta counter
(Beckman Coulter, Fullerton, CA). Blank and no-lysate controls were subtracted from the
experimental samples. Data were represented as fold-initial (untreated controls).

Calculating Ligand-Dependent IKK Responsiveness- IKK responsiveness profiles (i.e., the net
kinase capacity of IKK in response to a second challenge of TNFD, as a function of time after
initial 30 sec preconditioning) were calculated numerically from IKK-KA data using the
following formula:
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where PCx+10 is IKK activity of preconditioned+challenged cells, as recorded 10 minutes post
challenge. Px+10 is the residual IKK activity of preconditioned, but un-challenged cells at this
exact time point. C0 and PC0 are initial IKK activities of challenged but un-preconditioned, and
fully preconditioned and challenged cells, respectively. C10 is the maximal IKK activity of
challenged but un-preconditioned cells (recorded 10 minutes post challenge). Note that while all
parameter units in the nominator and denominator are in c.p.m., IKK responsiveness is
dimensionless, similar to INBD responsiveness.

Computational Simulations- To simulate the dynamics of major regulators on the IKK-NF-NB
axis, we used a well-established computational model generated by Hoffmann et al. [33] and
refined by Werner et al. [23]. Briefly, an experimentally- or hypothetically-derived IKK activity
profile was fed into the program as an input. Embedded in the model were 24 components, 70
reactions and 70 parameters or rate constants for these reactions. Differential equations were
solved numerically using Matlab 7.0 (Mathworks, Natick, MA) with subroutine Ode15.
Interpolated and extrapolated (0-360 min at 5 min intervals) IKK activity profiles were calculated
(Origin version 7.5, OriginLab, Northhampton, MA) from experimental IKK-KA data (see
above). To fit the model, initial steady-state IKK activity (i.e., intracellular concentration of
active IKK) was set to be 1 nM. To computationally simulate INBD dynamics of cells challenged
at different times after initial preconditioning, when assuming no upstream IKK or receptor
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regulation, we used hypothetical IKK activity profiles as inputs, derived from superimposing
experimentally-acquired IKK activity profiles of 30 sec-pulsed and continuously-treated cells, at
increasing intervals (30, 60, 120 and 240 min, see Fig 4, black lines).
Immunofluorescence Microscopy- HepG2 cells were seeded into 35 mm glass bottom culture
dishes (MatTek Corp.; Ashland, MA) and grown to ~40% confluency. Cells were pulsed for 30
sec with TNFD as above and fixed at the indicated time points (by washing once with PBS,
followed by fixation (4% paraformaldehyde for at least 15 min) and permeabilization (ice cold
methanol, 10 min at -20ºC)). Cells were washed in PBS, blocked in 5% normal goat serum in
0.3% Triton X-100/PBS (1 hour), and then incubated with anti-p65 antibody (Santa Cruz, 1:200
in 0.3% Triton X-100/PBS at 4ºC, overnight with rocking). Cells were next incubated with
AlexaFluor 635-conjugated goat anti-rabbit antibody (Invitrogen, 1:200 in 0.3% Triton X100/PBS, 90 min, at room temperature with rocking). Cells were washed three times with PBS
before being mounted with VECTASHIELD Mounting Media (Vector Laboratories; Burlingame,
CA). Confocal images were captured using the 40x objective (water immersion) on a Zeiss
Axiovert 200 (Zeiss, Thornwood, NY) laser scanning microscope equipped with the appropriate
filter sets and analyzed using Zeiss LSM Image Browser and Adobe Photoshop CS2.
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2.5

FIGURES

Figure 2.1: pNB5ĺINBD-FLuc: a transcriptionally-coupled reporter for monitoring INBD
dynamics in live cells. A. A schematic representing ligand-induced degradation and
transcriptionally-coupled re-synthesis of the reporter. B. Raw bioluminescence images of HepG2
cells transiently expressing pNB5ĺINBD-FLuc treated with TNFD ng/mL continuously (C)
or as a 30 sec pulse (P) or with vehicle only (V) and imaged for 360 min. Images show
pseudocolor-coded photon flux maps superimposed on black-and-white photographs of the assay
plate. C. Graphical representation of the changes in photon flux from (b) as a function of time
after TNFD addition. Data are plotted as fold-initial, fold-vehicle-treated (n=3 for all points;
s.e.m.  5%; representative of 3 independent experiments). D. Western blot analysis of
endogenous INBD from HepG2 cell lysates prepared at the indicated times after a 30 sec-pulse or
continuous treatment with TNFD (20 ng/mL). E. Pretreatment with cycloheximide (CHX, 1 h,
100 Pg/mL) totally abrogated TNFD-induced INBD-FLuc re-synthesis, but had no effect on
reporter degradation.
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Figure 2.2: TNFD-induced a transient refractory period for INBD processing. A. Dynamic
live-cell bioluminescence imaging profiles of INBD-FLuc from TNFDpreconditioning+challenge
experiments. Black arrows denote 30 sec preconditioning pulse; red arrows denote the beginning
of continuous TNFD challenge; black profiles represent cells pre-conditioned and then challenged
at the indicated time points; red profiles represent cells treated at time 0 with continuous
TNFD(denoting the maximal possible degradation response of INBD upon continuous TNFD
treatment). Data are presented as fold-initial, fold-TNFD-untreated. B. Schematic representation
of the experimental timeline as used in c. Cells were preconditioned with TNFD for 30 sec and
then, at increasing intervals (0-240 min), were continuously challenged with TNFD. Arrowheads
represent when cells were harvested and lysates prepared (25 min post challenge for quantitative
bioluminescence imaging and Western blot analysis). C. INBD-Fluc and endogenous INBD levels,
25 min post TNFD or vehicle challenge, as measured by bioluminescence imaging and Western
blot, respectively.
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Figure 2.3: Impact of receptor dynamics and IKK regulation on INBD responsiveness. A.
Dynamic live-cell bioluminescence imaging profiles of INBD-FLuc from TNFDpreconditioning,
IL-1E challenge experiments. Black arrows denote 30 sec preconditioning pulse of TNFD; blue
arrows denote the beginning of continuous IL-1E (10 ng/mL) challenge; black profiles represent
cells pre-conditioned and then challenged with IL-1E at the indicated time points; blue profiles
represent cells treated at time 0 with continuous IL-1E(denoting the maximal possible
degradation response of INBD upon continuous IL-1E treatment). Data are presented as foldinitial. B. IKK kinase activity was measured at the indicated time points after initiation of a
continuous (blue curve) or a 30 sec pulse (red curve) of TNFD (20 ng/mL). Results are presented
as background-normalized, fold-initial (untreated) controls. C. Western blot analysis of IKKD in
cytoplasmic fractions, used as inputs for immunoprecipitation and kinase reactions presented in
(b).
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Figure 2.4: Computational simulation of INBD responsiveness in the absence of upstream
receptor or IKK regulation. A. Interpolated and extrapolated (0-360 min, at 5 min intervals)
IKK activity profiles (right panel) of cells treated continuously (C, green curve) or by a 30 sec
pulse (P, blue curve) of TNFD (20 ng/mL) were used as inputs to computationally simulate total
INBD dynamics (right panel). B-E. Left panels: Hypothetical IKK activity profiles of
preconditioned cells, challenged at the indicated times (denoted by black arrowheads) with a
second, continuous dose of TNFD were generated by superimposing the continuous
TNFDinduced IKK profiles at increasing intervals after the 30 sec pulse TNFDinduced IKK
profile. For generating these hypothetical profiles, we assume no preconditioning-induced
receptor or IKK regulation. Right panels: The hypothetical IKK profiles were used as inputs into
the model to predict INBD dynamics. Note that challenge-induced INBD degradation (initiated at
the red arrowhead) is recovered in a time-dependent manner.
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Figure 2.5: Nuclear export of NF-NB may regulate INBD sensitivity to ligand-induced
degradation. A. A schematic illustrating sub-cellular localization and levels of free INBD, free
NF-NB, and NF-NB-bound INBD in response to a pulse of TNFD. B. Computationally-predicted
profile of all cytoplasmic populations of NF-NB following a pulse of TNFD. Note the exceeding
small free NF-NB population. C. HepG2 cells were stimulated with a 30 sec TNFD pulse. At the
indicated time points, cells were fixed, permeabilized and immunostained for p65 NF-NB. Shown
are representative immunofluorescence confocal photomicrographs.
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Figure 2.6: Refractory period in NF-NB signaling. Schematic representation of the different
ligand-induced autoregulatory mechanisms that control responsiveness in the NF-NB signaling
pathway.
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2.6

TABLES

Time after TNFD Preconditioning (min)
30’

60’

120’

240’

49%

80%

100%

82%

INBD-FLuc
(bioluminescence)

43%

74%

90%

94%

IKK Activity

35%

56%

75%

69%

INBD
(Western blot)

Table 2.1: Percent Responsiveness of INBD Processing
Quantification of INBD-FLuc and INBD responsiveness to a second continuous challenge
of TNFD at the indicated interval following a 30 sec preconditioning pulse of TNFD was
determined from the bioluminescence imaging and Western blot data shown in Figure
2C. Responsiveness at each challenge time was calculated by determining the percent of
challenge-specific INBD degradation divided by the percent of INBD degradation in unpreconditioned cells from the same plate. The responsiveness of IKK was determined by
IKK kinase assay.
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CHAPTER THREE
Synchronicity of the IțBĮ:NF-țB Negative Feedback Loop In
Cellulo and In Vivo

3.1 INTRODUCTION
Cells have evolved complex signaling networks that sense cues from the
environment and transduce this information to elicit appropriate biological responses [1].
These networks equip cells with sensitive, reversible, regulated, and robust responses to a
variety of signaling activators; in particular, these networks can confer on cells the ability
to distinguish weak signals from background noise with high precision and selectivity [2,
3]. The NF-N% signaling pathway and its downstream transcriptional targets are
responsive to a large number of different stimuli [4], and recent work has focused on NFN% pathway responsiveness to the mode of stimulation (i.e., stimulus concentration, pulse
duration, or pulse interval). Particularly relevant during cellular responses are
inflammatory cytokines, such as TNFĮ, which are likely perceived as transient pulses or
waves of TNFĮ occurring over a wide range of concentrations [5-10].
The transcription factor NF-N% is a pivotal regulator of innate immunity and
inflammation, and is active in both immune cells and non-immune tissues [11, 12]. In
this capacity, the NF-N% pathway must rapidly decode signals and integrate intracellular
information to control individual cell fate decisions (proliferation, apoptosis,
differentiation, etc.) and regulate the production and secretion of cytokines that can
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amplify and propagate the inflammatory response [13, 14]. NF-N% dimers are typically
sequestered and held inactive in the cytoplasm through binding to isoforms of the
,N%family, with ,N%D representing the prototypical member and major regulator of
canonical NF-N% activity. TNFĮ-induced stimulation of NF-N% relies on activation of
the ,N%kinase complex (IKK), which phosphorylates ,N%D, marking it for subsequent
ubiquitination and proteasomal degradation [4]. This series of events liberates NF-N%,
allowing it to undergo nuclear translocation and activation of target gene expression,
including the ,N%D gene itself [15], thus establishing a critical transcriptionally-coupled
negative feedback loop (Fig. 1A, [16]). Recently, NF-N% has emerged as a mechanistic
link between inflammation and cancer [17, 18]. This has been extensively studied in the
liver where hepatocellular carcinoma (HCC) slowly unfolds on a background of chronic
inflammation (often triggered by exposure to infectious agents or toxic compounds) [19].
TNFĮ-induced activation of NF-N% signaling plays a pivotal role in liver homeostasis
and pathophysiology due to its capacity to induce both hepatocyte cell death and
proliferation [20, 21]. In the liver, NF-N% signaling can have both tumor promoting and
tumor suppressing effects that are dependent upon the type of cells (i.e., liver resident
macrophages vs. hepatocytes), the stimuli, and cell context [19, 22, 23]. Thus, a more indepth understanding of the complexities and intricacies of NFN% signaling in the liver is
required to appropriately translate the use of NF-N%-targeted therapeutics to liver
pathologies.
Because of its biological importance, the NF-N% pathway has emerged as an
exemplary proving ground for systems biology approaches that couple computational
modeling and cellular imaging with conventional cell biology methods to study dynamic
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NFN% responses to cytokines. These studies have shown that continuous stimulation or
sequential pulsing of TNFĮ can induce oscillations in NF-N% nuclear translocation that
are dependent upon cycles of degradation and re-synthesis of INB proteins (i.e., negative
feedback loops), and that the frequency of these NFN% oscillations encode distinct gene
expression profiles [8, 24-27]. Additional work has suggested that the amplitude of NFN% activity, but not the temporal profile, is particularly sensitive to changes in TNFĮ
concentration and is crucially dependent on the transient nature of IKK activity [28].
Recently, single cell imaging has emerged as a paradigm-of-choice to study the dynamics
of NF-N% nuclear localization as monitored by nuclear:cytoplasmic shuttling of NF-N%
proteins fused to fluorescent protein reporters. Coupled with computational modeling,
these single cell studies have revealed stochastic, heterogeneous, and paracrine NFN%
responses at the single cell level, especially in response to low concentrations of TNFĮ
[9, 10, 13, 29]. A key unresolved issue in the field relates to how biological robustness is
achieved within cell populations displaying heterogeneous and dynamic single-cell
behavior [13, 29, 30], and the physiologic relevancy of these single-cell phenomena to
tissue- and organ-level biological responses in vivo.
To this end, we have developed, characterized, and utilized a dynamic
bioluminescent reporter for quantitative interrogation of NF-N%:,N%D negative feedback
loop regulation in live cells and at the tissue-level in live animals.

Previously we

demonstrated that fusing ,N%D to the firefly luciferase gene (,N%D-FLuc) enables
quantitative monitoring of ,N%D degradation (which can be directly correlated to IKK
activity) in vitro and in vivo [31]. We then placed the fusion reporter under the control of
an NF-N% responsive promoter (NB5o,N%D-FLuc) and showed that it recapitulates the
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endogenous ,N%D negative feedback loop (i.e., IKK-directed ,N%D degradation and
subsequent NF-N% driven re-synthesis of the ,N%D gene; Fig. 1A) and complements in
silico experiments conducted with a robust computational model of the NF-N% pathway
[5, 6, 16]. This reporter offers the advantage of monitoring protein activity within
different subcellular compartments as opposed to simply measuring changes in total
protein levels or localization.

For example, N%o,N%D-FLuc reports both TNFD-

induced degradation of ,N%D (which is dependent on the activity of IKK, ȕ-TrCP, and the
proteasome) and subsequent NF-N%-dependent transcriptional up-regulation of ,N%D
(which is dependent upon NF-N% nuclear translocation as well as additional posttranslational modifications and co-activator associations in the nucleus). Additionally, the
synthetic NB5 promoter has enhanced sensitivity that enables measurement of subtle
changes in transcriptional dynamics. In the present work, we have exploited the unique
characteristics of this negative feedback loop reporter to rigorously characterize dynamic
,N%D responses in single cells, populations of cell, and in vivo upon stimulation with a
range of TNFĮ concentrations and pulses, revealing surprisingly synchronous responses.

3.2 RESULTS
Characterization of the Effect of Modulating TNFĮ Pulse Duration or
Concentration on the ,N%D:NFN% Negative Feedback Loop in Cell Populations.
The ,N%D:NFN% negative feedback loop represents a major regulatory node
within the NFN% pathway and is a critical determinant of NFN% oscillatory behaviors
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that encode stimulus-specific gene expression programs [8, 24-27, 29]. To temporally
resolve the dynamics of ,N%D degradation and subsequent NFN%-driven re-synthesis in
living cells, we used our previously validated N%o,N%D-FLuc fusion-protein reporter in
HepG2 (human hepatocellular carcinoma) cells [5, 31] (Fig. 1A). Western blot analysis
of HepG2 cells transiently transfected with the N%o,N%D-FLuc reporter and exposed to
170 pM (3 ng/mL) TNFĮ indicated that the reporter was expressed at sub-endogenous
levels and that the kinetics and degree of endogenous ,N%D and chimeric ,N%D-FLuc
degradation were similar (Fig. 1B). However, the quantitative kinetics of reporter resynthesis were delayed compared to endogenous ,N%D, a trend noted previously [5] and
likely due to promoter differences (synthetic N%5 vs. endogenous ,N%D promoter).
With this real-time bioluminescent reporter system, we systematically evaluated
the impact of short duration TNFĮ pulses on the dynamic regulation of the ,N%D:NFN%
negative feedback loop within populations of cells in culture. HepG2 cells transfected
with N%o,N%D-FLuc were stimulated with the pro-inflammatory cytokine TNFĮ (1.2
nM, 20 ng/ml) either continuously or as a pulse (5 sec, 15 sec, 30 sec, 5 min or 15 min)
and images of cells were captured sequentially every 5 min for 6 hr. Generally, the
normalized ,N%D-FLuc photon flux (Fig. 2A) rapidly decreased to a transient minimum
(due to TNFĮ-induced degradation of ,N%D) and then strongly rebounded above initial
levels (due to NFN%-induced re-synthesis of ,N%D). This rebound was previously
shown to be consistent with de novo transcription and translation of ,N%D[5] and with
the previously-reported ligand-induced stabilization of newly-synthesized ,N%D [32, 33].
Surprisingly, a TNFĮ pulse as short as 5 sec in duration was capable of inducing
substantial ,N%D degradation (35 ± 9%, mean ± SEM unless noted otherwise), suggesting
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that extremely brief exposure can induce significant IKK-dependent activation of
canonical NFN% signaling (Fig. 2A). This was confirmed by Western blot analysis,
which exhibited substantial ,N%Ddegradation in response to a 5 sec TNFĮ pulse (Fig.
2B). As TNFĮ pulse duration was lengthened from 5 sec to 15 min, the degree of ,N%D
degradation increased, and when pulsed for 5 min or longer ,N%D degradation saturated
at levels (~70%) equivalent to continuous TNFĮ stimulation (Fig. 2A, inset; Fig. 2C).
The time at which maximal degradation occurred did not change as TNFĮ pulse duration
was modulated (Fig. 2D).
Examination of the degree of ,N%D re-synthesis (measured as percent of
maximum re-synthesis) in response to TNFĮ pulse duration revealed increasing levels of
,N%D re-synthesis that eventually peaked and leveled-off when pulsed for 5 min or longer
(Fig. 2E). Interestingly, TNFĮ pulses elicited a broader ,N%D re-synthesis phase with a
less defined peak when compared to continuous TNFĮ stimulation.

Furthermore,

maximal ,N%D re-synthesis in response to a 15 min TNFĮ pulse was higher (97 ± 3% of
maximum) than observed for continuous TNFĮ stimulation (65± 8% of maximum). As
had been observed for ,N%Ddegradation, modulating TNFĮ pulse duration did not
greatly affect the timing of the re-synthesis peak (Fig. 2F), suggesting that these cell
populations were responding synchronously.

Additionally, peak ,N%Dre-synthesis

occurred later (164 ± 16 min vs. 137 ± 5 min) for a 15 min TNFĮ pulse when compared
to continuous.
We next investigated the impact of TNFĮ concentration on the dynamic
regulation of the ,N%D:NFN% negative feedback loop in cellulo by treating HepG2 cells
with a range of TNFĮ concentrations (0.1 - 10 ng/mL, 0.57 - 570 pM) under continuous
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exposure conditions (Fig. 2G).

The degree of ,N%D degradation increased with

increasing TNFĮ concentration, eventually saturating (68 ± 2%) at the highest
concentrations tested (Fig. 2G, inset; Fig. 2H), yielding a degradation EC50 value of 6.7
pM TNFĮ (5.7 to 7.9 pM, 95% confidence interval). Moreover, examination of ,N%D
degradation kinetics (Fig. 2I) showed that increasing TNFĮ concentration resulted in
faster degradation, with the time of maximal degradation shifting from 53 ± 4 min to 29 ±
2 min.
The relationship between TNFĮ concentration and ,N%D re-synthesis was more
complex than was seen for degradation. Increasing the TNFĮ concentration elicited
increasing levels of ,N%D re-synthesis up to a maximum (corresponding to 57 pM; 1
ng/mL TNFĮ) beyond which higher amounts of TNFĮ actually elicited lower levels of resynthesis (i.e., a “roll-over” back down to 74 ± 3% of maximum levels; Fig. 2G, J).
Furthermore, increasing TNFĮ concentration resulted in faster ,N%D re-synthesis kinetics,
with the maximal re-synthesis time shifting from 278 ± 39 min to 148 ± 3 min and
eventually leveling off at this time between 57 pM and 171 pM (Fig. 2K).
Thus, we found that the N%o,N%D-FLuc reporter enabled quantitative
comparison of the effects of modulating TNFĮ pulse duration versus concentration in
real-time in live cells. This systematic analysis revealed that ,N%D degradation was
highly sensitive to both stimulation regimens and in each case eventually saturated at
approximately 70% degradation. Modulation of TNFĮ pulse duration had little effect on
the kinetics of ,N%D degradation, while increasing TNFĮ concentration resulted in faster
degradation. Both stimulation regimens elicited biphasic patterns in the degree of ,N%D
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re-synthesis, but only modulation of TNFĮ concentration had a strong effect on resynthesis kinetics.
Characterization of TNFĮ-Induced Regulation of the ,N%D:NF-N% Negative
Feedback Loop in Single Cells.
Having discovered complex and reproducible patterns of ,N%D dynamics in
response to modulating TNFĮ pulse duration and concentration in live cultured cell
populations, we next utilized the N%o,N%D-FLuc reporter to investigate whether the
,N%D:NF-N% negative feedback loop exhibits similar dynamic response patterns at the
level of single cells, or whether single cell responses are less reproducible, and more
heterogeneous and asynchronous. In other words, are broad peaks and complex kinetics
measured within cell populations the sum of heterogeneous single cell behaviors rather
than the synchronous behavior of cells residing in a population?
We first verified that we could image single bioluminescent cells in the IVIS100
imaging

system

by

transiently

transfecting

HepG2

cells

with

a

dual

bioluminescent/fluorescent reporter construct, FUW-FLG, comprising pGL3 firefly
luciferase fused through a flexible linker to EGFP and driven by a constitutive ubiquitin
promoter [34]. HepG2 cells were transfected with this plasmid as described above for the
N%o,N%D-FLuc reporter; however, 36 hr after transfection the cells were trypsinized
into a single cell suspension, counted, diluted, and plated at a density of 60 cells/well on
top of pre-plated, untransfected HepG2 cells in a black 24 well plate (to best simulate the
same conditions used in the earlier cell population studies). After a 12 hr recovery
period, cells were imaged first for bioluminescence and then for fluorescence on an
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InCell 1000 imager (Fig. 3A).

We found an excellent correlation between single

bioluminescent foci and single cell fluorescence (a small number of foci corresponded to
two or three cells). Thus, single HepG2 cells expressing a dual-imaging reporter could be
imaged in a lawn of otherwise isogenic cells, establishing the principle for studying the
TNFĮ–induced responses of single HepG2 cells expressing N%o,N%D-FLuc.
Using this same procedure with HepG2 cells expressing N%o,N%D-FLuc, we
carried out both continuous- and 30 sec pulse-TNFĮ stimulations. Under continuous
stimulation, the ,N%D-FLuc profiles of individual cells (Fig 3B) remarkably resembled
those observed for cell populations (Fig. 2). Interestingly, while single cells exhibited
substantial heterogeneity in the amplitude of degradation and re-synthesis, collective
analysis of the ,N%D-FLuc re-synthesis peaks of individual cells strongly resembled the
trends observed in cell populations (Fig. 2A), each peaking at almost the exact same
times (133 ± 4 min vs. 137 ± 5 min, respectively), indicating that this pattern is a property
of single cell responses to continuous TNFĮ. On the other hand, a 30” pulse of TNFĮ
yielded much broader ,N%D-FLuc re-synthesis peaks for single cells (Fig. 3C), which
strongly resembled the broad peaks observed for population studies (Fig. 2A) also
peaking at very similar times (154 ± 2 min for single cells vs. 170 ± 23 min for
populations) and similarly showing a delayed peak compared to continuous treatment
(Fig. 2F and Fig. 3G). Again, strong heterogeneity was noted in the amplitude of ,N%DFLuc re-synthesis (Fig 3C), though the amplitudes of the average ,N%D-FLuc profile for
all individual cells combined and the ,N%D-FLuc profile observed for a population of
cells are nearly the same (Fig. 3C black line versus Fig. 2A red line). The degree of
,N%Ddegradation observed in TNFĮ pulsed cells was less than that observed under
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continuous TNFĮ, recapitulating another trend noted in the population studies (Fig. 2).
Interestingly, 18% of continuously stimulated cells exhibited ,N%D-FLuc oscillatory
behavior, peaking once at 109 min (102.9 to 114.6, 95% CI) and again at 244 min (227.4
to 261.3, 95 % CI) (Fig 3E); this phenomenon was never observed in cells given a 30 sec
TNFĮ.
We next investigated individual cell responses to a range of TNFĮ concentrations
under continuous stimulation as described previously for cell population studies (Fig. 2GK).

While heterogeneous ,N%D-FLuc amplitudes were again observed, an obvious

general trend emerged with most cells exhibiting increased levels of degradation and resynthesis as the TNFĮ concentration increased (Fig. 3F). At the lowest doses tested, 0.57
and 1.7 pM, many cells (62%) did not respond to TNFĮ stimulation (as defined by falling
within the 95% CI of vehicle stimulated cells and not exhibiting a local maximum; Fig.
3F, 0 pM panel). For each higher TNFĮ concentration, less than 7% of cells were nonresponders.

When all cells that did respond were considered, increasing TNFĮ

concentration resulted in faster ,N%D-FLuc degradation, with the time of maximal
degradation shifting from 65 ± 8 min to 20 ± 1 min, a trend similar to that seen in our
population studies (Fig. 2). However, we did not observe a strong pattern of shifting
,N%D-FLuc maximum re-synthesis times in relation to altering TNFĮ, though the lowest
concentrations did exhibit a higher degree of variance in peak times (Fig. 3I). This
heterogeneity in re-synthesis times at low doses could account for the broad peaks and
variability in peak timing observed at 0.57 pM and 1.7 pM in cell populations (Fig. 2G,
K). Thus, single cell ,N%D dynamic profiles showed highly synchronous kinetics and
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remarkable similarity to ,N%D dynamic profiles observed in cell populations, especially
with regard to profile shape under different conditions.

Experimental Investigation of Complex ,N%D Re-Synthesis Patterns.
Having observed novel and complex patterns in the dynamics of ,N%D
degradation and re-synthesis in single cells and cell populations (hereafter combined into
the term in cellulo) in response to modulation of TNFĮ pulse duration and concentration,
we next sought to investigate potential mechanisms behind these highly-reproducible
behaviors. We first examined whether the experimentally observed patterns of ,N%D
dynamics could be recapitulated in an existing computational model of TNFĮ-induced
NF-N% signaling [6, 16]. We reasoned that if mathematical modeling could reproduce
the TNFĮ-driven complexities observed for ,N%D degradation and re-synthesis, it may
offer insight into the fundamental processes driving these patterns and assist in the
development of experimentally-testable hypotheses.
The computational model utilizes experimentally-derived IKK kinase activity
input profiles, of which we employed a previously determined IKK input derived from
HepG2 cells stimulated continuously with 20 ng/mL TNFĮ [5]. The IKK activity input
profile (Fig. 4A) was fitted with a shape-preserving interpolating polynomial in MatLab
(function pchip) simulating the duration of the IKK activation phase (a), peak IKK
activity (p), and the duration of the IKK deactivation phase (d). In an effort to simulate
the complex patterns in ,N%D dynamics seen in cellulo in response to altering TNFĮ
pulse duration and concentration, the IKK input profile was modified in the following
ways: 1) alteration of IKK activation phase duration (a: 5, 10, 20, 40, and 80 min from 0
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to peak activity), 2) alteration of IKK deactivation phase duration (d: 20, 30, 50, and 100
min post peak activity), or 3) alteration of IKK peak activity magnitude (p: 0.5-, 1-, 3-, 6,
and 10-fold over the previous experimentally-determined IKK activity peak). These
modifications resulted in a collection of 80 IKK activity profiles that could be used as
input functions into the model (Fig. 4A, Fig. S1) to generate predicted ,N%D dynamic
profile plots (Fig. 4B,C; S2). Generally, there was a remarkable correlation between the
computationally-predicted ,N%D profiles and the experimentally-generated ,N%D-FLuc
profiles (Fig. 2, 3), with the timing and extent of ,N%D degradation as well as the overall
dynamic behavior being highly similar. However, as noted previously [5], the
computationally-predicted amplitude of ,N%D re-synthesis was lower than seen for ,N%DFLuc and the kinetics of re-synthesis were faster, discrepancies that may stem from the
amplified sensitivity of the concatenated NB5 promoter driving ,N%D-FLuc.
Interestingly, we found that when the time required for IKK to deactivate was
prolonged from 20 min to 100 min (Fig. 4B, S2), no effect was observed upon ,N%D
degradation, but the magnitude of ,N%D re-synthesis increased with little effect on the
kinetics, resembling the ,N%D re-synthesis patterns observed upon stimulation with TNFĮ
pulses (Fig. 2, 3). On the other hand, increasing the magnitude of peak IKK activity (Fig.
4C, S2) yielded computational ,N%D plots in which both ,N%D degradation and resynthesis were enhanced and exhibited faster kinetics, strongly resembling the ,N%D
dynamics observed when TNFĮ concentration was modulated (Fig. 2, 3). However,
modifying IKK magnitude did not recapitulate ,N%D re-synthesis roll-over, even though
,N%D degradation had saturated.
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Thus far we had observed that (1) pulses of TNFĮ in cellulo strongly affected the
level of ,N%D re-synthesis without impacting the kinetics or shape of ,N%D re-synthesis
profiles and could be modeled in silico by altering the timing of IKK deactivation, and
(2) modulating TNFĮ concentration in cellulo affected the amplitude, kinetics, and shape
of ,N%D re-synthesis and could be accurately recapitulated in silico (with the exception of
re-synthesis roll-over) by modulating IKK peak magnitude. We hypothesized that many
of these complex patterns in ,N%D re-synthesis are a consequence of the continuous
presence of TNFĮ driving subsequent rounds of IKK-activation (i.e., possibly mimicking
prolonging the IKK deactivation phase in silico) and ,N%D degradation during the resynthesis phase. This hypothesis was supported by our previous finding that HepG2 cells
given a 30 sec pulse of TNFĮ regain the capacity to fully re-initiate a second TNFĮinduced ,N%D degradation only after 60-120 min, the approximate time frame during
which maximal ,N%D re-synthesis and roll-over occur [5].
To assess the impact of TNFĮ presence at various time points before and during
,N%Dre-synthesis, HepG2 cells were treated with increasing concentrations of TNFĮ that
was then washed out after 1, 5, 10, 15, 30, 60, 90, 120, and 180 min to remove the effect
of continuous TNFĮ driving subsequent rounds of IKK-mediated ,N%D degradation.
Two representative ,N%D plots are shown in Fig. 4D, E (un-normalized photon flux data
and additional TNFĮ and mock wash-out plots are shown in Fig. S3). The removal of
TNFĮ at any time before ,N%D re-synthesis had peaked (i.e., up to 120 min), resulted in
broadly shaped ,N%D re-synthesis profiles (Fig. 4D, S3), rather than the narrower peaks
seen under continuous TNFĮ (Fig. 2, 3) or mock TNFĮ wash-out stimulation (Fig. S3).
TNFĮ wash-outs performed at 120 min (Fig. S3) and 180 min (Fig. 4E) exhibited the
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expected primary ,N%D re-synthesis peak observed at 120 min under continuous TNFĮ,
followed by a second ,N%D peak (occurring at approximately 240 min and 300 min,
respectively), more similar to the peaks observed for earlier TNFĮ wash-out times (Fig.
4D, S3). When high concentrations of TNFĮ (170-570 pm) were washed out, cells
exhibited significantly higher levels of ,N%D re-synthesis compared to continuous TNFĮ
stimulation (Fig. 4F).

Furthermore, TNFĮ wash-out resulted in ,N%D re-synthesis

peaking later than continuously stimulated cells and nearly abolished the pattern of faster
,N%D re-synthesis observed in response to increasing TNFĮ concentration (Fig. 4G).
Additionally, ,N%D re-synthesis roll-over was still observed when TNFĮ was washed out
(Fig. 4F).
To further address the role of secondary (i.e., later time point) TNFĮ-induced
,N%D degradation in governing ,N%D-FLucre-synthesis phase dynamics, we utilized a
modified bioluminescent reporter, N%o,N%D(S32,36A)-FLuc [35].

The serine-to-

alanine substitutions render ,N%D unresponsive to IKK-directed phosphorylation and
subsequent proteasomal degradation; however, the reporter is still responsive to the
NFN% transcriptional activity elicited once endogenous ,N%D is degraded and NF-N%
translocates into the nucleus. If re-initiation of ,N%D degradation is critical in governing
the timing, magnitude and overall shape of ,N%D re-synthesis, or the re-synthesis rollover effect, then we would not expect to observe these phenomena with the
N%o,N%D(S32,36A)-FLuc reporter under continuous TNFĮ stimulation. As anticipated,
TNFĮ stimulation did not cause any ,N%D degradation (Fig. 4H), but did exhibit
subsequent NF-N%-directed re-synthesis of the reporter. Strikingly, these ,N%D profiles
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strongly resembled the TNFĮ wash-out experiments (Fig. 4D, E, S3): the ,N%D resynthesis phases were broad (regardless of TNFĮ concentration), the peak magnitude
increased (Fig. 4F), and the re-synthesis kinetics were more synchronized and delayed
(Fig. 4G) compared to wild type reporter, indicating that these patterns were indeed
affected by secondary IKK-driven degradation of wild-type ,N%D. Similarly, continuous
TNFĮ stimulation in single HepG2 cells transfected with the ,N%D(S32,36A)-FLuc
mutant reporter also exhibited broad IN%D re-synthesis peaks with synchronized and
delayed kinetics compared to wild-type reporter (Fig 3D, G), further highlighting the cellautonomous nature of these trends in IN%D dynamics.

Characterization of TNFĮ-Induced Regulation of the ,N%D:NF-N% Negative
Feedback Loop In Vivo.
Having discovered complex and synchronous patterns of ,N%D dynamics in
response to modulating TNFĮ pulse duration and concentration in single cells and in cell
populations in culture, we then utilized the N%o,N%D-FLuc reporter to investigate
whether the ,N%D:NFN% negative feedback loop exhibits similar patterns in response to
varying TNFĮ doses in vivo. Somatic gene transfer by hydrodynamic transfection was
employed to express the N%o,N%D-FLuc plasmid in murine livers [36]. Three to
twelve weeks post plasmid injection, sufficient time for hepatocellular recovery and
stable integration of reporter plasmids into a subpopulation of hepatocytes, animals were
administered vehicle (PBS) or TNFĮ (1, 10, or 30 ng/mouse) by bolus tail vein injection
and imaged at 5 min intervals for 3 hr to capture full ,N%D-FLuc dynamic profiles (Fig.
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5A, B). Strikingly, the general dynamics of the in vivo ,N%D profiles were highly
synchronous and strongly resembled the profiles observed in cellulo in response to TNFĮ
pulses (Fig. 2,3). Of the three TNFĮ doses used, the lowest (1 ng/mouse) appeared to
induce little or no ,N%D-FLuc reporter degradation, whereas the two higher doses showed
increasing amounts of degradation (Fig. 5C; 10 ng/mouse: 30% ± 7%; 30 ng/mouse: 59%
± 7%). Interestingly, the time of maximal degradation appeared to occur slightly earlier
in vivo (no later than 20 min, Fig. 5D) than was seen in cellulo (no earlier than 25 min for
the highest TNFĮ concentrations, Fig. 2D). Increasing the TNFĮ dose resulted in higher
levels of maximal re-synthesis (Fig. 5E) that peaked at nearly 20-fold over vehicle treated
animals. The re-synthesis phase was broad in shape (similar to the in cellulo ,N%D
profiles in response to TNFĮ pulses), and peaked and leveled off at approximately 100
min for both the 10 and 30 ng/mouse doses (Fig. 5F). This is in contrast to the highest
TNFĮ concentrations used in cellulo that did not achieve maximal re-synthesis until ~150
min (Fig. 2). Thus, even though TNFĮ was administered at varying doses in vivo, the
resultant ,N%D dynamic profiles exhibited kinetics that were highly synchronous,
suggesting uniform cellular responses within the liver. These in vivo patterns of ,N%D
dynamics closely resembled the patterns observed upon modulating TNFĮ pulse duration
in cellulo (Fig. 2, 4), and suggested that circulating TNFĮ is perceived by hepatocytes in
vivo as a pulse.
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3.3 DISCUSSION
Cells have evolved complex molecular networks to sense signals from the
environment and translate them into a wide variety of biological responses. The NF-N%
pathway is responsive to a variety of stimuli and to the mode of stimulation, which is of
critical importance during responses to inflammatory cytokines, such as TNFĮ, which are
likely perceived as transient pulses/waves occurring over a wide range of concentrations
[5, 7-10, 28]. Of particular interest is understanding how these diverse TNFĮ stimulation
modes impact the NF-N%:,N%D negative feedback loop in single cells and within
populations of cells in vivo, providing insight into a key cellular regulatory loop that
directs NFN% nuclear localization dynamics and transcriptional responses.
To this end, we have developed, characterized, and utilized a dynamic
bioluminescent reporter (N%o,N%D-FLuc) for quantitative interrogation of NFN%:,N%D negative feedback loop regulation in single cells, cell populations, and in vivo.
These non-destructive assays are based on luciferase reporters and as such, do not rely on
antibodies, have high temporal resolution, are amenable to high-throughput platforms, are
readily translatable to in vivo systems, and have potential for low-light microscopic
analysis of single cell and sub-cellular compartments [30, 37-40]. We have employed the
unique capabilities of our NF-N%:,N%D negative feedback loop reporter, coupled with in
silico modeling, to systematically interrogate the impact of modulating TNFĮ pulse
duration and concentration. We demonstrated that cells are sensitive to pulses of TNFĮ
stimulation as short as 5 sec (Fig. 2A, B), highlighting that the NF-N% network is
remarkably sensitive and tuned to elicit responses to very short bursts of ligand [7].
Increasing TNFĮ pulse duration did not strongly impact the kinetics or shape of ,N%D re-
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synthesis or generate re-synthesis roll-over, but did exhibit ,N%D re-synthesis levels that
tended to be higher and broader in shape than seen for continuous TNFĮ stimulation (Fig.
2). At the single cell level, continuous and 30 sec TNFĮ pulses (Fig 3B, C) yielded
,N%D-FLuc dynamic profiles that remarkably resembled the shape of the cell population
data (Fig. 2). Thus, the broad peaks observed in cell populations upon stimulation with
pulsatile TNFĮ are not a result of heterogeneous responses from individual cells
generating a broad average, but are an intrinsic property of single cell responses.
Additionally, most of the cells exhibited synchronous responses, as evidenced by the tight
95% confidence intervals (Fig. 3G) on the kinetics of peak re-synthesis. In the future, it
will be interesting to determine the impact of a wide range of TNFĮ pulses on the
heterogeneity of single cell responses, especially since our data indicate that the kinetics
of ,N%D degradation and re-synthesis do not significantly change as pulse duration
increases (Fig. 2). A similar trend in invariant temporal NF-N% nuclear localization was
observed by Werner et al. [7] in response to TNFĮ pulses; however, they did not observe
changes in the amplitude of NF-N% activity (as measured by EMSA and computational
prediction), while our reporter measured definitive pulse-dependent changes in the
amplitude of ,N%D re-synthesis, a process that is dependent upon NF-N% transcriptional
activity.
Additionally, real-time measurements indicated that the ,N%D:NF-N% negative
feedback loop is responsive to a wide range of TNFĮ concentrations, even as low as 0.57
pM (0.01 ng/mL), affirming what has been observed previously by NF-N% EMSA [28]
and single cell microscopy [9, 10]. Both of these TNFĮ stimulation paradigms (pulsing
cells or varying concentration) elicited increasing levels of ,N%D degradation that
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eventually saturated at ~70% degradation.

However, only changes in TNFĮ

concentration exhibited robust alteration of the temporal dynamics of degradation, with
degradation rates increasing as TNFĮ concentration increased (Fig. 2I). Interestingly,
this same trend held true at the single cell level, indicating that it is an inherent property
of TNFĮ responses in single cells (Fig. 3H). Whereas Paszek et al. [29] looked at the
time to ,N%Ddegradation following TNFĮ stimulation using RelA-dsRedxp and ,N%DEGFP fusion reporters and observed very degradation heterogeneous start times at 1.7
pM (0.03 ng/mL) TNFĮ (sometimes 100+ minutes post-TNFĮ), we observed that most
cells exhibited degradation of the N%o,N%D-FLuc reporter within 0-60 min and showed
re-synthesis peaks between 120-18 min TNFĮ (Fig. 3H, I). And while both Tay et al.
[10] and Paszek et al. [29] noted that the time to peak nuclear NF-N% in individual cells
tended to increase and became more variable at lower TNFĮ concentrations, we observed
very little change in the average peak re-synthesis time of the N%o,N%D-FLuc reporter
(a functional read-out of nuclear NF-N% activity), but it did exhibit greater heterogeneity
at the lowest concentrations tested (Fig. 3I).
Having observed novel and complex patterns in ,N%D dynamics in response to
modulation of TNFĮ pulse duration and concentration in single cells and cell populations,
we next sought to investigate potential mechanisms behind these highly-reproducible
behaviors.

We discovered that these complex ,N%D re-synthesis patterns (with the

exception of re-synthesis roll-over) resulted from the continuous presence of TNFĮ
initiating re-activation of IKK and driving secondary rounds of ,N%D degradation (Fig.
3D, 4). Previously, we and others discovered a TNFĮ-induced transient refractory period
during which TNFĮ-preconditioned cells are unable to fully respond (i.e., degrade ,N%D)
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upon a second TNFĮ challenge until 60-120 min post preconditioning [5, 8, 41]. This
refractory period is likely governed by the rate of ,N%D:NFN% nuclear export that
repopulates the cytoplasm with IKK-degradable complexes [5, 40, 42, 43]. Thus, we
suggest that the observed patterns in ,N%D re-synthesis dynamics are a manifestation of
this transient refractory period, whereby continuous TNFĮ is unable to induce a
subsequent round(s) of ,N%D degradation until the passage of this refractory period.
Interestingly, the single cell imaging experiments also revealed that 18% of cells
continuously stimulated with TNFĮ exhibited ,N%D-FLuc oscillatory behavior, with an
approximate period of 130 min (Fig. 3B, E).

This may correlate to the NF-NB

nuclear:cytoplasmic oscillations observed by others with a period of ~100 min [8-10, 2427], and may be slightly longer due to the time required to transcribe and translate new
,N%D-FLuc. This oscillation phenomenon was never observed in cells given a 30 sec
TNFĮ (Fig. 3C) or cells expressing the ,N%D(S32,36A)-FLuc mutant reporter (Fig 3D),
highlighting the critical role that secondary ,N%D degradation plays in the oscillation
phenotype.
After rigorous characterization of the TNFĮ-induced response patterns of the
N%o,N%D-FLuc reporter in single cells and cell populations in culture, we took
advantage of the amenability of luciferase reporter imaging in vivo to interrogate TNFĮinduced activation of the ,N%D:NF-N% negative feedback loop within mouse livers. Our
data indicated that circulating TNFĮ, administered at varying doses, produced ,N%D
dynamic behaviors in vivo (Fig. 5) with synchronized kinetics and very high levels of
,N%D re-synthesis, patterns that were consistent with in cellulo experiments in which
TNFĮ pulse duration was varied (Figs. 2, 3, 4). This strongly suggested that circulating
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TNFĮ is perceived by liver cells as a pulse, also plausible given the dual re-circulation
physiology of the liver (hepatic arterial and portal venous) as well as hemodilution
effects. This finding underscores the importance of studying cytokine signaling pathways
under conditions of pulsatile exposure (rather than just continuously bathing cells in
ligand) that may better reproduce physiologic cytokine stimulation paradigms.
Furthermore, while several in silico and in vitro studies have demonstrated highly
heterogeneous and/or asynchronous NF-N% responses to TNFĮ at the single cell level that
are largely masked when individual cells are averaged together into populations [8-10,
24, 26, 29], our single cell, cell population, and in vivo data indicated that ,N%D
degradation and re-synthesis is surprisingly robust and synchronous. These data, coupled
with the low frequency at which we observed ,N%D-FLuc oscillatory behavior, place
reservations on the physiologic relevance of the highly heterogeneous and oscillatory NFN% behaviors observed during continuous TNFĮ stimulation of single cells. On the other
hand, our data do support the relevancy of the synchronous NF-N% oscillatory behaviors
that are observed upon sequential TNFĮ pulsing and that drive frequency-encoded
transcriptional programs [8, 10].
Thus, our work revealed that the NF-N%:,N%D negative feedback loop exhibits
differential and reproducible dynamic patterns in response to modulating TNFĮ
concentration or pulse duration, and that responses to TNFĮ exhibited a remarkable
degree of synchronicity at the level of single cells, cell populations, and in vivo.
Interestingly, administration of TNFĮ at varying doses in vivo resulted in hepatocyte
responses that were most consistent with perception of TNFĮ as a single concentration
administered with increasing pulse duration.
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3.4 METHODS
Plasmids. The N%o,N%D-FLuc plasmid was produced by cloning an EcoRI – HpaI
(blunt) fragment from CMVo,N%D-FLuc [31] into the EcoRI and EcoRV (blunt) sites of
N%oFLuc [5]. The N%o,N%D(S32,36A)-FLuc mutant plasmid was prepared by
Quikchange mutagenesis (Stratagene, San Diego, CA, USA) following the protocol
provided by the manufacturer [35]. The FUW-FLG plasmid encoding a fusion of FLuc
and EGFP proteins driven by the human ubiquitin C promoter within an established
lentiviral backbone has been previously described [34]. All plasmids were propagated in
TOP10 electrocompetent E. Coli (Invitrogen, Carlsbad, CA) and purified using Hi-Speed
Plasmid Maxi kits (Qiagen, Valencia, CA).

Cell culture and transfection. HepG2 human hepatoma cells were from the American
Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in DMEM
supplemented with heat-inactivated FBS (10%) and L-glutamine (2 mM). Cell cultures
were grown at 37oC in a humidified 5% CO2 atmosphere. HepG2 cells (3 X 105) were
transiently transfected (Fugene 6, Roche, Indianapolis, IN) with N%o,N%D-FLuc (100
to 200 ng/well) and plated in black-coated 24-well plates (In Vitro Systems GmbH,
Gottingen, Germany). Cells were then allowed to recover for 48 hr prior to imaging.

Dynamic bioluminescence imaging measurements in live-cell. Prior to analysis by
bioluminescence imaging, HepG2 cells transiently expressing N%o,N%D-FLuc were
washed with pre-warmed phosphate-buffered saline (PBS, pH 7.4) and incubated in 900
ȝL of assay buffer (colorless sodium bicarbonate-buffered DMEM supplemented with
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heat-inactivated FBS (10%), L-glutamine (2 mM), and D-luciferin (150 ȝg/mL)). Cells
were allowed to equilibrate for 30 min (at 37°C in a 5% CO2 atmosphere) before
stimulation with 100 ȝL of pre-warmed assay buffer with or without TNFĮ (#210-TA050, R & D Systems, Minneapolis, MN). Bioluminescence measurements were acquired
in IVIS 100 imaging system (Caliper Life Sciences, Hopkinton, MA) at 37°C under 5%
CO2 flow. Typical acquisition parameters were as follows: acquisition time, 30-60 sec;
binning, 8 or 16; FOV, 10 or 23 cm; f/stop, 1; filter, open; image-image interval, 5 min;
total number of acquisitions, 73. Where indicated, cells were transiently exposed to TNFĮ
for the specified durations and concentrations, washed with pre-warmed PBS, returned to
pre-warmed assay buffer (with or without TNFĮ) and imaged as above. Bioluminescence
photon flux (photons/sec) data were analyzed by region of interest (ROI) measurements
in Living Image 3.2 (Caliper Life Sciences); this raw data was imported into Excel
(Microsoft Corp., Redmond, WA) or Sigma Plot 8.0 (Systat Software Inc., San Jose, CA)
and averaged, normalized to initial (t = 0) values (fold-initial), and normalized to vehicletreated controls (fold-vehicle) to generate ,N%D dynamic plots (for an example of unnormalized photon flux data, refer to Fig. S4A). Quantification of the amplitude and
timing of ,N%D degradation and re-synthesis was carried out in Excel; in the few
instances of noisy ,N%D data, a moving-average smoothing function was applied to ease
determination of true maximum ,N%D amplitudes and kinetics.

Single-cell bioluminescence imaging measurements. Cells were transfected as
described above with either the N%o,N%D-FLuc plasmid or the FUW-FLG construct,
but at 36 hr post-transfection were trypsinized, counted, diluted, and plated at 60
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cells/well onto pre-plated, untransfected HepG2 cells (3 X 105 cells/well plated at the
same time as initial transfection) in a black 24 well plate.

Proof of principle

bioluminescence and fluorescence measurements were acquired 12 hr later in gridded
black 24 well plates. Bioluminescence was imaged on an IVIS50 with the following
acquisition settings: acquisition time, 5 min; binning, 8; FOV, 4 cm; f/stop, 1; filter,
open; instrument, IVIS50. GFP expression was then analyzed on the InCell Analyzer
1000 using a 10X objective and by collecting 300 fluorescent and brightfield images with
a 10% overlap to allow image stitching. This large format image of the entire well,
coupled with the visible grid on both the fluorescent and bioluminescent image overlays
(Figure 3A), allowed easy correlation of bioluminescent foci with fluorescent cells.
Additional image processing and overlays were performed in ImageJ.
Full single-cell bioluminescence imaging sequences were acquired by stimulating
the cells exactly as described previously for cell populations with the following changes
to image acquisition settings on the IVIS100: acquisition time, 5 min; binning, 8; FOV,
10 cm; f/stop, 1; filter, open; image-image interval, 0 min; total number of acquisitions,
73. Bioluminescence photon flux (photons/sec) data were analyzed by region of interest
ROI measurements in ImageJ by drawing circular ROIs around each distinct glowing foci
visible at t = 0 min. This raw photon flux data was then imported into MatLab and fitted
with a fifth-degree polynomial to find the time of the first re-synthesis peak. Cells falling
within the 95% CI of the signal of vehicle stimulated cells were labeled non-responders
and excluded from time of min and max determinations.
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Western blot analysis. HepG2 cells were cultured in 35 mm dishes and stimulated with
TNFĮ (at the indicated concentrations) either continuously or as a 30 sec pulse. At the
indicated time points, cells were harvested and lysed in RIPA buffer (150 mM NaCl, 50
mM Tris, 5 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, pH 7.4),
supplemented with protease inhibitor cocktail (Roche, Basel, Switzerland), sodium
orthovanadate (1 mM), and PMSF (1 mM). Whole-cell lysates were normalized for
protein content by BCA assay (Pierce, Rockford, IL). Proteins were resolved by SDSPAGE (7.5% Biorad Precast Tris HCl or 4%-15%, Biorad Criterion Tris-HCl, Hercules,
CA), transferred to a PVDF membrane and probed with ,N%D antibody (#9242, Cell
Signaling Technology, Inc., Danvers, MA), GAPDH antibody(#G9545, Sigma, St. Louis,
MO), and Ȗ-Tubulin antibody (#sc-17787, Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). Secondary horseradish peroxidase-IgG antibodies were from GE Healthcare
Biosciences (Piscataway, NJ), and blots were exposed on the IVIS 100 imaging system.
Densitometric analysis was performed with Living Image 3.2 (Caliper Life Sciences) and
Excel software.

Hydrodynamic injections and in vivo imaging. In vivo transfection of mouse
hepatocytes was performed using the hydrodynamic somatic gene transfer method as
described [44, 45]. Briefly, N%o,N%D-FLuc (3 ȝg) was diluted in PBS (pH 7.4) in a
volume of 1 ml per 10 g of body weight and rapidly injected into tail veins of mice
(FVB/N, 6-week-old males) [45]. Imaging for luciferase activity was performed 3-12
weeks after somatic gene transfer; mice used more than once were allowed to recover for
8 weeks before use in another round of imaging. Cohorts of 4 mice were injected with D-
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luciferin (150 ȝg/g of body weight, i.p.), anesthetized under 2.5% isofluorane, and
imaged 10 min later in the IVIS 100 (acquisition, 4 min; binning, 8; FOV, 23 cm; f/stop,
1; filter, open) to obtain a pre-TNFĮ stimulation image. Following this, the mice were
then quickly administered 100 ȝL of vehicle (sterile PBS) or TNFĮ (at the indicated
concentrations) by tail vein i.v., placed back in the IVIS, and imaged every 5 min for 3 hr
under anesthesia. Uniform ROI’s were drawn around the liver, and total photon flux was
measured and normalized to the pre-TNFĮ stimulation levels (fold-initial) and to a
vehicle-treated animal (fold-vehicle).

Computational Concentration-Response Analysis. A well established computational
model generated by Hoffman et al. [16] and modified by Werner et al. [6] was used to
simulate ,N%D dynamics in response to varying IKK activity profiles.
A physiologic IKK activity profile in HepG2 cells was generated by kinase assay
following continuous TNFĮ (20 ng/µL) treatment and then interpolated and extrapolated
in 5 min intervals to a total time of 360 min by Moss, et al. [5]. To allow manipulation,
this experimentally obtained profile was reduced to three components of IKK activity:
activation phase duration (a), peak activity magnitude (p), and deactivation phase
duration (d) (Fig. 4A). The following values were used for each parameter: a = [5, 10, 20,
40, 80] min, p = [0.5, 1, 3, 6, 10] fold initial, d = [20, 30, 50, 100] min. A simple
algorithm was then developed to generate 80 unique parameter combinations (with the
constraint that the sum of (a) and (d) does not exceed 120 min), each defined by four
points that were then interpolated using MatLab function pchip, a shape preserving
interpolant (Fig. S1). These 80 IKK activity profiles were used as inputs into the
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computational model and the differential equations were solved numerically using
MatLab R2010b (Mathworks, Natick, MA) with subroutine Ode15. From these IKK
inputs, the model predicted the dynamics of six different free and bound ,N%D
subpopulations (free ,N%Dcyt, ,N%D:IKKcyt, ,N%D:NFN%cyt, ,N%D:IKK:NFN%cyt, free
,N%Dnuc, and ,N%D:NFN%nuc). Because live cell bioluminescence imaging of «B5-,N%DFLuc could not distinguish between these distinct ,N%D subpopulations, we summed the
concentrations of the six predicted subpopulations and plotted the 80 predicted total ,N%D
profiles as a function of time (Fig. S2).

Statistical Analysis. Statistical significance was evaluated using Students t test for ,N%DFLuc re-synthesis patterns (Fig. 4F,G).
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3.5 FIGURES

Figure 3.1: N%o,N%D-FLuc Bioluminescent Reporter System. (A) The N%o,N%DFLuc bioluminescent reporter utilizes an ,N%D gene fused by a flexible linker to a firefly
luciferase (FLuc) gene under the control of a synthetic NFN% promoter (N%5), thus
recapitulating the endogenous negative feedback loop. (B) HepG2 cells were transiently
transfected with N%o,N%D-FLuc and stimulated continuously with TNFĮ (170 pM; 3
ng/mL). Lysates were collected at the indicated time points, resolved on a 7.5% SDSPAGE gel, and blotted for ,N%D and GAPDH (loading control).
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Figure 3.2: ,N%D Dynamics as a Function of TNFĮ Pulse Duration & Concentration.
(A) HepG2 cells transiently expressing N%o,N%D-FLuc were pulsed with a saturating
concentration of TNFĮ (1.2 nM; 20 ng/mL) or vehicle for the indicated durations with
data acquisition over a period of 360 min. Data were normalized as fold-initial and foldvehicle (relative to cells pulsed with vehicle for the same duration), and represent the
mean of three independent TNFĮ exposure experiments, each performed in duplicate and
averaged. (B) HepG2 cells were stimulated with a 5 sec pulse of TNFĮ (1.2 nM; 20
ng/mL) and lysates were collected to capture ,N%D degradation and re-synthesis. Lysates
were resolved together on a 4-15% gradient gel and blotted for endogenous ,N%D and ȖTubulin (loading control). (C,D) Plots representing the extent of maximal ,N%D
degradation (C), and the time at which maximal ,N%D degradation occurred (D), as
functions of TNFĮ pulse duration. (E, F) Plots representing the extent of maximal ,N%D
re-synthesis (expressed as a percentage of the maximum level of re-synthesis achieved in
a given experiment) (E), and the time at which maximal ,N%D re-synthesis occurred (F),
as functions of TNFĮ pulse duration. Note that the x-axis is plotted on a log scale (min)
in (C-F). (G) HepG2 cells expressing N%o,N%D-FLuc were continuously treated with
TNFĮ or vehicle at the indicated concentrations and bioluminescent data were acquired
for 360 min. Data were normalized as before and represent three independent
experiments, performed in triplicate and averaged. (H, I) Plots representing the extent of
maximal ,N%D degradation (H), and the time at which maximal ,N%D degradation
occurred (I), as functions of TNFĮ concentration. (J, K) Plots representing the extent of
maximal ,N%D re-synthesis (J), and the time at which maximal ,N%D re-synthesis
occurred (K), as functions of TNFĮ concentration. The x-axis is plotted on a log scale
([TNFĮ] pM) in panels H-K.
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Figure 3.3: Characterization of ,N%D Dynamics in Single Cells. (A) Image of a single
well of a 24 well plate with bioluminescent foci representing sparsely plated HepG2 cells
transiently expressing the FUW-FLG luciferase-EGFP fusion reporter. Insets represent
10X fluorescent micrographs of the indicated bioluminescent foci, demonstrating that
most foci represent a single transfected cell, and occasionally a small group of 2-3 cells.
(B-E) Single HepG2 cells transiently expressing N%o,N%D-FLuc (B,C) or
N%o,N%D(S32,36A)-Fluc (D) were given continuous (B, D) or a 30 sec pulse (C) of
TNFĮ (1.2 nM; 20 ng/mL). Data were normalized as fold-initial, and data from two
independent experiments are plotted together. Black lines represent the mean and red
dashed lines represent the 95% confidence interval of the vehicle-treated controls. (E)
Select examples of ,N%D-Fluc oscillations observed in some of the cells from (B). (F)
Single HepG2 cells transiently expressingN%o,N%D-FLuc were continuously treated
with TNFĮ or vehicle at the indicated concentrations. (G-I) Scatter plots representing
the time of maximum re-synthesis (G) calculated from data in (B-D), and the time of
minimum degradation (H) and re-synthesis (I) from data in (F).
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Figure 3.4: Experimental Investigation of Complex ,N%D Re-Synthesis Patterns.
(A) A physiologic IKK time-activity plot obtained by Moss & Gross et al. shown in red
was reduced to four points capturing three components of IKK activity: activation rate
(activation time parameter a), peak magnitude (parameter p), and deactivation rate
(deactivation time parameter d). Each of the three IKK activity parameters described in
(A) were modified to generate a total of 80 IKK input profiles (inset). (B) Effect of IKK
deactivation (d) on ,N%D dynamics when a and p were held constant at 10 min and 1X
fold-initial, respectively. (C) Effect of IKK peak magnitude (p) on ,N%D dynamics when
a and d were held constant at 10 min and 30 min, respectively. (D, E) HepG2 cells
expressing N%o,N%D-FLuc were treated with the indicated TNFĮ concentrations or
vehicle at t = 0 min. At 60 or 180 min, the cells were washed and replenished with fresh,
TNFĮ-free media (wash-out conditions) or media containing TNFĮ at the initial
concentration (a mock wash-out). Data were acquired every 5 min for 360 min and
normalized as before to represent the mean of three or four independent TNFĮ exposure
experiments, each performed in triplicate and averaged. (F) Plot representing the effect
of washout time and TNFĮ concentration (5.7 pM or higher) on maximum ,N%D resynthesis magnitude. All 180 min data represent parameters calculated from the second
,N%D re-synthesis peak. Data are mean ± SEM. * indicates p < 0.05 for TNFĮ (170 or
570 pM) wash-out or mutant ,N%D(S32,36A)-FLuc versus continuous TNFĮ wild-type
,N%D-FLuc. The 30 min and 60 min data were n = 2 and thus were excluded from
statistical analysis. (G) Plot representing the effect of wash-out time and TNFĮ
concentration on the timing of maximum ,N%D re-synthesis. # indicates p < 0.05 for
lowest vs. highest TNFĮ concentration within a given TNFĮ treatment. (H) HepG2 cells
expressing N%o,N%D(S32,36A)-FLuc were treated continuously with TNFĮ at the
indicated concentrations or with vehicle and imaged every 5 min for 360 min; data were
normalized as described previously and represent three independent experiments, each
performed in triplicate and averaged.
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Figure 3.5: ,N%D Dynamics as a Function of TNFĮ Dose In Vivo. (A) In
vivo transfection of mouse hepatocytes was performed using the hydrodynamic somatic
gene transfer method. Mice were imaged in an IVIS 100 to obtain a pre-stimulation
reading, followed by tail vein injection of 100 µL of vehicle (sterile PBS) or TNFĮ (at the
indicated doses), and then imaged at 5 min intervals for 3 hr. (B) Data from five
independent experiments are plotted normalized to the pre-TNFĮ stimulation levels (foldinitial) and to a vehicle-treated animal (fold-untreated); error bars represent mean ± SEM.
(C-F) Quantitative analysis of in vivo measurements from that represent the extent of
maximal ,N%D degradation (C) and re-synthesis (E), and the time of maximal ,N%D
degradation (D) and re-synthesis (F), as functions of TNFĮ dose. All data are presented
as mean ± SEM; the x-axis is plotted on a linear scale. The 1 ng/mouse data point in (D)
represents n = 3 because two animals showed no degradation at that dose and thus no
degradation time could be calculated.
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3.6 SUPPLEMENTARY FIGURES

Supplemental Figure 3.1: Modified IKK Input Profiles. (A) The duration of the IKK
deactivation phase and the IKK peak magnitude were held constant while the duration of
the IKK activation phase was modulated. (B) The duration of the IKK activation phase
and the IKK peak magnitude were held constant while the duration of the IKK
deactivation phase was modulated. (C) The durations of the IKK activation and
deactivation phases were held constant, while the IKK peak magnitude was modulated.
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Supplemental Figure 3.2: Predicted ,N%D Dynamic Profiles in Response to
Modulating IKK Activation, Deactivation, and Peak Magnitude. (A) The duration of
the IKK deactivation phase and the IKK peak magnitude were held constant while the
duration of the IKK activation phase was modulated. (B) The duration of the IKK
activation phase and the IKK peak magnitude were held constant while the duration of
the IKK deactivation phase was modulated. For a more detailed view, see Fig. 4B. (C)
The durations of the IKK activation and deactivation phases were held constant, while the
IKK peak magnitude was modulated. For a more detailed view, see Fig. 4C.
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Supplemental Figure 3.3: Representative Raw Data and Normalized Plots from
Mock and TNFĮ Wash-Out Experiments. (A-H) HepG2 cells expressing N%o,N%DFLuc were treated with the indicated TNFĮ concentrations or vehicle at t = 0 min. At the
indicated time point, the cells were washed and replenished with fresh, TNFĮ-free media
(wash-out conditions) or with media containing TNFĮ at the initial concentration (a mock
wash-out). Images were taken every 5 min for 360 min; data were normalized as foldinitial and fold-vehicle, and the mean of three or four independent TNFĮ exposure
experiments, each performed in triplicate and averaged, was plotted against time; the data
in the mock wash-out plots represent a single experiment performed in triplicate. (I) The
raw photon flux (photons/sec) from three wells each treated with the indicated
concentration of TNFĮ were measured, averaged, and plotted as a function of time. A
slight perturbation in signal is noted at 60 min when the cells were washed with PBS and
placed back into TNFĮ- or vehicle-containing media; the perturbation also occurred in
the vehicle-treated control (gray circles), and is thus accounted for when the data is
normalized as fold-initial and fold-vehicle (Fig. S3F).
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CHAPTER FOUR
High-Throughput Phosphatase RNA Interference Screen
Identifies Novel Regulators of TNFĮ-Induced IKK:IțBĮ:NFțB Negative Feedback Loop Dynamics

4.1 INTRODUCTION
It is currently believed that activation/de-activation of IKK (and other members of
the

NF-NB

signaling

cascade)

is

regulated

by

the

opposing

effects

of

kinases/phosphatases [1], and although a large body of literature exists on the
mechanisms by which kinases act during NF-NB signaling, much less is known about the
role of phosphatases in regulating members of the NF-NB signal cascade. A number of
phosphatases have been implicated in negative regulation of IKK activity and in
regulation of NF-NB activity (including PP2Cȕ, PP2A, PP1, PPM1A, PPM1B and
WIP1), and they often operate to counteract the activity of a kinase. Study of these
phosphatases has revealed differential activity dependent on stimulus and cell specificity,
redundant or compensatory pathways, and positive and negative regulatory roles
(occasionally based on conflicting evidence; for example, PP2A has been posited by
some to be a positive regulator of IKK and others claim it to be a negative regulator) [211].

Furthermore, an RNAi phosphatase library was recently utilized to identify

unknown phosphatase regulators of NF-NB transcriptional activity in mouse astrocytes
[9]. The authors identified 19 phosphatases that activate or suppress NF-NB activity 6-8

hours post-TNFĮ stimulation; their work indicated that the PP2A catalytic subunit
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interacts with and inactivates IKKȕ, however, this function was not conserved in the
context of human cell lines [8]. Given that our țB5oIțBĮ-FLuc reporter had enabled us
to study the IKK-IțBĮ-NF-NB negative feedback loop with high temporal resolution
[12], and given that temporal control of this and other negative feedback loops has
emerged as a critical regulatory component of the intensity and specificity of the NF-NB
transcriptional program [13-16], we sought to perform an RNAi screen to identify novel
regulators of IKK-IțBĮ-NF-NB negative feedback loop dynamics.

4.2 RESULTS
Optimization of siRNA and țB5ĺ IțBĮ-FLuc co-transfection in 96 well plate
format.
We initially intended to perform the high-throughput RNAi screen by transfecting
siRNAs into HepG2 cells stably transfected with a bi-directional pBI Tet vector to
simultaneously express țB5ĺIțBĮ-CBR and a constitutive SV40ĺCBG (which could
be used to normalize for cell number and non-specific effects induced by siRNA
knockdown and/or other experimental conditions). The two-color imaging capabilities
on the IVIS 100 bioluminescence imager, coupled with spectral un-mixing software, can
allow deconvolution of the signals from each of these reporters [17]. Additionally, the
Tet-inducible pBI plasmid system would have given us the ability to “dial-in” an optimal
level of reporter expression (i.e., allow expression optimization for high signal-to-noise
and effective dynamic range). Pilot transient transfection experiments with the pBIțB5ĺIțBĮ-CBR/SV40ĺCBG reporter revealed leaky expression of both reporters and
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doxycycline-induction actually dampened the dynamic range (amount of IțBĮ-CBR
degradation and re-synthesis) of the țB5ĺIțBĮ-CBR reporter.

Attempts at making

stable HepG2 Tet-ON cells with the pBI-țB5ĺIțBĮ-CBR/SV40ĺCBG reporter were
unsuccessful. Efforts were then focused towards employing HepG2 cells transiently
expressing the pBI-țB5ĺIțBĮ-CBR/SV40ĺCBG reporter construct and making use of
the fact that leaky expression gave reasonable dynamic range and TNFĮ dose
responsiveness. After scaling down to 96 well plate format and testing a panel of
plasmid/siRNA co-transfection reagents, X-TremeGENE (Roche) was chosen and cotransfections of siRNA and plasmid reporter were optimized. This was accomplished by
using control siRNAs designed against either IțBĮ or CBR; when these siRNAs are
efficiently transfected they will knock-down bioluminescent signal from the țB5ĺIțBĮCBR portion of the reporter, a phenotype that is easily quantified by imaging cellular
bioluminescence.

It was found that optimal knock-down of luciferase signal was

achieved using 50 ng/well reporter, 88 ng/well siRNA, and 0.8 µL/well X-TremeGENE
with a 48 hr transfection.
Using the optimized co-transfection protocol, we stimulated HepG2 cells with
TNFĮ (20 ng/mL) and measured the effect of siRNA expression upon IțBĮ dynamics. It
became apparent that HepG2 cell expression levels of SV40ĺCBG in 96 well plate
format were too low to reliably use for normalization purposes, and for that reason,
taking a series of red, green, and open filtered images for each time point was adding
unnecessary complexity. Therefore, the decision was made to abandon the pBI vector,
and go back to our original țB5ĺIțBĮ-FLuc construct. Several unsuccessful attempts
were made to develop HepG2 cells stably expressing the țB5ĺIțBĮ-FLuc, so we
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subsequently began optimizing transient co-transfections of this plasmid reporter and
siRNA. We were able to achieve robust knock-down using X-tremeGENE and to
successfully perform real-time imaging of IțBĮ-FLuc dynamics with high-temporal
resolution, allowing us to investigate not only changes in the amplitude of IțBĮ-FLuc
degradation and re-synthesis (as typically measured in high-throughput screens), but also
the effect of siRNAs on the kinetic aspects of the negative feedback loop (i.e., times of
maximal degradation and re-synthesis, rate of re-synthesis, and re-synthesis lag time).

Optimization of a novel method by which high-throughput robotic screening
strategies can be used to assay for alterations in the dynamics (both amplitude and
kinetics) of the IKK:IțBĮ:NF-țB negative feedback loop.
Once the optimal conditions for bioluminescent reporter and siRNA cotransfection were determined, we sought to develop, optimize, and determine the
robustness of a novel method for robotic high-throughput RNAi screening that would
allow us to assay for phosphatases involved in regulating INBD dynamics.

The

Washington University High-Throughput Screening Robotics Core (HTC) has purchased
an siRNA phosphatase library (consisting of 444 duplexes against 222 phosphatases and
phosphatase-associated genes in the human genome; Qiagen, Inc.) as well as a BeckmanCoulter Biomek FX dual bridge liquid handler, bar-code printer and independent reader, a
lid station capable of removing and replacing lids, a tip-lift, an ambient temperature
carousel, a heated, humidified CO2 incubator and a MultiDrop dispensing station. These
instruments are controlled by the Sagian SAMI software and accessed by a Sagian ORCA
robot.
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A script was written to program the robot and liquid handler to perform triplicate
co-transfections of țB5ĺIțBĮ-FLuc reporter and siRNA from a library plate onto three
96 well plates pre-plated with HepG2 cells (see a detailed description of this protocol in
the Methods Section).

Each library plate contained 80 experimental siRNAs (two

different duplexes/well towards the same target) arrayed in Columns 2-11, two negative
control siRNAs (a scrambled negative control sequence and a sequence targeting GFP) in
the last two wells of Column 12, and the remaining wells in Columns 1 and 12 were
empty to allow addition of screen-relevant positive, negative, and transfection controls.
The additional controls we added were: (1) siTNFR1 as a positive control for nonresponse to TNFD treatment, (2) siFLuc as a control of transfection efficiency, (3) Qiagen
AllStars siNeg as a negative control, (4) siPPP2CA as a biological positive control given
its known role as a regulator of IKK, and (5) no siRNA as a control for transfection
toxicity (Figure 4.1).
Of critical importance to our screen was acquiring data with high temporal
resolution that would enable evaluation of kinetic parameters of the IKK-IțBĮ-NF-țB
negative feedback loop. Due to the fast rate of photon flux change at certain times post
TNFĮ stimulation, bioluminescence images must be taken at least every 5 min, with all
wells of a 96 well plate being imaged simultaneously. The only instrument available to
us with this capability is the aforementioned IVIS 100 bioluminescence imager (Caliper
Life Sciences, Inc.), which also allows controlled temperature and CO2 conditions.
A test transfection was carried using a test library plate and three plates of preplated HepG2 cells. Forty-eight hours post-transfection, cells were stimulated with TNFĮ
and bioluminescence imaging was carried out for 6 hr on the IVIS to capture a set of full
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dynamic IțBĮ profiles.

The knock-down efficiency, as measured by a decrease in

luciferase signal in wells transfected with siFLuc, was 87.1 ± 0.3 % (mean ± SD),
indicating efficient siRNA transfection. Bioluminescent photon flux values (normalized
as fold-initial) from each control well were graphed as a time course (Figure 4.2). The
data showed good correlation of controls within plates during the IțBĮ-FLuc degradation
phase (with Plate 2 demonstrating more intra-plate variability). TNFR1 knock-down
completely abolished responsiveness to TNFĮ stimulation while PPP2CA knock-down
showed little effect on the degree of degradation when compared to no siRNA or siNeg
controls. A higher degree of intra- and inter-plate variability was noticed during the
IțBĮ-FLuc re-synthesis phase, but siTNFR showed no evidence of re-synthesis, and
siPPP2CA treatment resulted in slowed re-synthesis rate and decreased amplitude
compared to negative controls. This gave us confidence that novel phosphatase siRNAs
that impact IțBĮ-FLuc dynamics could be readily discerned from negative control
siRNAs during the subsequent screen.

Execution of phosphatase RNAi screen to identify novel regulators of IțBĮ
dynamics in the presence of TNFĮ-induced stimulation.
The screen was performed by co-transfecting the phosphatase siRNA library with
the țB5oIțBĮ-FLuc reporter in HepG2 cells in 96 well plate format (Figure 4.3). The
co-transfected cells were then stimulated with TNFĮ and imaged for luciferase
bioluminescence under (for more details, see Methods section). This regimen provided a
dynamic read-out with high-temporal resolution, allowing us to investigate not only
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changes in the amplitude of degradation and re-synthesis (as typical high-throughput
screens monitor), but also the effect of siRNAs on the kinetic aspects of the negative
feedback loop (i.e., times of maximal IțBĮ-FLuc degradation and re-synthesis, rates of
re-synthesis, and re-synthesis lag times). Though other RNAi screens have been
published looking for novel regulators (including phosphatases) of the NF-țB pathway
([7, 9, 18]), most have examined down-stream NF-țB transcriptional activity many
hours-to-days following pathway stimulation and none have honed in specifically on the
IKK-IțBĮ-NF-țB negative feedback loop or on the kinetic aspects of NF-țB signaling.
The raw bioluminescence time course data was normalized as fold initial and then
graphed as a first-pass examination of quality control (see example plate in Fig. 4.4). We
noted that within a triplicate, the replicates were tight correlated in regard to IțBĮ-FLuc
degradation and re-synthesis rate, though more variability was observed in magnitude of
peak re-synthesis. Of particular note was the variety of IțBĮ-FLuc dynamic profiles
observed, many with vastly different shapes than seen under control siRNA treatment.
For example (Fig. 4.4) some wells exhibited very sharply defined re-synthesis peaks (row
5, column 6) and others had much broader peaks (row 7, column 5); some wells showed
higher levels of re-synthesis (row 3, column 4) and others less re-synthesis (row 7,
column). Surprisingly, when focusing on the IțBĮ-FLuc degradation phase (Fig. 4.4) we
observed that the experimental siRNAs did not greatly affect shape, degree, or kinetics of
IțBĮ-FLuc. The few exceptions were siRNAs that seemed to prolong the duration of the
degradation phase (for example row 6, column 2).
While the controls within a given plate triplicate were very tightly correlated, we
observed a minor degree of inter-plate (across the three siRNA library plates) control
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well variability during screen run #1 and a larger degree during run #2. This variability
may have stemmed from the fact that the screen inherently monitors a common stressactivated pathway with highly sensitive temporal and dynamic readouts. Thus, we chose
to analyze the phosphatase screen data on a plate-by-plate basis rather than screen-wide.
While this method makes it difficult to rank hits found on one plate against hits found on
another, it does somewhat overcome the non-random alphabetic placement of siRNAs
within library plates, an issue that can result in over-representation of hits from one plate.
Additionally, hits from each plate can be ranked against each other during secondary
screening analysis.

Rigorous statistical analysis of phosphatase screen data and identification of highconfidence hits.
The raw bioluminescent photon flux data was normalized as fold-initial as a
means of intra-well normalization. The phosphatase screen was analyzed plate-by-plate
due to high variability observed within internal controls between plates. Three different
approaches were undertaken to analyze the screen data and determine hits. The first
approach was a quartile-based method that is robust to outliers, true hits, and nonsymmetrical data [21, 22] and that has been successfully used in previous highthroughput screens [19]. The second approach was to apply unbiased K-means clustering
and Principal Component Analysis (PCA) for exploratory data analysis and to group
siRNA treatments based on similarity of corresponding IțBĮ-FLuc bioluminescent
profiles.

The third approach, cumulative log-likelihood analysis, was based on a
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Gaussian probability density function and allowed us to rank the deviation of an
experimental siRNA treatment from the negative controls screen wide (personal
communication with Dr. Joshua Swamidass and Mr. Reece Goiffon).
In quartile-based analysis, both raw photon flux data and fold-initial normalized
data from each run of the screen were analyzed plate-by-plate.

A total of seven

parameters were chosen for evaluation (Figure 4.5):
(1) Initial Photon Flux Level (the raw photon flux signal at t = 0 min)
(2) Degradation Level (i.e. the minimum flux or fold-initial signal detected during
IțBĮ-FLuc degradation)
(3) Degradation Time (the time at which minimum occurred)
(4) Re-Synthesis Level (the maximum flux or fold-initial signal achieved during
IțBĮ-FLuc re-synthesis)
(5) Re-Synthesis Time (the time at which maximal re-synthesis occurred)
(6) Re-Synthesis Rate (the slope of re-synthesis between the minimum and
maximum)
(7) Re-Synthesis Lag Time (the value of the x-intercept of the linear regression of the
IțBĮ-FLuc re-synthesis rate)

The first five parameters were determined by descriptive statistics methods and the last
two parameters were defined and analyzed by linear regression of the IțBĮ-FLuc resynthesis phase. Hits were identified for each parameter using a quartile-based method
that is robust to outliers, true hits, and non-symmetrical data [19, 20]; statistical analysis
was completed using both low stringency (targeted error rate ¢ = 0.05) and high
stringency (targeted error rate ¢ = 0.0027) cut-offs. The collections of hits from each
independently-run screen were then compared and the common strong and weak hits for
each parameter are listed in Supplemental Table 4.1; a summary of strong hits for fold110

initial analysis are presented in Table 4.1.

The known IKK regulators PPP1CB,

PPP2CA, and PPP2C (the catalytic subunits of protein phosphatase 1 and protein
phosphatase 2) showed up as weak hits in re-synthesis rate and maximum, confirming the
ability of this screening technique to identify known regulators of NF-țB signaling [2, 3,
5, 6, 8-10].
However, this analytical technique was not ideal for our time course data for a
number of reasons: (1) many of the IțBĮ-FLuc profiles had shapes that made regression
analysis and determination of peak re-synthesis parameters difficult or impossible, (2)
rather than relying on single points on the curve (minimums, maximums, etc), we sought
a method that would allow simultaneous analysis of many or all data points along the
IțBĮ-FLuc profile, and (3) we sought a means of quantifying differences/similarities in
IțBĮ-FLuc profiles that are qualitatively obvious. We attempted to address some of
these issues by the use of data clustering approaches, specifically by using unbiased Kmeans clustering and Principal Component Analysis (PCA) for exploratory data analysis
and to group siRNA treatments based on similarity of corresponding IțBĮ-FLuc
bioluminescent profiles. Unfortunately, we found that overall these techniques did not
contribute greatly to our data analysis, mainly because the minor degree of control well
inter-plate variability proved to be a more significant issue during clustering, and the
resultant multi-dimensional clusters were often difficult to interpret and did not
significantly contribute information that could not easily be validated qualitatively.
The third analytical method, cumulative log-likelihood, was undertaken to
compensate for inter-plate variability and for the non-random array of siRNAs. This
technique quantifies the degree of deviation for a given siRNA treatment from the
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negative controls (Fig. 4.6). This method adjusts for confounding variance that otherwise
prevents direct comparisons between plates. More specifically, we first made a Gaussian
probability density function at each time point based on the mean and variance of the
plate negative controls. We then input each siRNA measurement into this function to
quantify the normalized deviation from the set of negative controls.

To combine

replicates, and to later make a cumulative sequence, we prevented computational
rounding error by taking the negative logarithm of the likelihood (log-likelihood) and
summing (log A + log B = log AB). In general, the greater the difference from the
negative controls the greater the log-likelihood value for a given siRNA. The siRNA
were then ranked and visualized in a bar graph in which each division of the bar height
represents the contribution of an individual time point to the cumulative log-likelihood
value (Sup. Fig. 4.1). This rank-based method allows for approximate comparison
between plates and precise comparison within each plate. In addition, the bars were
colored-coded based on Directional Replicate Agreement, wherein a value of ±3 means
all plates within the triplicate agreed and were either above or below the negative
controls, and a value of ±1 means imperfect agreement, with one of the replicates
deviating from the others because it registered differentially above or below the negative
controls.
Table 4.2 lists the top 10 hits from each plate separated into degradation phase, resynthesis phase, and cumulatively for both degradation and re-synthesis considered
together. The degradation phase analysis (Sup. Fig. 4.1) had low log-likelihood values
(indicating they were not strongly different than controls) and many of the siRNAs
exhibited directional replicate disagreement (denoted by green and yellow shading).
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While the known IKK regulators PPP1CB, PPP2CA and PPP2CB (the catalytic subunits
of protein phosphatase 1 and protein phosphatase 2) were identified as weak hits (i.e.
falling towards the center of rank graphs), the recently identified PPM1A frequently
showed up as a medium strength hit (i.e., towards the left end of the rank graphs) when
considering both degradation and re-synthesis, confirming the ability of this screening
technique and analytical method to identify true regulators of NF-țB signaling [2-11].
This confirmed that the log-likelihood means of analysis could be successfully applied to
dynamic time course data from a high-throughput RNAi screen, and may represent a new
paradigm for analysis of this type of data.

Execution of a focused secondary RNAi screen in the presence of TNFĮ or IL-1ȕ.
Next, a focused secondary screen was executed. Preparation for the secondary
screen was initiated prior to the development of the log-likelihood analytical method;
therefore, hits for the secondary screen (Figure 4.7) were chosen based on the strongest
stringency hits from each parameter analyzed by the quartile-based method (the results of
both resazurin normalized and un-normalized data analysis were included). This screen
was performed with the purposes of (1) ranking the top hits from both runs across all
plates, and (2) comparing TNFĮ- and IL-1ȕ-induced IțBĮ-FLuc dynamics to determine
whether any of the top hits from the primary screen exhibited a TNFĮ-specific phenotype
(understanding of which could potentially expedite mechanism-of-action investigations
for the top hits). The 39 top hits from quartile-based analysis, 5 siRNAs that did not
show up as strong or weak hits, and scrambled negative control siRNAs were re-arrayed
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into a 96 well master plate (Fig. 4.8). The secondary screen was carried out using the
procedures described for the primary screen (see Methods), however one half each plate
was stimulated with 20 ng/mL TNFĮ and the other half with 10 ng/mL IL-1ȕ. The raw
bioluminescence time course data was normalized as fold-initial and then graphed (see
example plate in Fig. 4.9). The IțBĮ-FLuc re-synthesis phase of control siRNA wells
under IL-1ȕ stimulation mostly resembled TNFĮ-treated controls, except that at “peak”
re-synthesis the signal kept gradually drifting up rather than reaching plateau. Visual
comparison of the TNFĮ-stimulated wells versus the identical IL-1ȕ-stimulated wells
revealed no obvious strong differences between the two different ligands, indicating that
these top hits are likely general regulators of the NF-țB pathway rather than regulators of
ligand-specific induction of the pathway.
Data were analyzed using the log-likelihood method described above given the
limitations of quartile-based analysis mentioned previously, especially on a small data
set. As was noted previously for the primary screen, the degradation phase analysis (Sup.
Fig. 4.2) had low log-likelihood values (indicating they were not strongly different than
controls) and many of the siRNAs exhibited directional replicate disagreement (denoted
by green and yellow shading). Furthermore, a number of the non-hit and negative siRNA
controls (denoted in bold) ranked high, giving further indication that the degradation
phase did not significantly differ from negative controls. Log-likelihood analysis of the
re-synthesis phase revealed a number of strong hits with large log-likelihood values and
consistent directional replicate agreement (Sup. Fig. 4.2). Upon knock-down, CDNK3,
PPFIA3, ENPP3, SKIP and PPP1R3D exhibit IțBĮ-FLuc re-synthesis profiles with a
faster rate of re-synthesis and higher or more pronounced peak re-synthesis (i.e., negative
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regulators).

Additionally, PTPN3, PTPRJ, and PTPRN were identified as possible

positive regulators (i.e., knock-down produced IțBĮ-FLuc re-synthesis profiles with
slower rate of re-synthesis and lower or delayed peak re-synthesis). The top 15 loglikelihood hits for degradation, re-synthesis, and degradation combined with re-synthesis
are listed in Table 4.3

Validation of PTPRJ as a Novel Regulator of IKK:IțBĮ:NF-țB Negative Feedback
Loop Dynamics.
PTPRJ was chosen for validation as an interesting candidate positive regulator of
IKK:IțBĮ:NF-țB negative feedback loop dynamics given that, (1) it had a very strong
phenotype in the screen, (2) it is a receptor-type tyrosine phosphatases with no known
function in NF-țB signaling, and (3) because researchers at Washington University in St.
Louis had recently identified a novel mutation of PTPRJ through a DNA deepsequencing screen of genome remodeling in basal-like breast cancer [21].
First, four siRNA sequences targeting PTPRJ were transiently co-transfected
along with the țB5oIțBĮ-FLuc reporter plasmid into HepG2 cells.

Cells were

stimulated with TNFĮ and imaged for 6 hr in the IVIS100 to capture full IțBĮ-FLuc
bioluminescent profiles. Interestingly, only one sequence showed a similar phenotype as
observed in the primary and secondary screens (sequence #5; Fig. 4.10): prolonged IțBĮFLuc degradation phase, decreased rate of IțBĮ-FLuc re-synthesis, and lower IțBĮ-FLuc
re-synthesis peak that is not sharp peak but instead yields a gradually-rising plateau. This
same siRNA was confirmed to knock-down endogenous PTPRJ expression (by 50%) in
HepG2 cells (Fig. 4.10, inset).
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Given that only one siPTPRJ sequence resulted in a phenotype similar to that seen
in the screens, we next sought to use shRNA to more stably and thoroughly knock-down
PTPRJ expression in HepG2 cells. Four different PTPRJ hairpin shRNAs (and a shGFP
negative control) were packaged into lentivirus and used to infect HepG2 cells.
Following selection, HepG2 cells expressing the shRNAs were transiently transfected
with the țB5oIțBĮ-FLuc reporter as previously described, stimulated with TNFĮ, and
imaged. The strongest knock-down (as quantified by Western blot; Fig. 4.11, inset) was
achieved with hairpins 21 and 22; the strongest IțBĮ-FLuc phenotype was noted for
hairpin 21.

Even though several siRNA sequences and shRNA hairpins did not

reproduce the PTPRJ phenotype observed in the screen, we felt that we had sufficient
compelling evidence to proceed with further investigation of the potential role of PTPRJ
in the NF-țB pathway.
We next tested the hypothesis that over-expression of PTPRJ should enhance
TNFĮ-induced IțBĮ-FLuc re-synthesis. Compared to empty vector control, PTPRJ overexpression yielded greater levels of IțBĮ-FLuc degradation and greater re-synthesis (Fig.
4.12). A phosphatase-dead mutant form of PTPRJ (C1239S; [22]) was also tested and we
found that it similarly enhanced IțBĮ-FLuc degradation, but not re-synthesis. These
same constructs were also tested in HepG2 cells against a simple NF-țB transcriptional
activity reporter (țB5oFLuc) to assess the effect of PTPRJ over-expression on basal NFțB activity and TNFĮ-induced transcriptional activity. We found that PTPRJ overexpression tended to give lower basal levels of bioluminescence from the țB5oFLuc
reporter when compared to either empty vector or the C1239S mutant (Fig. 4.13).
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Furthermore, upon stimulation with TNFĮ, cells over-expressing wild-type PTPRJ
showed enhanced activation compared to either control.
Additional follow-up on hits from the phosphatase screen is ongoing.

Of

particular interest will be CDKN3 which strongly impacted IțBĮ-FLuc re-synthesis
levels, and PTPRN which phenocopies PTPRJ. Initial knock-down experiments have
proven difficult, so future validation studies will utilize protein over-expression
methodologies.

4.3 DISCUSSION
It is currently believed that activation/de-activation of IKK (and other members of
the

NF-NB

signaling

cascade)

is

regulated

by

the

opposing

effects

of

kinases/phosphatases [1], and while much effort has been directed towards understanding
the mechanisms by which kinases act during NF-NB signaling, much less is known about
the role of phosphatases in regulating members of the NF-NB signal cascade. One of the
critical regulatory nodes known to be regulated by kinases and phosphatases is the IKKIțBĮ-NF-NB negative feedback loop [2-11]. Furthermore, this negative feedback loop
plays a major role in regulating the strength and duration of NF-NB transcriptional
activity [13-16]. Therefore, we performed a high-throughput phosphatase RNAi screen
to identify novel regulators of the dynamics of the IKK-IțBĮ-NF-NB negative feedback
loop utilizing our țB5oIțBĮ-FLuc reporter.
Our unique screen was carried out with high temporal resolution (taking images
every 5 min for 6 hr) in order to fully capture both degradation and re-synthesis of the
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țB5oIțBĮ-FLuc reporter upon stimulation with TNFĮ, with the hope of identifying
siRNA targets that might strongly impact kinetic aspects of feedback loop regulation.
We observed many different țB5oIțBĮ-FLuc profiles in the screen, some with vastly
different shapes than seen under control siRNA treatment (Fig. 4.4). Surprisingly, when
focusing on the IțBĮ-FLuc degradation phase, we did not observe siRNAs that exhibited
strong effects on IțBĮ-FLuc shape, degree, or kinetic.

It is possible that strong

degradation phase hits were not observed because the degradation phase has a small
dynamic range and is dependent on signal decrease, or because the screen was run using a
saturating concentration of TNFĮ (20 ng/mL) that could have masked the effects of some
weaker degradation regulators. In the future, it could prove useful to run similar screens
under a range of TNFĮ concentrations to assess whether hits with weaker effects can be
identified.
Because our phosphatase screen dataset contained IțBĮ-FLuc dynamic profiles of
a variety of shapes and sizes, we sought an analytical method that would allow us to
quantify how different the overall profile (or select sections of the profile) was from
negative controls. This led to the application and optimization of log-likelihood analysis,
a method that was able to identify known pathway regulators (PPP1CB, PPP2CA,
PPP2CB, and PPM1A; Sup. Fig. 4.1). This confirmed that the log-likelihood means of
analysis could be successfully applied to dynamic time course data from a highthroughput RNAi screen, and may represent a new paradigm for analysis of this type of
data.

We then successfully applied this method to our secondary screen data and

identified a number of novel hits (Sup. Fig. 4.2), including CDNK3, PPFIA3, ENPP3,
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SKIP, PPP1R3D PTPN3, PTPRJ, and PTPRN (Table 4.3). Many of these hits are part of
ongoing validation studies in our lab, including PTPRJ.
The human receptor-type protein tyrosine phosphatase type J (PTPRJ, also known
as DEP-1 and CD148) is a trans-membrane receptor that is involved in signal
transduction in leukocytes, contributing to cellular differentiation processes, and is found
on the surface of several epithelial cell types [23]. Additionally, as its name might imply,
it was found in fibroblasts cell lines to become upregulated 10-fold in cultures grown at
high-density [24], suggesting another role in sensing cell-contacts and in densitydependent growth inhibition. Additionally PTPRJ has emerged as a tumor suppressor
capable of negatively regulating cell proliferation and motility [25, 26]. PTPRJ tends to
negatively interfere with surface receptor signaling at several levels, including at the level
of receptor tyrosine kinases (such as PDGFR, VEGFR2, and MET) and downstream
mediators of cell signaling pathways (including PKB/Akt, SRC, p120 catenin, and
ERK1/2) [22, 27-29]. Recently, a PTPRJ mutation was found to be highly enriched in
both metastasis and xenograft in a DNA sequencing screen of genome remodeling in
basal-like breast cancer [21], and missense polymorphisms of PTPRJ were found to
influence susceptibility to a wide spectrum of cancers [30].
In our screen, PTPRJ emerged as a positive regulator of TNFĮ-induced IțBĮFLuc dynamic profiles: knock-down of PTPRJ resulted in a prolonged IțBĮ degradation
phase and a dampened re-synthesis phase (Fig. 4.9). This phenotype was confirmed
using siRNA and shRNA knock-down strategies (Fig. 4.10, 4.11). When we overexpressed PTPRJ in HepG2 cells, we found increased TNFĮ-induced IțBĮ degradation
and re-synthesis, as well as enhanced NF-țB transcriptional activity (Fid. 4.12, 4.13).
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This data would suggest that PTPRJ can act to enhance TNFĮ-induced activation of NFțB signaling (a pro-proliferative signal), and that loss of PTPRJ would result in delayed
or decreased NF-țB activation (a more anti-proliferative effect). Thus, in the context of
NF-țB signaling, and in contrast to its previously known roles, PTPRJ seems to be acting
to positively regulate TNFĮ-induced activation of NF-țB signaling. Further validation
and investigation of the mechanism by which PTPRJ impinges upon the NF-țB pathway
will hopefully confirm this novel new role for PTPRJ and lead to investigation of the
physiological and/or pathophysiological relevance of PTPRJ in NF-țB signaling.
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4.4 METHODS
High-throughput primary siRNA screen. siRNA screening was performed in black,
clear-bottomed, 96-well culture plates (Corning 3904) using a Beckman-Coulter Core
robotics system, including an FX liquid handler, controlled by the Sagian graphical
method development tool (SAMI scheduling software). A day prior to transfection, we
manually seeded 10,000 cells in complete medium (DMEM supplemented with 10%
heat-inactivated fetal bovine serum (ǻFBS) and 1% glutamine) at 150 µl/well into three
plates. Plates were maintained in an environmentally controlled incubator until needed
for operations, thereby optimizing health and uniform treatment of all plates. Prior to
transfection, siRNA library plates were thawed from -80C and centrifuged to pool the
siRNA in the bottom of the well. Experimental siRNA oligos were pre-arrayed in
columns 2-11 of each plate and individual controls comprising mock-transfected wells,
non-targeting AllStars Negative Control sequence (siNeg, Qiagen Inc.), Firefly
luciferase-targeting PGL3 siRNA (Integrated DNA Technologies, Inc.), TNFR1 targeting
sequences (siTNFR1, Integrated DNA Technologies, Inc.), and a PPP2CA siRNA
(siPP2Ca, Integrated DNA Technologies, Inc.) were placed manually in columns 1 and
12 (Figure 4.1).
Forward co-transfection of siRNA and plasmid reporter was performed in
triplicate. First, țB5oIțBĮ-FLuc reporter plasmid was diluted into serum-free media
and transferred onto one siRNA library plate (containing enough siRNA to transfect three
identical cell plates) with a 96 multichannel head on the FX liquid handler and allowed to
incubate for 5 min at room temperature. Next, 50 uL of X-TremeGENE (Roche, Inc.)
transfection reagent, diluted in serum-free media, was added to the plasmid/siRNA
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mixture with a 96 multichannel head on the FX liquid handler, mixed, and allowed to
incubate for 15 min at room temperature. Subsequently, 30 uL/well of this mixture was
transferred to the three previously seeded cell plates to a final concentration of 50 ng/well
reporter plasmid, 0.8 uL/well X-TremeGENE reagent, and 88 ng siRNA/well in a final
volume of 180 uL. Plates were maintained in an incubator for 24 hrs, and then aspirated
and 150 uL/well of fresh colorless full media was added using the FX liquid handler.
At 48 hours post-transfection, D-luciferin (Biosynth) was added using the FX
liquid handler to a final concentration of 150 µg/mL bringing the final volume up to 180
uL/well. Cells were allowed to equilibrate in this media for 30-60 min before the
addition 20 uL/well of TNFĮ (20 ng/mL final concentration; #210-TA-050, R&D
Systems, Minneapolis, MN) or vehicle (D-luc imaging media).

Bioluminescence

measurements were acquired in an IVIS 100 imaging system (Caliper Life Sciences,
Hopkinton, MA) at 37°C under 5% CO2 flow for 6 hr. Typical acquisition parameters
were as follows: acquisition time, 15-30 sec; binning, 4-8; FOV, 25 cm; f/stop, 1; filter,
open; image-image interval, 5 min; total number of acquisitions, 73. Immediately postIVIS imaging, phase contrast photographs were acquired on the InCell 1000 (three 10X
fields of view per well). Cell viability was then determined with resazurin dye (Sigma
R7017) (final conc., 44 µM after a 2 hr incubation at 37ºC as monitored on a FLUOstar
OPTIMA fluorescence reader (BMG Labtech); excitation, 544 nm, emission, 590 nm).
This procedure was repeated twice for all three plates of the Qiagen Human Phosphatase
siRNA Library 2.0.
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Focused secondary siRNA screen. The top hits from the primary screen were rearrayed onto a single master plate by the FX liquid handler using a cherry-picking script
written by Jayne Marasa. The master plate (Fig. 4.8) was arrayed such that columns 1
and 12 were duplicates of control siRNAs: 3 Qiagen AllStars negative control sequences,
4 non-hit phosphatases selected at random from the library (PPP2R5C, ENpp1, and
PTPN13), and 1 siFLuc transfection control. Columns 2-6 and 7-11 were duplicates of
the 39 strong stringency hits from the primary screen plus 1 scrambled negative control
from the phosphatase library plate. All subsequent transfections, incubations, media
changes, and measurements were performed as previously described with the exception
that one half of the plate was stimulated with TNFĮ (20 ng/mL final concentration) and
the other half with IL-1ȕ (10 ng/mL final concentration).

Statistical analysis and “high confidence hit” selection. Data were analyzed using
Living Image 3.2 for data acquisition and raw data capture, and PASW Statistics 18 and
MatLab 2011a for data analysis, statistics, and graphing. Circular regions of interest
(ROIs) were drawn around each well and the photon flux at every time point was
measured using Living Image 3.2. This raw data was then imported into PASW and the
data were normalized to the signal at the first timepoint (with or without normalization to
resazurin viability measurements).
Quartile-based analysis method. Descriptive statistics were used to calculate five
parameters describing properties of the amplitude and kinetics of the IțBĮ-FLuc dynamic
profile (Figure 4.5):
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(1) Initial Photon Flux Level (the raw photon flux signal at t = 0 min)
(2) Degradation Level (i.e. the minimum flux or fold-initial signal reached during
IțBĮ-FLuc degradation)
(3) Degradation Time (the time at which minimum occurred)
(4) Re-Synthesis Level (the maximum flux or fold-initial signal achieved during
IțBĮ-FLuc re-synthesis)
(5) Re-Synthesis Time (the time at which maximal re-synthesis occurred)
Two additional parameters were defined and analyzed by linear regression of the IțBĮFLuc re-synthesis phase by considering all 3 replicates at once, but the center point
(between time-of-min and time-of-max) is found for each individual curve.
(6) Re-Synthesis Rate (the slope of re-synthesis between the minimum and
maximum)
(7) Re-Synthesis Lag Time (the value of the x-intercept of the linear regression of the
IțBĮ-FLuc re-synthesis rate)
For each parameter, the median (Q2), first (Q1) and third (Q3) quartile values were
calculated for all fold-initialized values and subjected to plate-by-plate analysis. Upper
and lower boundaries were calculated as Q3 + 2c(Q3 –Q2) and Q1 – 2c(Q2-Q1),
respectively, for c = 1.7239 corresponding to a high stringency targeted error rate (Į =
0.0027) and c = 0.9826 corresponding to a lower stringency targeted error rate (Į=0.046)
[19, 20, 31].

For each run of the screen, data were analyzed plate-by-plate.

The

collections of hits from each independently-run screen were then compared and the
common strong (based on the high stringency error rates) for each parameter are listed in
Table 4.1.
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Log-likelihood analysis method. The cumulative log-likelihood approach quantifies the
deviation of an experimental siRNA treatment from the negative controls (scrambled
negative controls and siGFP). This was done by generating a Gaussian probability
density function at each time point based on the mean and variance of the negative
controls on within a given plate.

We then input each siRNA measurement to this

function to quantify the deviation from the set of negative controls. To combine
replicates, and to later make a cumulative sequence, we prevented computational
rounding error by taking the negative logarithm of the likelihood (log-likelihood) and
summing (log A + log B = log AB). The log-likelihood values were determined
separately for the degradation phase (which was defined as from t = 0 min to the median
time point of the minimum value of the negative controls) and the re-synthesis phase
(defined between the end of the degradation phase to the median time of greatest
downward inflection in the kinetic profile of the negative controls), or cumulatively for
both degradation and re-synthesis. The individual siRNAs from a given plate triplicate
were then ranked according to their negative log-likelihood value and presented as a bar
graph in which each division of the bar height represents the contribution of an individual
time point to the cumulative log-likelihood value (Figure 4.6). In addition, the bars were
colored-coded based on directional replicate agreement, wherein a value of ±3 means all
plates within the triplicate agreed and were either above or below the negative controls,
and a value of ±1 means imperfect agreement with one of the replicates deviating from
the others because it registered differentially above or below the negative controls. This
rank-based method allows for approximate comparison between plates and precise
comparison within each plate.
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siRNA Transfection for Validation of Screen Hits
HepG2 cells were plated (8,000 or 10,000 cells/well) the day before transfection.
Forward co-transfection of siRNA (Qiagen, Inc) and plasmid reporter was achieved using
X-TremeGENE (Roche, Inc.) transfection reagent as per manufacturer recommendations.
Subsequently, 30 uL/well of this mixture was transferred to the cell plates to a final
concentration of 50 ng/well reporter plasmid, 0.8 uL/well X-TremeGENE reagent, and 88
ng siRNA/well in a final volume of 180 uL. Plates were maintained in an incubator for
24 hrs, and then aspirated and 150 uL/well of fresh colorless full media was added. At 48
hours post-transfection, D-luciferin (Biosynth) was added to a final concentration of 150
µg/mL bringing the final volume up to 180 uL/well. Cells were allowed to equilibrate in
this media for 30-60 min before the addition 20 uL/well of TNFĮ (20 ng/mL final
concentration) or vehicle (D-luc imaging media). Bioluminescence measurements were
acquired in an IVIS 100 imaging system (Caliper Life Sciences, Hopkinton, MA) at 37°C
under 5% CO2 flow for 6 hr. Typical acquisition parameters were as follows: acquisition
time, 15-30 sec; binning, 4-8; FOV, 25 cm; f/stop, 1; filter, open; image-image interval, 5
min; total number of acquisitions, 73. Data were analyzed using Living Image 3.2 for
data acquisition and raw data capture, and Excel 2007 for analysis and graphing.
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shRNA Infection for Validation of Screen Hits
Lentivirus expressing constructs (pLKO.1 puro) were obtained pre-synthesized
from the Genome Sequencing Center at Washington University. The targeting sequences
for the 4 shPTPRJ constructs and shGFP are as follows:
Sequence

target

shGFP

GCCACAACATCGAGGACGGCA

19

CCACACAAGCACGTATGACAA

exon 8 (2101-2121)

20

GCCATAGAGTTCAGGACAAAT

spans exon 6 & 7 (1430-1450)

21

CCGATACAATGCCACCGTTTA

exon 6 (1372-1392)

22

CCTACTGTGTCTTGGAATCTA

exon 26 (4778-4798) specific to isoform 1

To generate lentivirus containing hairpins, 500,000 293T cells were pre-plated in 60 mm
dishes and co-transfected the following day with 1 µg of hairpin construct, 900 ng
packaging plasmid pCMV-ǻR8.2, and 100 ng of envelope plasmid pVSVG using Fugene
6. Two days after transfection, virus containing supernatant was collected from 293T
cells and filtered through a 0.45 Pm filter, mixed with 5ug/mL protamine sulfate, and
added to HepG2 cells at 50% confluency in a 10cm2 dish. Media was replenished 12 hrs
post-transduction cells were subsequently maintained in media supplemented with 750
ng/mL puromycin hydrochloride to retain expression of the hairpins. Two days posttransduction, shPTPRJ or shGFP cells were plated in parallel for protein knockdown
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confirmation

(MAB1934)

and

transient

transfection

and

subsequent

imaging

measurements with the țB5oIțBĮ-FLuc reporter as previously described.

PTPRJ Over-Expression Studies
PTPRJ expression constructs were obtained from Dr. Len Maggi who had
previously cloned wild-type PTPRJ cDNA (Open Biosystems) into the pDEST26 vector
backbone to generate pDEST26-His-PTPRJ. The C1239S phosphatase-dead mutant of
PTPRJ was made by site-directed mutagenesis.
HepG2 cells were plated (7,000 cells/well) in black 96 well plates the day before
transfection.

Co-transfection of PTPRJ or backbone control plasmid (75 ng/well),

țB5oIțBĮ-FLuc (50 ng/well) or țB5oIțBĮ-FLuc (25 ng/well), and TKoRLuc
transfection control plasmid (5 ng/well) was achieved using Fugene 6 (Roche, Inc.)
transfection reagent as per manufacturer recommendations. Media was replenished 24
hours post-transfection and imaging was carried out 48 hours post-transfection as
described above for siRNA experiments.
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4.5 FIGURES





Figure 4.1: Schematic of the siRNA Phosphatase Master Plate with Added Controls
96 well plate grid denoting the location of each manually plated control siRNA duplex
(white boxes), the phosphatase library controls (labeled gray boxes), and the
experimental siRNAs (unlabeled gray boxes). The red symbols mark the two controls
wells that were treated with vehicle in the screen.
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Figure 4.2: Schematic Efficient siRNA Transfection and Knock-Down of Luciferase Signal
A test transfection was carried using a test phosphatase siRNA library plate and three plates of pre-plated HepG2 cells. 48
hours post-transfection the cells were stimulated with TNFĮ or vehicle and bioluminescence imaging was carried out for 6 hr
on the IVIS to capture a set of full dynamic IțBĮ. The photon flux from each control well was plotted as fold-initial versus
time.
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Figure 4.3: Timeline of High-Throughput Phosphatase siRNA Screening Procedure
By staggering transfections, the entire phosphatase siRNA library could be screened in 6
days.
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Figure 4.4: Normalized photon flux data from the Qiagen Human Phosphatase
Library 2.0 Plate 1 triplicate.
The raw photon fluxes for each well were normalized as fold-initial and then plotted
against time. The first graph represents the full 6 hr profile; the second graph represents
the degradation phase. The different colored symbols differentiate the data from each
plate triplicate.
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Figure 4.5: Definition of IțBĮ-FLuc dynamic parameters that were evaluated for
modulation by siRNA treatment.
Example IțBĮ-FLuc dynamic profile with corresponding visual representations of the
seven parameters evaluated following the high-throughput siRNA screen.
(1) Initial Photon Flux Level (the raw photon flux signal at t = 0 min)
(2) Degradation Level (i.e. the minimum flux signal reached during IțBĮ-FLuc
degradation)
(3) Degradation Time (the time at which minimum occurred)
(4) Re-Synthesis Level (the maximum flux signal achieved during IțBĮ-FLuc resynthesis)
(5) Re-Synthesis Time (the time at which maximal re-synthesis occurred)
(6) Re-Synthesis Rate (the slope of re-synthesis between the minimum and
maximum)
(7) Re-Synthesis Lag Time (the value of the x-intercept of the linear regression of the
IțBĮ-FLuc re-synthesis rate)
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Figure 4.6: Cumulative Log-Likelihood Normalization Procedure
The cumulative log-likelihood approach quantifies the deviation of an experimental
siRNA treatment from the negative controls (scrambled negative controls and siGFP) by
generating a Gaussian probability density function at each time point based on the mean
and variance of the negative controls on a given plate. We then input each siRNA
measurement to this function to quantify the deviation from the set of negative controls at
each time point. To combine replicates, and to later make a cumulative sequence, we
prevented computational rounding error by taking the negative logarithm of the
likelihood (log-likelihood) and summing (log A + log B = log AB). The individual
siRNAs from a given plate triplicate were then ranked according to their cumulative loglikelihood value and presented as a bar graph in which each division of the bar height
represents the contribution of an individual time point to the cumulative log-likelihood
value. (modified from figure provided by Brandon Kocher)
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Figure 4.7: Primary Phosphatase Screen Hits Chosen for Secondary Screening
The highest stringency hits from each parameter analyzed in the quartile-based analysis
of the primary phosphatase screen (with or without the inclusion of viability
normalization) were combined to generate a master-list of common hits. This collection
of hits was used as the basis for performing a secondary siRNA screen.
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Figure 4.8: Re-Arraying Hits from the Phosphatase Library for Focused Secondary
Screening
Top hits from the primary screen were re-arrayed from the primary phosphatase library
onto a single master plate by the FX liquid handler using a cherry-picking script written
by Jayne Marasa. It was arrayed such that columns 1 and 12 were duplicates of control
siRNAs and Columns 2-6 and 7-11 were duplicates of the 39 strong stringency hits from
the primary screen plus 1 scrambled negative control from the phosphatase library plate.
This master plate was used to transfect 3 identical plates of HepG2 cells. One half of each
cell plate was stimulated with TNFĮ (dark green) and the other half was stimulated with
IL-1ȕ (light green).
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Figure 4.9: Normalized Photon Flux Data From the Secondary Phosphatase Screen.
The raw photon fluxes for each well were normalized as fold-initial and then plotted
against time. The first graph represents the full 6 hr profile; the second graph represents
the degradation phase. The different colored symbols differentiate the data from each
plate triplicate. Orange dashed boxes high-light top hits from the screen analysis.
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Figure 4.10: Validation of siPTPRJ Phenotype and Knock-Down
HepG2 cells were co-transfected with țB5ĺIțBĮ-FLuc and siRNA targeting PTPRJ.
Cells were then stimulated with TNFĮ and imaged for bioluminescence. The photon flux
from each control well was plotted as fold-initial versus time. The inset confirms 50%
knock-down of PTPRJ compared to negative control siRNAs.
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Figure 4.11: Validation of PTPRJ as a Regulator of IțBĮ-FLuc Dynamics by
shRNA-Mediated Knock-Down
HepG2 cells infected with shPTPRJ or control hairpins were transfected with țB5ĺIțBĮFLuc. Cells were then stimulated with TNFĮ and imaged for bioluminescence. The
photon flux from each control well was plotted as fold-initial versus time. While sh21
strongly reproduces the knock-down phenotype observed previously, the other hairpins
only impact IțBĮ-FLuc dynamics weakly if at all. The inset confirms nearly complete
knock-down of PTPRJ with hairpin 21 and 22 and partial knock-down for sh19 and sh20,
compared to negative control shGFP.
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Figure 4.12: Over-Expression of PTPRJ Enhances IțBĮ-FLuc Dynamics
HepG2 cells were co-transfected with țB5ĺIțBĮ-FLuc and wild-type or phosphatase
dead PTPRJ constructs (or vector control). Cells were then stimulated with TNFĮ and
imaged for bioluminescence. The photon flux from each control well was plotted as foldinitial versus time. WT PTPRJ enhanced both IțBĮ-FLuc degradation and re-synthesis,
while the PTPRJC1239S mutant affected only degradation. Error bars represent
propagated standard deviation.
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Figure 4.13: Over-Expression of PTPRJ Decreases Basal NF-țB Transcriptional
Activity, but sensitizes TNFĮ-Induced NF-țB Activity
HepG2 cells were co-transfected with țB5ĺFLuc reporter, TKĺRLuc transfection
control reporter, and wild-type or phosphatase dead PTPRJ constructs (or vector control).
Cells were then stimulated with TNFĮ and imaged for bioluminescence. The basal
photon flux level was calculated as a ratio of FLuc signal over RLuc signal for a given
treatment population. Error bars represent propagated standard deviation.
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4.6 SUPLEMENTAL FIGURES

Supplemental Figure 4.1: Primary Phosphatase Screen Cumulative Log-Likelihood
Plate-By-Plate Ranking
Each plate triplicate was analyzed separately for each run of the phosphatase screen. The
cumulative log-likelihood value for each siRNA within that plate triplicate was then
presented as a bar graph in which each division of the bar height represents the
contribution of an individual time point to the cumulative log-likelihood value. This was
done separately for each run of the screen, with each plate being denoted as 1.n or 2.n to
represent the first and second screen runs. (A-C) Log-likelihood rank graphs from for
plates 1.1, 1.2, and 1.3 considering just the degradation phase (A), just the re-synthesis
phase (B), and both phases together (C). (D-F) Log-likelihood rank graphs from for
plates 2.1, 2.2, and 2.3 considering just the degradation phase (D), just the re-synthesis
phase (E), and both phases together (F).
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Supplemental Figure 4.2: Secondary Screen Cumulative Log-Likelihood Ranking
The cumulative log-likelihood value for each siRNA within the TNFĮ-stimulated plate
triplicate is presented as a bar graph in which each division of the bar height represents
the contribution of an individual time point to the cumulative log-likelihood value.
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4.7 TABLES

PTPRN
PTPRJ
PTPN3
PPP1R3D
PPP1R3C
PPP1R13B
PPP1R12C
PPFIA3
PIB5PA
CDKN3
ALPL

PTPRN
PTPRJ
PTPN3
PSTPIP2
PPP1R1B
PME-1
G6PC3

faster
slower

longer
shorter

Table 4.1: Reproducible High Stringency Hits from the Phosphatase Screen
The strong hits (targeted error rate D = 0.0027) calculated for each IțBĮ-FLuc dynamic
profile parameter using quartile-based analysis. The color indicates where the hit fell in
relation to negative control siRNA treatment. The order of hits within each parameter
does not indicate rank order, though rank order will be determined during secondary
screening.
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Table 4.2: Reproducible High Stringency Hits from the Phosphatase Screen
The strong hits (targeted error rate D = 0.0027) calculated for each IțBĮ-FLuc dynamic
profile parameter using quartile-based analysis. The color indicates where the hit fell in
relation to negative control siRNA treatment. The order of hits within each parameter
does not indicate rank order, though rank order will be determined during secondary
screening.
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Degradation
Plate 1.1
PTPN3
1
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2
PPP2R1A
3
PPP1R2
4
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5
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6
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7
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8
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9
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Plate 1.2
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PPP1R3D
PPM1A
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CDC25C
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Plate 2.1
PTPRN
PTPRH
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PTPRJ
PNKP
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PSTPIP2
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Plate 2.2
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PTPRN
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PTP4A3
PTPRD
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CTDP1
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Plate 3.1
ACPT
PPP1R1B
PTPN5
PPP1R9B
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PPP1R14C
DUSP19
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Plate 3.2
TA-PP2C
PTPDC1
PPP1R1B
PPP1R14C
PTPN5
PPP1R9B
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PLIP
DUSP15
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Plate 2.1
PIB5PA
PTPRJ
PPP1R12C
PTPRN
PPFIA3
PPP1R13B
PPM1E
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PNKP
DUSP14

Plate 2.2
PIB5PA
PPFIA3
PTPRJ
PTPRN
PPP1R12C
PPM1E
PPP1R13B
SKIP
PPP1R14D
PNKP

Plate 3.1
LOC391025
DOLPP1
PLIP
G6PC3
DUSP16
TA-PP2C
LHPP
LPPR2
PPP1R3F
PPP1R1C

Plate 3.2
LOC391025
LPPR2
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PPP1R3F
PPP1R1B
TA-PP2C
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Plate 3.1
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Plate 3.2
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PTPLB
DOLPP1
TA-PP2C
LPPR2
DUSP19
G6PC2
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Re-Synthesis
Plate 1.1
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1
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2
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3
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4
PPP2R1A
5
PPP2R2C
6
PPP1R2
7
PTEN
8
PTPN12
9
10 PTPN7

Plate 1.2
CDKN3
ALPL
PPP1R3D
PTPN3
ALPPL2
PPP1R2
PPP1R3C
PTPN7
CDC25B
PPM1A
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Plate 1.1
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1
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2
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3
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4
PPP1R2
5
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6
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8
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Plate 1.2
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ENPP3
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Plate 2.1
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PPP1R12C
PPFIA3
PTPRJ
PPM1E
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Plate 2.2
PIB5PA
SKIP
PPFIA3
PPM1E
PPP1R14D
PPP1R12C
TENC1
PNKP
PTPRJ
PPFIA4
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Table 4.3: Secondary Phosphatase Screen Top Hits
The top 15 hits from log-likelihood analysis of the secondary phosphatase screen; data
were analyzed for hits within the IțBĮ-FLuc reporter degradation phase alone, the resynthesis phase alone, or both phases combined. PTPRJ is highlighted.

1
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DUSP16
CDKN3
ALPL
fasterrate
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Supplemental Table 4.1: Reproducible Strong & Weak Stringency Hits From the
Phosphatase Screen
Black lettering indicates strong hits (targeted error rate D = 0.0027), while white lettering
denotes weaker hits (targeted error rate D = 0.05) using quartile-based analysis. Black
boxes indicate phosphatases that, for a given parameter, registered as hits in both raw
photon flux data and fold-initial normalized data. The kinetic parameters are listed in
bold, underlined text. The order of hits within each parameter does not indicate rank
order, though rank order will be determined during secondary screening (see above text).
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CHAPTER FIVE
High-Throughput Kinase RNA Interference Screen Identifies
Novel Regulators of TNFĮ-Induced IKK:IțBĮ:NF-țB Negative
Feedback Loop Dynamics

5.1 INTRODUCTION
In resting cells, NF-NB dimers are sequestered in the cytoplasm through binding
to isoforms of the INB family. Canonical activation of NF-NB relies on ligand-dependent
stimulation of IKK, a large heterotrimeric kinase complex containing two catalytic
subunits (IKKD and IKKE) and a regulatory subunit (IKKJ, NEMO) [1, 2]. Many
different surface receptors signal to IKK through multi-protein complexes containing
TRAFs (TNF receptor associated factors which seem to serve as adaptors and may
mediate K63-linked regulatory ubiquitination events) and a multitude of other adaptor
proteins (with specific receptors interacting with specific subsets of TRAFs and other
adaptors) that recruit and activate the IKK complex [1, 3].

Activation of IKK requires

phosphorylation of T loop serines, however, the precise mechanism by which this occurs
(trans-autophosphorylation or through phosphorylation by an upstream kinase) remains a
major unanswered question, and adaptor protein mediated multimerization also seems to
significantly contribute to IKK activation [3]. Upon activation, IKK phosphorylates
IN%D (on Ser 32/36), thus rendering INBD a substrate for poly-ubiquitination and
proteasomal degradation. This series of events releases NF-NB to freely translocate to the
nucleus where it can modulate expression of its target genes, including INBD, thus
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forming a transcriptionally-coupled negative feedback loop [4]. This newly synthesized
INBD enters the nucleus and binds to NF-NB which dissociates from the DNA and the
complex translocates back to the cytoplasm [4-6], and, along with the activity of INBİ,
drive NF-NB nuclear:cytoplasmic oscillations [4, 7, 8]. Thus, this negative feedback loop
plays a major role in regulating the strength and duration of NF-NB transcriptional
activity [9-12]. With respect to negative feedback, other transcriptionally-independent
processes, aimed at auto-inhibition of NF-NB activity, do exist. Such mechanisms downregulate NF-NB signaling on a much shorter timeframe (sec-min).

These include

homologous receptor desensitization [13, 14], asymmetric heterologous receptor
desensitization [14, 15], autocatalytic C-terminal IKK hyperphosphorylation [16] and
protein phosphatase 2E (PP2E)-dependent dephosphorylation of IKK [17].
Given that our țB5oIțBĮ-FLuc reporter has enabled us to study the IKK-IțBĮNF-NB negative feedback loop with high temporal resolution [18], and given that
temporal control of this and other negative feedback loops has emerged as a critical
regulatory component of the intensity and specificity of the NF-NB transcriptional
program [9-12], we sought to perform an RNAi screen to identify novel kinase regulators
of IKK-IțBĮ-NF-NB negative feedback loop dynamics. This information, coupled with
the data acquired in our phosphatase RNAi screen, could add to our understanding of the
opposing effects that kinases/phosphatases might play in activation/de-activation of IKK
(and other members of the NF-NB signaling cascade) [1].
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5.2 RESULTS
Execution of kinase RNAi screen to identify novel regulators of IțBĮ dynamics in
the presence of TNFĮ-induced stimulation.
The screen was performed by co-transfecting the Qiagen Human Kinase
siRNA Library 2.0 (which consists of nine 96 well plates with columns 1 & 12 empty for
user-specified controls) with the țB5oIțBĮ-FLuc reporter in HepG2 cells in 96 well
plate format. A staggered schedule of transfection and imaging was rigorously followed
as the IVIS 100 chamber can only accommodate three 96 well plates per session. The cotransfected cells were stimulated with TNFĮ and imaged for luciferase bioluminescence
under the conditions described above (for more details, see Methods section). This
regimen provided a dynamic read-out with high-temporal resolution, allowing us to
investigate not only changes in the amplitude of degradation and re-synthesis (as typical
high-throughput screens monitor), but also the effect of siRNAs on the kinetic aspects of
the negative feedback loop (i.e. times of maximal degradation and re-synthesis, rate of resynthesis, and re-synthesis lag time). Though other RNAi screens have been published
looking for novel regulators of the NF-țB pathway ([19-21]), most have examined downstream NF-țB transcriptional activity many hours-to-days following pathway stimulation
and none have honed in specifically on the IKK-IțBĮ-NF-țB negative feedback loop or
on the kinetic aspects of NF-țB signaling.
The kinase library was screened once in triplicate with negative and positive
controls on each plate: Qiagen negative control siRNA and siGFP served as negative
controls, siTNFR1 and siPPP2CB were used as biological positive controls as they have
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been previously shown to positively and negatively regulate canonical NF-țB,
respectively.

Rigorous statistical analysis of kinase screen data and identification of highconfidence hits.
Raw photon flux data were normalized as fold initial and subsequently subjected
to various types of statistical analysis in an attempt to utilize the entirety of the complex
dataset. In one method, we characterized the dynamics of țB5oIțBĮ-FLuc responses
under each siRNA treatment and used linear regression to determine maximum reporter
re-synthesis and degradation rates between signal minima and maxima. We then used
quartile-based analysis to find outliers in these parameters. However, these parameters
proved to be problematic as the assumptions behind the regression were not consistently
met by the data. Additionally, quartile analysis was problematic for this experimental set
up: the Qiagen siRNA library is arrayed by function and gene symbol, which results in
clustering related kinases such as members of the MAPK family. Thus, quartile analysis
led to false negative and positive hits based on which groups of kinases were on each
plate.
The cumulative log-likelihood method was undertaken to compensate for interplate variability and the non-random array of siRNAs. This approach quantifies the
deviation of a siRNA treatment from the negative controls and adjusts for confounding
variance that otherwise prevents direct comparisons between plates. More specifically,
we first made a Gaussian probability density function at each time point based on the
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mean and variance of the plate negative controls.

We then input each siRNA

measurement into this function to quantify the normalized deviation from the set of
negative controls. To combine replicates, and to later make a cumulative sequence, we
prevented computational rounding error by taking the logarithm of the likelihood (loglikelihood) and summing (log A + log B = log AB). In general, the greater the difference
from the negative controls the greater the log-likelihood value for that siRNA. This value
correlates with the deviation from negative controls and allowed us more direct
comparison between siRNA plates. The siRNA were then ranked and visualized in a bar
graph in which each division of the bar height represents the contribution of an individual
time point to the cumulative log-likelihood value (Fig. 5.1). Each plate was analyzed for
hits in the degradation phase (Sup. Fig. 5.1), the re-synthesis phase (Sup. Fig. 5.2), and
cumulatively for both degradation and re-synthesis considered together (Sup. Fig. 5.3).
This rank-based method allows for approximate comparison between plates and precise
comparison within each plate.

In addition, the bars were colored-coded based on

Directional Replicate Agreement, wherein a value of ±3 means all plates within the
triplicate agreed and were either above or below the negative controls, and a value of ±1
means imperfect agreement with one of the replicates deviating from the others because it
registered differentially above or below the negative controls. Internal analysis showed
that the top hits according to log-likelihood (highest log likelihood or lowest likelihood)
analysis displayed no plate nor well position preference within plates.
Several known proteins involved in NF-țB signaling were identified as top hits
when considering degradation and re-synthesis together, including: NIK, JAK2, NLK,
SPHK1, KSR2, ROCK2 and MK2 (Figure 5.2). This further confirmed that the log169

likelihood means of analysis could be successfully applied to dynamic time course data
from a high-throughput RNAi screen, and may represent a new paradigm for analysis of
this type of data. In contrast to the phosphatase siRNA screen, a number of strong hits
impacting the IțBĮ-FLuc degradation phase were identified (Sup. Fig. 5.1), including
PRKACB and LIMK1 as positive regulators (i.e. upon knock-down less IțBĮ-FLuc
degradation is seen in comparison to controls, suggesting a role in positively regulating
IKK activity), and GALK1, FER, and GAK as negative regulators (i.e. upon knock-down
greater IțBĮ-FLuc degradation is seen in comparison to controls, suggesting a role in
negatively regulating IKK activity). PRKACB is especially interesting since it was also
identified as positive regulator of IțBĮ-FLuc re-synthesis (Sup. Fig. 5.2). Most of the
strong hits identified for the re-synthesis phase were negative regulators, including JAK2,
JAK3, and DAPK3.

Validation of DAPK3 as a novel regulator of TNFĮ-Induced NF-țB Signaling.
Death associated protein kinase 3 (DAPK3/ ZIPK) was identified as a strong
candidate regulator in the primary screen (Figure 5.2), acting as a negative regulator.
Secondary validation experiments were carried out to confirm that stable knock-down of
DAPK3 by lentivirus shRNA in HepG2 cells reproduced the same phenotype as that
identified in the screen. We confirmed that two independent shRNA constructs targeting
different sequences of the DAPK3 coding sequence showed robust knockdown (>90%)
which correlated with increased țB5oIțBĮ-FLuc re-synthesis levels compared to
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negative controls (~3.3 fold shGFP) upon TNFĮ treatment (Fig. 5.3), consistent with
DAPK3 as a negative regulator of the NF-țB pathway.

5.3 DISCUSSION
The transcription factor NF-NB is a pivotal regulator of innate immunity and
inflammation, and is active in both immune cells and non-immune tissues [22, 23]. In
this capacity, the NF-NB pathway must rapidly decode signals and integrate intracellular
information to control individual cell fate decisions (proliferation, apoptosis,
differentiation, etc.) and regulate the production and secretion of cytokines that can
amplify and propagate the inflammatory response [24, 25]. NFN% dimers are typically
sequestered and held inactive in the cytoplasm through binding to isoforms of the
,N%family, with ,N%D representing the prototypical member and major regulator of
canonical NF-NB activity. TNFĮ-induced stimulation of NF-NB relies on activation of
,N%kinase complex (IKK), which phosphorylates ,N%D, marking it for subsequent
ubiquitination and proteasomal degradation [2]. This series of events liberates NF-NB,
allowing it to undergo nuclear translocation and activation of target gene expression,
including the ,N%D gene itself [26], thus establishing a critical transcriptionally-coupled
negative feedback loop [4]. Furthermore, this negative feedback loop plays a major role
in regulating the strength and duration of NF-NB transcriptional activity [9-12]. Given
that temporal control of this negative feedback loops has emerged as a critical regulatory
component of the intensity and specificity of the NF-NB transcriptional program and that
our țB5oIțBĮ-FLuc reporter has previously enabled us to study the IKK-IțBĮ-NF-NB
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negative feedback loop with high temporal resolution [18] and to run a phosphatase
RNAi screen for novel regulators the feedback loop, we sought to perform an additional
RNAi screen to identify novel kinase regulators of IKK-IțBĮ-NF-NB negative feedback
loop dynamics.
Recently, NF-NB has emerged as a mechanistic link between inflammation and
cancer [27, 28]. This has been extensively studied in the liver where hepatocellular
carcinoma (HCC) slowly unfolds on a background of chronic inflammation (often
triggered by exposure to infectious agents or toxic compounds) [29].

TNFĮ-induced

activation of NFN% signaling plays a pivotal role in liver homeostasis and
pathophysiology due to its capacity to induce both hepatocyte cell death and proliferation
[30, 31]. In the liver, NFN% signaling can have both tumor promoting and tumor
suppressing effects that are dependent upon the type of cells (i.e., liver resident
macrophages vs. hepatocytes), the stimuli, and cell context [29, 32, 33]. Thus, a more indepth understanding of the complexities and intricacies of NFN% signaling in the liver is
required to appropriately translate the use of NFN%-targeted therapeutics to liver
pathologies.
Death associated protein kinase 3 (DAPK3/ ZIPK) was identified as a strong
candidate regulator in the primary screen (Figure 5.2; Fig. 5.1), acting as a negative
regulator of IțBĮ-FLuc dynamics (i.e. showing higher IțBĮ degradation and higher resynthesis upon knock-down; Sup. Fig. 5.3). DAPK3 was validated as a true hit in work
carried out by Brandon Kocher in our lab (Fig. 5.3). DAPK3 is a member of the deathassociated protein (DAPK) serine/threonine kinase family which consists of several
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kinases originally identified in the context of apoptosis [34]. DAPK3 shares 83% amino
acid conservation in its kinase domain with that of DAPK, and is unique among the
DAPK family as it contains a leucine zipper domain and several putative nuclear
localization signals.

Orthologues of DAPK3 have been identified in several lower

eukaryotes such as D. rerio and X. laevis.
Unlike DAPK, there is limited evidence to support a pro-apoptotic role for
DAPK3. Over expression of DAPK3 causes morphological characteristics of autophagylike apoptosis (membrane blebbing, nuclear condensation) that are lost upon mutation of
DAPK phosphorylation sites [35]. DAPK3 is phosphorylated on over 12 serines and
threonines by several kinases most notably DAPK at T299. T299D DAPK3 mutants
display cytoplasmic localization and increased cell death, whereas T299A mutants
display nuclear localization and no significant effects on cell death compared to WT [35,
36]. This suggests that DAPK antagonizes nuclear DAPK3 functions by maintaining it in
the cytoplasm. A larger body of literature suggests that DAPK3 participates in the
positive and negative regulation of gene expression at various levels. In the cytoplasm,
the DAPK-DAPK3 cascade negatively regulates IFN-Ȗ induced inflammatory selective
mRNA translation through activation of an inhibitory RNA binding protein complex [37].
DAPK3 also facilitates STAT3 and AR transcriptional activation through direct or
indirect interactions [38, 39].

DAPK3 localizes to promyelocytic leukemia protein

(PML) nuclear bodies, chromatin, centrosomes, mitotic centrosomes and the contractile
ring during cytokinesis [34]. It is unclear as to how DAPK3 may be regulating NF-țB as
it was identified as a negative regulator of NF-țB, which contrasts with its previously
established role as a transcriptional co-activator. Overall, our preliminary data suggests
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that DAPK3 may play a repressive role in the context of NF-țB transcription/translation
and/or that its transcriptional role is more complex than originally appreciated.
Intriguingly, DAPK is overwhelming down-regulated in many primary tumor
tissues as reported by many groups (hepatocellular, non-small cell lung carcinomas,
renal, leukemia, head and neck, colon, gastric, ovarian cancers and brain metastases)
which correlates with disease reoccurrence and unfavorable prognosis [40-47]. Loss of
DAPK therefore seems to facilitate tumorigenesis, and in part may be explained by a loss
of cytoplasmic-apoptotic DAPK3 and a gain in DAPK3 nuclear activities. This would be
advantageous to a cancer cell as DAPK3 facilitates activation of several HCC oncogenic
transcriptional programs (STAT3 and AR) and DAPK exerts its tumor suppressive
function by presumably preventing DAPK3-mediated activation of these pathways.
Indeed, activation of the IL-6/JAK/STAT3 pathway is hepatoprotective, promotes
compensatory proliferation of hepatocytes and is tumor promoting in carcinogen-induced
mouse models of HCC [48].

Hepatocyte deletion of AR delays the development of

carcinogen-induced HCC indicating that active AR is HCC promoting [49]. In the
context of the screen conditions, TNFĮ induces NF- țB activation which is associated
with cytostatic effects in HepG2 cells [50]. Given that DAPK3 inhibits TNFĮ-mediated
NF- țB activation; this suggests that DAPK3 antagonizes these cytostatic effects thereby
maintaining a proliferative signaling environment in conjunction with STAT3 and AR
pathways. Thus, a better mechanistic understanding of the role of DAPK3 in the NF-țB,
STAT3 and AR pathways is needed as they may represent novel therapeutic targets for a
variety of human cancers. Brandon Kocher, a graduate student in our lab is currently
pursuing further study of DAPK3 and its role in NF-țB pathway regulation.
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Additionally, we are continuing to validate other hits from the kinase screen. Of
particular interest for further study are PRKACB and LIMK1; knock-down of either
results in decreased levels of IțBĮ-FLuc degradation, a rarely observed phenotype in
either the phosphatase or kinase screens. These proteins may a play a role in positively
regulating IKK activity, and thus directly impact the degree of IțBĮ degradation upon
ligand stimulation.

Furthermore, it will be interesting to merge the data from the

phosphatase and kinase screens into a single dataset for analysis in an effort to identify
potentially novel pairs of phosphatases/kinases that similarly regulate the dynamics of the
IKK-IțBĮ-NF-NB negative feedback loop.
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5.4 METHODS
High-throughput primary siRNA screen. siRNA screening was performed in black,
clear-bottomed, 96-well culture plates (Corning 3904) using a Beckman-Coulter Core
robotics system, including an FX liquid handler, controlled by the Sagian graphical
method development tool (SAMI scheduling software). A day prior to transfection, we
manually seeded 10,000 cells in complete medium (DMEM supplemented with 10%
heat-inactivated fetal bovine serum (ǻFBS) and 1% glutamine) at 150 µl/well into three
plates. Plates were maintained in an environmentally controlled incubator until needed
for operations, thereby optimizing health and uniform treatment of all plates. Prior to
transfection, siRNA library plates were thawed from -80C and centrifuged to collect all
liquid into the bottom of the well. Experimental siRNA oligos were pre-arrayed in
columns 2-11 of each plate and individual controls comprising mock-transfected wells,
non-targeting AllStars Negative Control sequence (siNeg, Qiagen Inc.), Firefly
luciferase-targeting PGL3 siRNA (Integrated DNA Technologies, Inc.), TNFR1 targeting
sequences (siTNFR1, Integrated DNA Technologies, Inc.), and a PPP2CA siRNA
(siPP2CA, Integrated DNA Technologies, Inc.) were placed manually in columns 1 and
12.
Forward co-transfection of siRNA and plasmid reporter was performed in
triplicate. First, țB5oIțBĮ-FLuc reporter plasmid was diluted into serum-free media
and transferred onto one siRNA library plate (containing enough siRNA to transfect three
identical cell plates) with a 96 multichannel head on the FX liquid handler and allowed to
incubate for 5 min at room temperature. Next, 50 uL of X-TremeGENE (Roche, Inc.)
transfection reagent, diluted in serum-free media, was added to the plasmid/siRNA
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mixture with a 96 multichannel head on the FX liquid handler, mixed, and allowed to
incubate for 15 min at room temperature. Subsequently, 30 uL/well of this mixture was
transferred to the three previously seeded cell plates to a final concentration of 50 ng/well
reporter plasmid, 0.8 uL/well X-TremeGENE reagent, and 88 ng siRNA/well in a final
volume of 180 uL. Plates were maintained in an incubator for 24 hrs, and then aspirated
and 150 uL/well of fresh colorless full media was added using the FX liquid handler.
At 48 hours post-transfection, D-luciferin (Biosynth) was added using the FX
liquid handler to a final concentration of 150 µg/mL bringing the final volume up to 180
uL/well. Cells were allowed to equilibrate in this media for 30-60 min before the
addition 20 uL/well of TNFĮ (20 ng/mL final concentration) or vehicle (D-luc imaging
media). Bioluminescence measurements were acquired in an IVIS 100 imaging system
(Caliper Life Sciences, Hopkinton, MA) at 37°C under 5% CO2 flow for 6 hr. Typical
acquisition parameters were as follows: acquisition time, 15-30 sec; binning, 4-8; FOV,
25 cm; f/stop, 1; filter, open; image-image interval, 5 min; total number of acquisitions,
73. Immediately post-IVIS imaging, phase contrast photographs were acquired on the
InCell 1000 (three 10X fields of view per well). Cell viability was then determined with
resazurin dye (Sigma R7017) (final conc., 44 µM after a 2 hr incubation at 37ºC as
monitored on a FLUOstar OPTIMA fluorescence reader (BMG Labtech); excitation, 544
nm, emission, 590 nm). This procedure was repeated once for all nine plates of the
Qiagen Human Kinase siRNA Library 2.0.
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Statistical analysis and “high confidence hit” selection. Data were analyzed using
Living Image 3.2 for data acquisition and raw data capture, and PASW Statistics 18 and
MatLab 2011a for data analysis, statistics, and graphing. Circular regions of interest
(ROIs) were drawn around each well and the photon flux at every time point was
measured using Living Image 3.2. This raw data was then imported into PASW and the
data were normalized to the signal at the first timepoint (without normalization to
resazurin viability measurements).
Log-likelihood analysis method. The cumulative log-likelihood approach quantifies the
deviation of an experimental siRNA treatment from the negative controls (scrambled
negative controls and siGFP). This was done by generating a Gaussian probability
density function at each time point based on the mean and variance of the negative
controls on within a given plate.

We then input each siRNA measurement to this

function to quantify the deviation from the set of negative controls. To combine
replicates, and to later make a cumulative sequence, we prevented computational
rounding error by taking the negative logarithm of the likelihood (log-likelihood) and
summing (log A + log B = log AB). The log-likelihood values were determined
separately for the degradation phase (which was defined as from t = 0 min to the median
time point of the minimum value of the negative controls) and the re-synthesis phase
(defined between the end of the degradation phase to the median time of greatest
downward inflection in the kinetic profile of the negative controls), or cumulatively for
both degradation and re-synthesis. The individual siRNAs from a given plate triplicate
were then ranked according to their negative log-likelihood value and presented as a bar
graph in which each division of the bar height represents the contribution of an individual
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time point to the cumulative log-likelihood value (Figure 4.6). In addition, the bars were
colored-coded based on directional replicate agreement, wherein a value of ±3 means all
plates within the triplicate agreed and were either above or below the negative controls,
and a value of ±1 means imperfect agreement with one of the replicates deviating from
the others because it registered differentially above or below the negative controls. This
rank-based method allows for approximate comparison between plates and precise
comparison within each plate.

DAPK3 Validation Studies
Lentivirus expressing constructs (pLKO.1 puro) were obtained pre-synthesized
from the Genome Sequencing Center at Washington University. The targeting sequences
for the 4 shDAPK3 constructs and shGFP are as follows:
#1 - 5’ CGTTCACTACCTGCACTCTAA
#3 - 5’ CATCGCACACTTTGACCTGAA
#5 - 5’GAAGGAGTACACCATCAAGTC
#7 - 5’CGTTCACTACCTGCACTCTAA
shGFP - 5’ CGGGATCACTCTCGGCATGGA
To generate lentivirus containing hairpins, 500,000 293T cells were pre-plated in 60 mm
dishes and co-transfected the following day with 1 µg of hairpin construct, 900 ng
packaging plasmid pCMV-ǻR8.2, and 100 ng of envelope plasmid pVSVG using Fugene
6. Two days after transfection, virus containing supernatant was collected from 293T
cells and filtered through a 0.45Pm filter, mixed with 5ug/mL protamine sulfate, and
added to HepG2 cells at 50% confluency in a 10cm2 dish. Media was replenished 12 hrs
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post-transduction cells were subsequently maintained in media supplemented with
750ng/mL puromycin hydrochloride to retain expression of the hairpins. Two days posttransduction, shDAPK3 or shGFP cells were plated in parallel for protein knockdown
confirmation (Abcam, #ab2057) and transient transfection and subsequent imaging
measurements with the țB5oIțBĮ-FLuc reporter as previously described.
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5.5 FIGURES

Figure 5.1: Cumulative Log-Likelihood Normalization Procedure
A) Representative image of rank based bar graph with cumulative-log likelihood values
for all kinase siRNAs. Hits are arranged in descending cumulative log-likelihood values
from left to right. B) Enlarged plot for top 25 rank based hits, including DAPK3*.
Legend indicates a simple representation of time directionality and time point
contribution to cumulative log-likelihood. Note the y-axis is truncated to allow
visualization of high hit values.
181

A

B

Figure 5.2: Top Kinase Hits from Cumulative Log-Likelihood Analysis of IțBĮFLuc Degradation and Re-Synthesis
A) List of top ranked hits and a description of the known mechanisms by which they
influence the NF-țB pathway. DAPK3 (*) was chosen for secondary validation and
further investigation. (B) siDAPK3 IțBĮ-FLuc dynamic profile from the primary kinase
screen compared to Qiagen negative control siRNA.
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Figure 5.3: Validation of DAPK3 as a Negative Regulator of TNFĮ-Induced IțBĮ
Dynamics
A) Western blot of shRNA knockdown (%GFP = shRNA/COXIV/ shGFP/COXIV) of
DAPK3 in HepG2 cells 3 days post transduction. COXIV protein levels were used for a
loading control. B) Bioluminescence imaging sequence of lentivirus mediated DAPK3
knockdown in HepG2 cells transiently transfected with țB5- IțBĮ-FLuc at 2 days post
transduction. 24 hours post transfection cells were pre-incubated with 150ug/mL Dluciferin and subsequently treated with 10ng/mL of TNFĮ and imaged using the IVIS 50
system at 37ºC under 5%CO2 and atmospheric oxygen. Data provided by Brandon
Kocher.
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5.6 SUPPLEMENTAL FIGURES

Supplemental Figure 5.1 Cumulative Log-Likelihood Ranking of Degradation Phase
Hits from the Kinase Screen
Screen-wide analysis of the top hits identified for the IțBĮ-FLuc degradation phase. The
cumulative log-likelihood value for each siRNA is presented as a bar graph in which each
division of the bar height represents the contribution of an individual time point to the
cumulative log-likelihood value. Data shown represent the hits that differed the most
from negative controls (i.e. have the largest log-likelihood values). Yellow highlighting
denotes two hits discussed in the text, PRKACB and DAPK3.

184

185

Supplemental Figure 5.2 Cumulative Log-Likelihood Ranking of Re-Synthesis
Phase Hits from the Kinase Screen
Screen-wide analysis of the top hits identified for the IțBĮ-FLuc re-synthesis phase. The
cumulative log-likelihood value for each siRNA is presented as a bar graph in which each
division of the bar height represents the contribution of an individual time point to the
cumulative log-likelihood value. Data shown represent the hits that differed the most
from negative controls (i.e. have the largest log-likelihood values). Yellow highlighting
denotes two hits discussed in the text, PRKACB and DAPK3.
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Supplemental Figure 5.3 Cumulative Log-Likelihood Ranking of Combined
Degradation and Re-Synthesis Phase Hits from the Kinase Screen
Screen-wide analysis of the top hits identified for the IțBĮ-FLuc degradation and resynthesis phases combined. The cumulative log-likelihood value for each siRNA is
presented as a bar graph in which each division of the bar height represents the
contribution of an individual time point to the cumulative log-likelihood value. Data
shown represent the hits that differed the most from negative controls (i.e. have the
largest log-likelihood values). Yellow highlighting denotes two hits discussed in the text,
PRKACB and DAPK3.
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CHAPTER SIX
Conclusions and Future Directions
The transcription factor NF-NB is a pivotal regulator of mammalian cell function,
modulating genes implicated in cellular stress responses, proliferation, differentiation,
cell survival and apoptosis, as well as immune and inflammatory responses [1]. Improper
regulation of NF-NB signaling has been implicated in a myriad of human pathological
disorders,

including

cardiovascular

and

neurodegenerative

diseases,

chronic

inflammation, and various cancers [2, 3]. A key regulatory node within canonical NFN%signaling is the IKK:NF-N%:,N%D negative feedback loop that plays a major role in
regulating the strength and duration of NF-N%transcriptional activity [29-32]. In recent
years, bioluminescence imaging has proven an invaluable tool to probe the complex
dynamics of NF-NB signaling both in cellulo and in vivo. Our work utilizing the unique
N%o,N%D-FLuc bioluminescent reporter has focused on understanding how diverse
stimuli (i.e., ligand type, duration, concentration, sequential stimulation, etc.) impact the
IKK:NF-N%:,N%D negative feedback loop in cellulo and in vivo, providing insights into a
key cellular regulatory loop that controls NF-N% nuclear localization dynamics and
transcriptional responses.
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6.1 Identification of a Ligand-Induced Transient Refractory Period in
Nuclear Factor-țB Signaling
Adequate resolution of an inflammatory reaction is as equally important as
initiation. Persistent or fulminant responses can cause detrimental consequences both
locally and systemically [4], and resolution of inflammation is important for both
termination of an acute response as well as for prevention of destructive chronic
responses. In this regard, recent studies have shown that nuclear factor-NB (NF-NB)
signaling plays a critical role in both initiation and resolution of inflammation [5, 6]. The
transcription factor NF-NB is a key regulator of innate and adaptive immune responses, as
well as a mediator of cell survival and proliferation [7]. Improper regulation of NF-NB
contributes to induction and progression of a wide range of human disorders, including a
variety of pathological inflammatory conditions, neurodegenerative diseases, and many
ypes of cancer [3, 8]. Considering the complex nature of the inflammatory milieu, one
would expect that stationary tissue-residing cells are exposed to a myriad of temporallydistinct NF-NB-stimulating cues. Central to any signaling desensitization mechanism is a
refractory period during which cells cannot fully respond to a second insult (autologous
or heterologous desensitization). Therefore, consideration of the dynamic pattern of
stimulus exposure described above begs the immediate question of whether cells can
instantly initiate an NF-NB response to a second activating stimulus, and if not, when will
such cells be able to remount a full response again? Specifically, are ligandpreconditioned cells capable of eliciting NF-NB activation to the same extent as naïve
cells?
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To study in real time the temporal regulation of NF-NB and its major regulator,
inhibitor of NF-NB D (INBD), we developed, characterized, and utilized a novel
transcriptionally-coupled INBD-firefly luciferase fusion reporter (N%o,N%D-FLuc) that
recapitulated the activity of the endogenous IKK:NF-N%:,N%D negative feedback loop.
We then utilized this reporter to characterize the dynamics and responsiveness of INBD
processing upon a short 30 sec pulse of tumor necrosis factor D (TNFD) or a continuous
challenge of TNFD following a 30 sec preconditioning pulse. Strikingly, a 30 sec pulse
of TNFD robustly activated inhibitor of NF-NB kinase (IKK), leading to INBD
degradation, NF-NB nuclear translocation, and strong transcriptional up-regulation of
INBD. Furthermore, we identified a transient refractory period (lasting up to 120 min)
following preconditioning, during which the cells were not able to fully degrade INBD
upon a second TNFD challenge. Kinase assays of IKK activity revealed that regulation of
IKK activity correlated in part with this transient refractory period. In contrast,
experiments involving sequential exposure to TNFD and interleukin-1E (IL-1E) indicated
that receptor dynamics could not explain this phenomenon. Utilizing a well-accepted
computational model of NF-NB dynamics, we further identified an additional layer of
regulation, downstream of IKK, that may govern the temporal capacity of cells to
respond to a second pro-inflammatory insult. Overall, the data suggested that nuclear
export of NF-NB:INBDcomplexes represented another rate-limiting step that may impact
this refractory period, thereby providing an additional regulatory mechanism. Since
completion of this work [9], the existence of this transient TNFD-induced refractory
period has been confirmed by others [10, 11].
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Our study highlights the multifaceted regulation of NF-NB signaling and sheds light
on the refractory nature of INBD processing as a route to transiently desensitize NF-NB
activity upon subsequent rounds of stimulation. Rapid and transient deactivation of IKK
activity as well as temporal reduction in its capacity to respond to a subsequent challenge
(IKK responsiveness) seems to play a crucial role in this process. Previous studies
indicated that both the amplitude and the timing of IKK activation affect not only the
intensity of NF-NB-dependent transcription, but also the specificity of the transcriptional
response [12, 13]. This indicated that besides resolution of the inflammatory response and
induction of a refractory period (temporally preventing subsequent rounds of INBD
degradation upon re-stimulation), rapid down-regulation of IKK activity [14] plays a
pivotal role in determining the type of elicited transcriptional program. In the present and
previous studies [15], we demonstrated that dynamic bioluminescence imaging of INBDFLuc reporters in live cells provides robust and accurate readouts of ligand-induced INBD
dynamics. In effect, real time bioluminescence imaging was equivalent to performing
continuous on-line Western blots of INBD at five minute intervals.

6.2 Synchronicity of the IțBĮ:NF-țB Negative Feedback Loop In
Cellulo and In Vivo
Cells have evolved complex signaling networks that sense cues from the
environment and transduce this information to elicit appropriate biological responses
[16]. These networks equip cells with sensitive, reversible, regulated, and robust
responses to a variety of signaling activators; in particular, these networks can confer on
cells the ability to distinguish weak signals from background noise with high precision
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and selectivity [17, 18]. The NF-N% signaling pathway and its downstream transcriptional
targets are responsive to a large number of different stimuli [7], and recent work has
focused on NF-N% pathway responsiveness to the mode of stimulation (i.e., stimulus
concentration, pulse duration, or pulse interval). Particularly relevant during cellular
responses are inflammatory cytokines, such as TNFĮ, which are likely perceived as
transient pulses or waves of TNFĮ occurring over a wide range of concentrations [9, 10,
12, 19-21]. Recent studies have shown that continuous stimulation or sequential pulsing
of TNFĮ can induce oscillations in NF-N% nuclear translocation that are dependent upon
cycles of degradation and re-synthesis of INB proteins (i.e., negative feedback loops), and
that the frequency of these NFN% oscillations encode distinct gene expression profiles
[10, 22-25]. Additionally, the amplitude of NF-N% activity, but not the temporal profile,
is particularly sensitive to changes in TNFĮ concentration and is crucially dependent on
the transient nature of IKK activity [14].

Single cell imaging of NF-N% nuclear

localization (as monitored by nuclear:cytoplasmic shuttling of NF-N% proteins fused to
fluorescent protein reporters) and computational modeling have suggested that single
cells exhibit stochastic, heterogeneous, and paracrine NFN% responses, especially in
response to low concentrations of TNFĮ [20, 21, 26, 27]. A key unresolved issue in the
field relates to how biological robustness is achieved within cell populations displaying
heterogeneous and dynamic single-cell behavior [26-28], and the physiologic relevancy
of these single-cell phenomena to tissue- and organ-level biological responses in vivo.
We exploited the unique characteristics of the N%o,N%D-FLuc negative
feedback loop reporter to rigorously characterize dynamic ,N%D responses in single cells,
populations of cell, and in vivo upon stimulation with a range of TNFĮ concentrations
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and pulses. Remarkably, modulation of either TNFĮ pulse duration or concentration
produced highly complex and reproducible patterns in ,N%D-FLuc dynamics that did not
change significantly when measured in single cells versus cell populations. Single cell
responses were highly synchronous upon stimulation with TNFĮ pulses or medium-tohigh range TNFĮ concentrations. Individual cells exhibited synchronized ,N%D-FLuc
degradation and re-synthesis kinetics, even though the amplitudes of degradation and resynthesis varied greatly. Of particular note was the observation in cell populations that
pulses of TNFĮ tended to elicit very broadly shaped ,N%D-FLuc re-synthesis peaks,
whereas continuous TNFĮ stimulation elicited a more defined peak that occurred earlier.
These same trends were observed for single cell ,N%D-FLuc dynamic profiles, indicating
that broad re-synthesis peaks and complex kinetics are inherent properties of single cells
rather than the sum of heterogeneous single cell behaviors. Furthermore, we discovered
that these complex ,N%D re-synthesis patterns resulted from the continuous presence of
TNFĮ initiating re-activation of IKK and driving secondary rounds of ,N%D degradation.
After rigorous characterization of the TNFĮ-induced response patterns of the
N%o,N%D-FLuc reporter in single cells and cell populations in culture, we took
advantage of the amenability of luciferase reporter imaging in vivo to interrogate TNFĮinduced activation of the ,N%D:NF-N% negative feedback loop within mouse livers. Our
data indicated that circulating TNFĮ, administered at varying doses, produced ,N%D
dynamic behaviors in vivo with synchronized kinetics and very high levels of ,N%D resynthesis and broad re-synthesis peaks, patterns that were consistent with in cellulo
experiments in which TNFĮ pulse duration was varied. Thus, even though TNFĮ was
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administered at varying doses in vivo, this data strongly suggested that circulating TNFĮ
is perceived by hepatocytes in vivo as a pulse.
Thus, while several in silico and in vitro studies have demonstrated highly
heterogeneous and/or asynchronous NF-N% responses to TNFĮ at the single cell level that
are largely masked when individual cells are averaged together into populations [10, 2022, 24, 27], our single cell, cell population, and in vivo data indicated that ,N%D
degradation and re-synthesis is surprisingly robust and synchronous. These data, coupled
with the low frequency at which we observed ,N%D-FLuc oscillatory behavior, place
reservations on the physiologic relevance of the highly heterogeneous and oscillatory NFN% behaviors observed during continuous TNFĮ stimulation of single cells. On the other
hand, our data do support the relevancy of the synchronous NF-N% oscillatory behaviors
that are observed upon sequential TNFĮ pulsing and that drive frequency-encoded
transcriptional programs [10, 21].
Thus, our work revealed that the NF-N%:,N%D negative feedback loop exhibits
differential and reproducible dynamic patterns in response to modulating TNFĮ
concentration or pulse duration, and that responses to TNFĮ exhibited a remarkable
degree of synchronicity at the level of single cells, cell populations, and in vivo.

6.3 High-Throughput Phosphatase and Kinase RNA Interference
Screens Identify Novel Regulators of TNFĮ-Induced IKK:IțBĮ:NF-țB
Negative Feedback Loop Dynamics
It is currently believed that activation/de-activation of IKK (and other members of
the

NF-NB

signaling

cascade)

is

regulated
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by

the

opposing

effects

of

kinases/phosphatases [29], and although more is known about the mechanisms by which
kinases act during NF-NB signaling, much less is known about the role of phosphatases in
regulating members of the NF-NB signal cascade. A number of phosphatases have been
implicated in negative regulation of IKK activity and in regulation of NF-NB activity
(including PP2Cȕ, PP2A, PP1, PPM1A, PPM1B and WIP1), and they often operate to
counteract the activity of a kinase. Study of these phosphatases has revealed differential
activity dependent on stimulus and cell specificity, redundant or compensatory pathways,
and positive and negative regulatory roles (occasionally based on conflicting evidence;
for example, PP2A has been posited by some to be a positive regulator of IKK and others
claim it to be a negative regulator) [30-39]. Furthermore, an RNAi phosphatase library
was recently utilized to identify unknown phosphatase regulators of NF-NB
transcriptional activity in mouse astrocytes [37]. The authors identified 19 phosphatases
that activate or suppress NF-NB activity 6-8 hours post-TNFĮ stimulation; their work
indicated that the PP2A catalytic subunit interacts with and inactivates IKKȕ, however,
this function was not conserved in the context of human cell lines [36].
Given that our țB5oIțBĮ-FLuc reporter has enabled us to study the IKK-IțBĮNF-NB negative feedback loop with high temporal resolution [9], and given that temporal
control of this and other negative feedback loops has emerged as a critical regulatory
component of the intensity and specificity of the NF-NB transcriptional program [10, 12,
19, 40], we sought to perform ambitious phosphatase and kinase RNAi screens to identify
novel regulators of IKK-IțBĮ-NF-NB negative feedback loop dynamics, and possibly
new pairs of phosphatases/kinases that act in concert [29]. In addition to developing a
novel method by which high-throughput robotic RNAi screening strategies can be used to
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assay for alterations in the dynamics (both amplitude and kinetics) of the IKK:IțBĮ:NFțB negative feedback loop, we concurrently developed an analytical method, cumulative
log-likelihood analysis, capable of simultaneously analyzing many or all data points
along the IțBĮ-FLuc profiles and that afforded us the ability to rigorously evaluate and
identify hits within these complex datasets.
We observed many different țB5oIțBĮ-FLuc profiles in the screens, some with
vastly different shapes than seen under control siRNA treatment (Fig. 4.4), highlighting
the large number and diverse activities of kinases and phosphatases regulating the NF-țB
pathway. Separate analysis of the phosphatase and kinase siRNA screens identified a
number of novel regulators whose knock-down either attenuated (phosphatases PTPN3,
PTPRJ, and PTPRN; kinases PRKACB and LIMK1) or enhanced (phosphatases CDNK3,
PPFIA3, ENPP3, SKIP and PPP1R3D; kinases GALK1, FER, GAK, JAK2, JAK3, and
DAPK3) TNFĮ-induced activation of the IKK-IțBĮ-NF-NB negative feedback loop.
Both PTPRJ and DAPK3 have been validated and are the subjects of current
investigations to understand the physiological and/or pathophysiological relevance in NFțB, especially in the context of TNFĮ signaling during cancer and inflammation in the
liver.
Additionally, we are continuing to validate other hits from the screens.

Of

particular interest for further study are the kinases PRKACB and LIMK1; knock-down of
either resulted in decreased levels of IțBĮ-FLuc degradation, a rarely observed
phenotype in either the phosphatase or kinase screens. These proteins may play a role in
positively regulating IKK activity, and thus directly impact the degree of IțBĮ
degradation upon ligand stimulation. Furthermore, it will be interesting to merge the data
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from the phosphatase and kinase screens into a single dataset in an effort to identify
potentially novel pairs of phosphatases/kinases that similarly regulate the dynamics of the
IKK-IțBĮ-NF-NB negative feedback loop.
In conclusion, our studies using dynamic, real-time bioluminescence imaging
have demonstrated the utility of employing bioluminescent reporters alongside traditional
biochemical assays, in silico modeling, and cell/molecular biology techniques to
rigorously interrogate how diverse stimuli (i.e., ligand type, duration, concentration,
sequential stimulation, etc.) impact the IKK:NF-N%:,N%D negative feedback loop in
single cells, cell populations, and at the organ- and tissue-level in vivo.
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